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Prostaglandins are an important class of naturally occurring molecules which have 
multifaceted biological functions and widespread medical applications.  Chapter 1 discusses 
the development of concise syntheses of four ∆12-Prostaglandin J natural products, enabled 
by convergent stereoretentive cross-metathesis by Ru-based metathesis catalyst.  Exceptional 
control of alkene geometry was achieved through stereoretention.  Short syntheses (7–8 steps 
in longest linear sequences) were realized in a modular approach.  An improved route using 
enzymatic resolution to obtain enantiopure 15d-PGJ2 was also discussed.  
Chapter 2 discusses a mild palladium-catalyzed aerobic intramolecular aminoacetoxylation 
method.  Pyrrolidine and indoline derivatives were synthesized using molecular oxygen as 
oxidant mediated by catalytic NOx species, which acts as an electron transfer mediator to 
access high-valent palladium intermediate as the presumed active oxidant. 
Chapter 3 presents a new, robust synthesis of gem-dialkyl acyclic diene monomers with low-
cost.  Telechelic gem-dialkyl polyethylenes can be made by the metathesis polymerization 
of the gem-dialkyl acyclic diene monomers, followed by hydrogenation.  These polymers 
feature low glass transition temperature and can be used as elastomers in the synthesis of 
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∆12-Prostaglandin J family is a type of secondary metabolite isolated in cell culture, and is 
recently discovered to have potent anticancer activity.  Concise syntheses of four ∆12-Prostaglandin 
J natural products (7–8 steps in the longest linear sequences) are developed, enabled by convergent 
stereoretentive cross-metathesis by Ru-based metathesis catalyst.  Exceptional control of alkene 
geometry was achieved through stereoretention.   
 
1.1  INTRODUCTION 
Prostaglandins are an important class of naturally occurring molecules that are found in 
mammalian tissues and exhibit a broad range of biological functions and widespread medical 
applications.1   The recently discovered ∆12-prostaglandin J family (1–4, Figure 1.1.1) features a 
unique cross-conjugated dienone motif and has multifaceted biological properties that are uniquely 
different from other components of the PG family and have appealing anti-cancer activity.2 
                                               
† Adapted with permission from Li, J.; Ahmed, T. S.; Xu, C.; Stoltz, B. M.; Grubbs, R. H. “Concise Syntheses of 
Δ12-Prostaglandin J Natural Products via Stereoretentive Metathesis”, J. Am. Chem. Soc., 2019, 141, 154–158 
Copyright © 2019, American Chemical Society 
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Figure 1.1.1. Structures of ∆12 Prostaglandin J Natural Products
 
The proposed biosynthetic pathway to ∆12-prostaglandin J family is shown in Figure 1.1.2.  
Arachidonic acid (ARA) is released from membrane phospholipids, and then is converted by 
cyclooxygenase (COX; also known as PGH synthase) to PGH2.  This pivotal intermediate is 
converted enzymatically to a variety of biologically active prostaglandins, including PGD2 , PGΕ2, 
PGF2α , and PGI2.  PGD2 can spontaneously undergo non-enzymatic dehydration and isomerization  
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to form ∆12-PGJ2.3  Further dehydration by loss of the 15-hydroxyl group results in the formation 
of 15d-PGJ2.  A similar biosynthetic pathway was known to account for the formation of ∆12-PGJ3 
from the ω-3 eicosapentaenoic acid (EPA, Figure 1.1.2).4  
 
15d-PGJ2 is the most well-studied cyclopentenone prostaglandin and is reported to exert 
its effects on cells by binding the peroxisome proliferator activated receptor.  It was demonstrated 
for the first time in 1995 that 15d-PGJ2 is an endogenous ligand for PPAR-γ.5  15d-PGJ2 up-
regulates the expression, transcriptional activity, and DNA binding activity of PPAR-γ, and many 
of other cellular events mediated by 15d-PGJ2 have been shown to be PPAR-γ-dependent.6  PPARs 
are a family of ligand-activated nuclear transcription factors, which modulate gene expression 
through binding to specific DNA sequences, termed PPAR response elements (PPREs) in the 
enhancer regions.  PPARs play an important role in physiological processes such as adipogenesis, 
glucose metabolism, and macrophage function, and also in regulation of cancer cell proliferation, 
survival, apoptosis, and tumor growth.7  Crystallography data showed that 15d-PGJ2 is the natural 
high affinity ligand to PPAR-γ and can form a covalent bond with cysteine C285 through a Michael 
addition (Figure 1.1.3) at C13.  Furthermore, the carboxyl group of 15d-PGJ2 is required for the 
formation of a hydrogen bond with Y327 residue.8 
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Figure 1.1.3. 15d-PGJ2 Bind to PPAR-γ	9	
 
∆12-PGJ3 (3) was recently identified in 2011 to have activity against leukemia stem cells 
with high potency, without adverse activity against the normal cells.4  The interest in cancer stem 
cells (CSCs) is due to their inherent resistance against conventional chemotherapies which allow 
for relapse and metastasis.  ∆12-PGJ3 showed impressive in vitro potency and selectivity of against 
chronic myelogenous leukemia (CML) stem cells (IC50 = 12 nm), and exceptional ability to 
effectively cure this form of leukemia in a mouse model.  Studies of its stability, bioavailability, 
and hypersensitivity make ∆12-PGJ3 a lead compound for further investigation in search of new 
therapies for the treatment of acute and chronic myelogenous leukemia (AML and CML).10  
 
1.2  PRIOR SYNTHETIC EFFORTS 
 
Efforts directed toward the synthesis of various prostaglandins has had a profound effect 
on the development of new strategies and tactics employed in the field of synthetic chemistry, 
emanating from the seminal studies of Corey beginning in the 1960’s.11   Elegant contribution to 
the total synthesis of ∆12-PGJ3 (3) was reported by Nicolaou and co-workers in 2014 (Scheme 
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1.2.1).12  The synthesis of cyclopentenone fragment 8 began with the preparation of racemic 
acetate by reduction of commercially available 2-cyclopentenone followed by acetylation.  The 
C8 stereocenter was introduced by asymmetric Tsuji–Trost allylic alkylation of racemic acetate 5 
with dimethyl malonate in the presence of [(η3-C3H5)PdCl]2 (0.5 mol%) and (S,S)-DACH-phenyl 
Trost ligand (1.5 mol%).  The enantio-enriched dimethyl ester 6 was obtained in 71% yield and 
97% ee.  Upon a 4-step process, aldehyde 7 can undergo Wittig reaction with 2.5 equivalents of 
IPh3P(CH2)5OPMB in the presence of NaHMDS at –78 ºC, furnished the desired Z-alkene in high 
yield (79%) and good Z-selectivity (Z/E ≥ 10:1), which was converted to enone fragment 8 by PCC 
oxidation.  To construct the ω-chain aldehyde, Mukaiyama aldol reaction with hex-3-ynal (10) and 
TMS-protected acetal 11, in the presence of (R)-NOBIN catalyst developed by Carreira and co-
workers13 could afford homopropargylic alcohol 12 in 72% yield and 95% ee.  Protection of the  
 












































































12: R = H
13: R = TBSTBSCl (88%)
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secondary alcohol with TBS group, semi-hydrogenation of the alkyne (H2, Lindlar catalyst, 
quinoline) followed by DIBAL-H reduction provided ω-chain aldehyde 14 as the only geometrical 
isomer.  At this stage, regioselective deprotonation of cyclopentenone 8 at the C12 position was 
achieved with LDA at –78 ºC, then ω-chain aldehyde 14 was added, and the aldol product was 
generated (79%) as a pair of C13 epimers (ca. 3:1 d.r.).  Treatment of the aldol product with a 
mixture of MsCl and Et3N gave the corresponding mesylate, which did not undergo β-elimination 
even with excess amount of Et3N.  By adding activated commercial neutral alumina, the cross-
conjugated dienone intermediate 15 can be formed when while leaving the OTBS group intact.  
∆12-PGJ3 (3) can be prepared in three additional steps. 
 
In 2016, Nicolaou and co-workers reported a streamlined synthesis of ∆12-PGJ3 (Scheme 
1.2.2).14 The synthesis commenced with the preparation of ω-chain aldehyde 14 in a modified 
route.  Ring-opening of chiral epoxide 16 with lithium acetylide under Lewis acidic conditions, 
and TBS protection of secondary alcohol formed 17.  Reduction of alkyne in 17 with nickel acetate 
furnished the desired Z-alkene.  Deprotection of the primary alcohol with DDQ, followed by DMP 
oxidation furnished the ω-chain aldehyde 14.  The α-chain fragment was prepared from terminal 
alkyne 18, which was alkylated with formaldehyde to produce propargyl alcohol 19.  Then, the 
alkyne was reduced to the Z-alkene in the same conditions with nickel acetate.  The allylic alcohol 
was subjected to Appel conditions to provide allylic bromide 20.  Chiral induction of C8 was 
achieved by introducing L-menthol to cyclopentanedione 21 to form the vinyl ether 22.  Alkylation 
of 22 with allyl bromide 20 formed two diastereomers (23:24 ca. 1:2.2) favored the β-H at C8 
position.  The undesired diastereomer 23 could be epimerized to 24 when subjected to KOt-Bu, 
which resulted in 1:1 ratio of two epimers.  DIBAL-H reduction and hydrolysis elaborated enone 
25, which can undergo aldol reaction with ω-chain aldehyde 14 in the presence of LDA.  MsCl 
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and excess amount of DMAP can eliminate the secondary alcohol of aldol product to form 
intermediate 26.  Global deprotection under aqueous HBF4 gave ∆12-PGJ3 (3) in excellent yield 
(92%, Scheme 1.2.2).  A number of ∆12-PGJ3 analogues were also accessible via this streamlined 
route by Nicolaou and co-workers in 2016, which enabled a comprehensive structural-activity 
relationship (SAR) study of their anti-cancer activities.15 
 
Scheme 1.2.2. Nicolaou’s 2nd Generation Synthesis of ∆12 Prostaglandin J3 
 
 
In 2018, the Aggarwal group reported a synthesis of ∆12-PGJ3 features an L-Proline 
catalyzed homodimerization of succinaldehyde to form a key intermediate 27 in high 
enantioselectivity (99:1 e.r., Scheme 1.2.3).16  Upon a six-step process, 27 was converted into the 
previously reported enone fragment 25.  The ω-chain aldehyde was prepared from asymmetric 
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in good yield and enantioselectivity (79% over 2 steps, 93:7 e.r.).  Similar to the previous 
approaches by Nicolaou and co-workers, an aldol reaction was performed with enone fragment 25 
and aldehyde 29 in the presence of 2.0 equivalent of LDA.  Then the crude reaction mixture from 
the aldol reaction was treated with MsCl and Et3N to give the corresponding mesylate, and 
subsequent elimination upon reaction with DBU produced exclusively the E-configured 
elimination product.  Subsequent oxidation with NaBO3•4H2O gave the late stage intermediate 31.  
Finally, treatment of 31 with aqueous HBF4 gave ∆12-PGJ3 (3) in 75 % yield.  
 
Scheme 1.2.3. Aggarwal’s Synthesis of ∆12 Prostaglandin J3 
 
 
Synthetic efforts toward ∆12-PGJ2 and 15d-PGJ2 compounds began in 2003, with a 
number of syntheses reported through various approaches.17   In 2019, the synthesis of ∆12-PGJ2 
was enabled by a concise approach using Z-selective cross-metathesis by Nicolaou and co-
workers (Scheme 1.2.4).18   Stereoselective conjugate addition of enantiomerically pure enone 
(+)-33 with the allyl cuprate reagent generated from allyl magnesium bromide, CuI and LiCl in 
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enantiopure intermediate 34 in 77% yield over the two steps.  Chiral epoxide 16 was reacted with 
n-BuMgBr in the presence of CuI to form the secondary alcohol 35 (72% yield).  Protection of 
35 with TBS group furnished the TBS-ether 36 (90% yield).  Removal of the PMB group of 36 
with DDQ followed by oxidation with DMP elaborated the ω-chain aldehyde 37  in 76% over 2 
steps.  Then the dienone intermediate 38 was obtained by aldol reaction of 34 and aldehyde 37 
with LDA, followed by the treatment with MsCl and DMAP.  Subjecting 38 with to an excess 
amount of tert-butyl ester 39 with 10 mol% loading of Z-selective metathesis catalyst Ru-2, 
furnished the protected ∆12-PGJ2 derivative 40 in 42% yield (>95:5 Z/E, 52% recovered starting 
material 38, 90% yield based on recovered enone 38), which was exposed to aqueous HBF4 to 
reveal ∆12-PGJ2 (1) in 71% yield.  This work presented a shorter synthetic sequence to ∆12-PGJ2 
and its analogs, and the dimeric, trimeric, and tetrameric macrocyclic lactones consisting of ∆12-
PGJ2 units were prepared for the biological evaluation of those compounds. 
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1.3  INTRODUCTION OF STEREORETENTIVE METATHESIS 
 
Olefin cross-metathesis is a convergent method for building C–C double bonds in natural 
product syntheses.19  Most importantly, conventional metathesis catalysts typically gave imperfect 
control of alkene geometry.  Previous syntheses relied on the semi-hydrogenation of alkynes or 
Wittig reactions, requiring multi-step functional group manipulation with concomitant waste 
generation.  From a strategic perspective, chemoselectivity among multiple alkenes has also been 
another concern, especially in the later stages.  Stereo- and chemoselective metathesis catalysts are 
in demand to realize a convergent synthesis from simple alkene building blocks.  However, it has 
seldom been applied in the previous syntheses of ∆12-PGJ family.  
Figure 1.3.1. Structures of Z-selective and Stereoretentive Metathesis Catalysts 
 
A series of cyclometallated ruthenium-based catalysts (e.g. Ru-1, Ru-2, Figure 1.3.1) were 
recently developed by Grubbs and co-workers,  which enable Z-selective metathesis through a 
favored syn-metallacyclobutane intermediate (Figure 1.3.2, Path A).20  More recently, catechodi-
thiolate-based catalyst Ru-3 and its dithiolate variants were developed by Hoveyda group and 
showed high Z-selectivity in ring-opening metathesis polymerizations, ring-opening cross-
metathesis, and cross-metathesis with Z-olefins.21   In fact, high kinetic E-selectivity in cross-
metathesis with E-starting materials was also observed with Ru-3, the sIPr analogue Ru-4, and 
other less bulky fast-initiating analogues developed by Materia, Inc. and the Grubbs group,  that 
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formation of a side-bound metallacyclobutane intermediate, of which the α-substituents are forced 
down to minimize steric interactions with the bulky N-aryl groups of the NHC.  As a result, when 
starting with Z-alkenes, the α-substituent points down to generate Z-alkene products (Figure 1.3.2, 
Path B).  When starting with E-alkenes, however, the β-substituent has to point up into the open 
space between two N-aryl groups, leading to the generation of E-alkene products, albeit with 
slower rates (Figure 1.3.2, Path C).  Cross-metathesis between two terminal alkenes is not possible 
with stereoretentive metathesis catalysts, however, because the intermediate methylidene species 
are unstable and lead to catalyst decomposition.  A methylene capping strategy was recently re-
ported as a remedy to this problem, enabling the cross-metathesis of two terminal alkenes.23    
Despite the unique properties of these stereoretentive catalysts, to date, limited synthetic 
evaluation has been conducted with Ru-based stereoretentive catalysts,24 as well as with Mo, W-
based catalysts.25  Total synthesis of the olefin-enriched Δ12-prostaglandin J natural products 1–4 
sets a perfect test ground to evaluate the reactivity, chemoselectivity, and functional group 
compatibility of these newly developed metathesis catalysts. 
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1.4   RESULTS AND DISCUSSIONS 
1.4.1 Total Synthesis of ∆12-PGJ2, 15d-PGJ2, ∆12-PGJ3, and 15d-PGJ3  
Retrosynthetically, ∆12-PGJ3 (3) for example can be simplified into a truncated 
prostaglandin structure 56 by use of stereoretentive metathesis (Scheme 1.4.1).  A three-
component coupling strategy26 can be applied toward the synthesis of 56, using a relatively simple 
and commercially available allyl Grignard reagent, ω-chain aldehyde 14, and a chiral 
cyclopentenone (R)-43.  The O-Boc group of (R)-43 can be used as a traceless stereoinductive 
group to set the C8 stereocenter and give the desired enone moiety.27 
 
Scheme 1.4.1. Retrosynthetic Analysis 
 
 
To construct chiral 4-hydroxyl-cyclopentenone (R)-42, asymmetric reduction with (R)-
BINAL-H reagent developed by Noyori and co-workers28 was firstly investigated.  However, this 
reaction resulted in low yield of the alcohol product (R)-42, and required tedious cryogenic 
conditions.  Alternatively,  Boc-protected chiral cyclopentenone (R)-43 was prepared from furfuryl 
alcohol in a three-step process.  Kinetic resolution in the presence of Pd2(dba)3 and (R,R)-DACH 
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Scheme 1.4.2. Synthesis of (R)-43 
 
Then, CuBr•Me2S and LiCl facilitated the diastereoselective conjugate addition of the allyl 
magnesium bromide.  The enolate formed can then be trapped by the subsequently added 
commercially available trans-2-octenal, and the O-Boc group was eliminated in the course of the 
aldol reaction to form the desired cyclopentenone motif.  The enal functionality of the aldehyde 
was well tolerated in the aldol step.  Elimination with MsCl and DMAP favored 12E-product 44 
as the major product in reasonable yield (41% over 2 steps, Scheme 1.4.3).  
Scheme 1.4.3. Synthesis of 44 by Three-component Coupling 
 
Stereoretentive metathesis was then evaluated on 44.  Since 44 cannot react with another 
terminal alkene using stereoretentive metathesis catalysts, we considered a symmetric Z-alkene 46 
as the coupling partner, which could also be made by homodimerization of readily available 45 
through stereoretentive metathesis.  However, the homodimerization reaction only gave 50% 
conversion in the ambient pressure because of the thermodynamic equilibrium (Table 1.4.1, entry 














































1. CuBr.Me2S, LiCl, allylMgBr
    THF, –78 ºC
    then trans-2-octenal, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
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mixture.  Performing the reaction under static vacuum gave 62% conversion, in which conditions 
cis-3-hexene still cannot be effectively removed (Table 1.4.1, entry 2).  Decreasing the pressure 
will result in higher conversion (Table 1.4.1, entry 3–5), and using high boiling solvent such as 
toluene could ensure full conversion.  With 1 mol% loading of Ru-4 as the catalyst, 98% 
conversion could be achieved by applying dynamic vacuum to remove the by-product, cis-3-
hexene (Table 1.4.1, entry 6).  Next, 44 with an additional 5 mol% catalyst Ru-4 were added into 
the reaction mixture, and the alcohol product 47 could be isolated in 95% yield in high Z-selectivity 
(>99% Z).  This result established the efficacy of an efficient one-pot, stereoretentive 
homodimerization/cross-metathesis strategy to build the C5 Z-alkene.  In contrast, synthesis of 
PGE2 and PGF2α using stereoretentive metathesis catalyst Ru-3 required a large excess of gaseous 
butene and more complicated operations in the previously reported methylene capping strategy.  
The full conversion of first homodimerization step is necessary to avoid the formation of 
byproducts such as 48.  Under standard cross-metathesis conditions with alcohol 45, the major  







































6b 6 mmol toluene 23 ºC dynamic vacuum
e
(ca. 2 torr) >98% 49%
a Conversion was measured by GC analysis
b 1 mol% of catalyst was added
c Static vacuum was applied after one freeze-pump-thaw cycle of the reaction mixture in the Schlenk tube.
d Dynamic vacuum was performed by attaching the Schlenk tube to a vacuum regulator.
e The Schlenk tube was directly connected to high vacuum.
45 46
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product is 48 from the reaction with propylidene (Scheme 1.4.4), which is hard to be converted 
further into the desired product 47 by a second cross-metathesis with alcohol 45, unless dynamic 
vacuum is applied to effectively remove cis-3-hexene from the reaction system. 
The C14 E-alkene tolerated the reaction, consistent with the much slower reaction of E-
alkenes with Ru-4 as seen previously.22 The enantiopurity of intermediates 44 and 47 was also 
assessed.  Three-component coupling product 44 proceeded with a small loss in enantiopurity (88% 
ee) from (R)-43 (>99% ee), but the metathesis product 47 was obtained without significant erosion 
of enantiopurity (87% ee, Scheme 1.4.4).  This result demonstrates that stereoretentive metathesis 
with catalyst Ru-4 also retained the stereochemistry of the C8 stereocenter.  Finally, Ley 
oxidation30 of 47 with TPAP and NMO•H2O gave 15-deoxy-D12,14-prostaglandin J2 (2) in 68% 
yield (Scheme 1.4.5). 













toluene, 23 ºC 
ca. 2 torr
B. One-pot homodimerization/stereoretentive metathesis
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SCHEME 1.4.5. Completion of Synthesis of 15d-PGJ2 
 
To synthesize ∆12-PGJ2, the ω-chain aldehyde 37 was firstly prepared from 5-hexenal (49) 
through asymmetric Keck allylation,31 TBS protection, and ozonolysis (Scheme 1.4.6).  With all 
the starting materials in hand, the same three-component coupling sequence was performed to 
obtain 38 in good yield (45% over 2 steps).  38 was then subjected to the standard one-pot 
stereoretentive homodimerization/cross-metathesis conditions, and alcohol 52 was obtained in 
excellent yield (95% yield, Scheme 1.4.6) with high Z-selectivity (>99% Z).  Ley oxidation and 
deprotection of the TBS group of 52 in aqueous HF furnished the natural product ∆12-PGJ2 (1) in 
89% yield over the last two steps. 
 
















50: R = H


















1. CuBr.Me2S, LiCl, allylMgBr
    THF, –78 ºC
    then 37, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
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Synthesis of ∆12-PGJ3 (3) began with the preparation of the ω-chain aldehyde 14.  We 
envisioned the Z-alkene in 14 could also be generated from stereoretentive metathesis.  First, we 
obtained chiral alcohol 53 through a reported chiral pool strategy with (R)-epichlorohydrin as the 
starting material (Scheme 1.4.7A).32   TBS protection of the alcohol and subsequent removal of 
the 1,3-dithiol gave aldehyde 55.  Stereoretentive metathesis of 55 with an excess amount of cis-
3-hexene using catalyst Ru-4 (4 mol%) afforded ω-chain aldehyde 14 in good yield (88%) with 
high Z-selectivity (>99% Z).  The short synthesis of aldehyde 14 proved that a broad range of 
functional groups, including aldehydes, can be tolerated without protecting group manipulations 
using stereoretentive catalysts.  Then, 56 was synthesized through the standard three-component 
coupling sequence from (R)-43 (40% yield over 2 steps, Scheme 1.4.7B).  
  














1. CuBr.Me2S, LiCl, allylMgBr
    THF, –78 ºC
    then 14, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
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Surprisingly, fast ring-closing metathesis (RCM) with Ru-4 yielded 59 as a by-product (31% 
yield) bearing an unusual 9-membered ring, and the desired alcohol product 57 was obtained in 
only 44% yield (Scheme 1.4.7C).  Alternatively, we chose to use cyclometallated catalyst Ru-2 to 
circumvent the crossover of alkene reactivity.  Because tri-substituted metallacyclobutane 
intermediates are highly unfavorable with this cyclometallated catalyst, this pathway can be easily 
avoided (Scheme 1.4.7D).33   Chemoselective cross-metathesis of 5-hexen-1-ol with the allyl 
group of 56 furnished the desired product 57 in good yield (52%) with a trace amount of by-product 
58 (less than 2%, Scheme 1.4.7B).  The RCM product 59 was not observed under these conditions.  
The side-reaction of C17 internal Z-alkene could be attributed to ethylene produced or the residual 
ruthenium methylidene species in the solution.  Then, Ley oxidation of 57 and deprotection of the 
TBS group with aqueous HF provided ∆12-prostaglandin J3 (3) in 8 linear steps.   
 Scheme 1.4.8. Synthesis of 15d-PGJ3 
 
Finally, in the synthesis of 15d-PGJ3 (4), crossover of metathesis reactivity between the 
allyl group and the C17 Z-alkene of 61 could also be expected.  Standard stereoretentive metathesis 





62 (36%, > 99:1 Z/E) 
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    then 60, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
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(Scheme 1.4.8).   Compared to ∆12-PGJ3 (3) synthesis, where the steric bulk of the OTBS group 
may be beneficial to achieving good chemoselectivity, 61 has no such steric hindrance.  However, 
no RCM of 61 was observed, possibly due to the ring strain of RCM product.  Though 62 could 
not be separated from 63, the mixture was subjected to PCC oxidation and Pinnick oxidation 
conditions, allowing us to isolate 15-deoxy-∆12,14-prostaglandin J3 (4) (12% yield from 61). 
 
1.4.2 Improved Synthesis of Enantiopure 15d-PGJ2  
In the previous synthesis, erosion of enantioselectivity was observed in compound 44 after 
three-component coupling reaction (Scheme 1.4.3, 88% ee), due to the racemization of the relative 
acidic C8 stereocenter in the reactive 2-alkylidene cyclopentenone moiety.  Previous approaches 
toward these types of cross-conjugated dienone prostaglandins utilized masked forms of this 
structural motif, and the enone was unmasked in the final step of the syntheses.  For example, 
through retro-Diels–Alder reaction, 34  Saegusa–Ito oxidation,17g bisallylic alcohol oxidation17b 
(Scheme 1.4.9).  We hypothesize that racemization could be attenuated in the masked enone motif 
above.  Retro-Diels-Alder reaction is an appealing approach since the 3-oxodicyclopentadiene 
starting material is readily available, which was also utilized in Nicolaou’s recent synthesis of ∆12-
PGJ2 (Scheme 1.2.4).18  The C8 stereocenter was introduced by stereoselective conjugate addition 
of enantiomerically pure enone (+)-33 with allyl magnesium bromide, CuI and LiCl in the presence 
of TMSCl. Then, it was directly unmasked with thermally induced retro-Diels−Alder reaction, 
furnished enantiopure intermediate 34 in 77% yield over the two steps.  We proposed that this 
unmasking step could be performed after the three-component coupling step, to have a better 
strategic efficiency and avoid the relatively volatile intermediate 34.   
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Scheme 1.4.9. Reported Synthetic Strategies to Cross-Conjugated Dienone 
 
Several approaches have been reported to access chiral 3-oxodicyclopentadiene moiety, 
including enzymatic resolution by lipase, 35  and keto reductases, 36  Co-catalyzed asymmetric 
intermolecular Pauson−Khand reaction (PKR) of norbornadiene and alkynes, 37  and kinetic 
resolution via Cu-catalyzed 1,3-dipolar cycloaddition reactions.38  Lipase-mediated enzymatic 
resolution was performed to synthesize enantiomerically pure 33, since racemic endo-3-
oxodicyclopentadiene (±)-33 can be readily obtained through one-pot allylic photooxidation of 
dicyclopentadiene catalyzed by tetraphenylporphyrin (TPP).39  Then, the endo-alcohol (±)-65 was 
obtained from DIBAL-H reduction in excellent yield.  Kinetic resolution was successfully 
performed on 4.0 gram scale when (±)-65 was treated with vinyl acetate (0.6 equivalent) in tert-
butyl methyl ether in the presence of commercially available lipase PS-on-celite (10% w/w of the 
substrate).  The endo-acetate (–)-66 was isolated in 48% yield, leaving the endo-alcohol (+)-65 in 
49% yield after 48 h at 37 ºC.  The endo-acetate (–)-66 was treated with 1 equivalent of K2CO3 in 
methanol, which liberated the endo-alcohol (–)-65.  Both enantiopure (+)- and (–)-65 can be 
obtained (>99% ee) by oxidation of endo-alcohol enantiomers by TPAP and NMO, in the presence 
of 4 Å molecular sieves in CH2Cl2/MeCN.40  Alternatively, (+)-65 could also be oxidized in the 
reaction conditions reported by Stahl and coworkers,41 which resulted in higher yield to obtain (–)-
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Scheme 1.4.10. Enzymatic Resolution  
 
In previous reports by Nicolaou and others,12,14,16,18 aldol reaction in the presence of LDA 
usually resulted in moderate yield (30–40%), although the first deprotonation step is selective at 
cyclopentenone to form the enolate.  In our improved route, the overall yields were largely 
improved in the three-component coupling step.  In the presence of CuI and Me2S, allyl Gringard 
reagent firstly can form allyl cuprate, which undergoes regio- and stereoselective conjugate 
addition to the enone to form an enolate.  Then, the resulting enolate can be trapped by the 
subsequent addition of an aldehyde, which could ensure the full conversion of starting material 
and reduce the by-product formation that occurred in previously reported aldol reactions with LDA.  
The reaction gave a mixture of aldol diastereomers, with adduct 68 identified as the major 
diastereomer, indicating an anti-aldol process.  After elimination with MsCl and excess amount of 
DMAP, the mixture of diastereomers can be converted to the thermodynamically favored E-alkene 
in good yield (77% yield for (+)-67, 75% yield for (–)-67).  Then, both enantiomers of 44 can be 
readily obtained in high enantioselectivity (>99% ee, Scheme 1.4.11), by Lewis acid-catalyzed 
retro-Diels-Alder reaction developed by Grieco,42  using EtAlCl2 and stoichiometric amount of 
maleic anhydride at a lower temperature (80 ºC) than the thermally induced conditions (> 160 ºC).  




lipase PS (10 wt%)
vinyl acetate (0.6 equiv)
MTBE, 37 ºC, 48 h +
1. K2CO3, MeOH (98%)































MeCN, air, 23 ºC
 (97%, >99% ee)
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adjacent to enone and C8-H presents certain acidity, which is prone to racemize in the presence of 
base.  However, when the enone was masked with the cyclopentadiene motif, the proton in the 
corresponding stereocenter is less prone to deprotonation.  In addition, this reaction sequence was 
performed on a larger scale (1.6 gram starting material), and enantio-enriched enone (+)-33 was 
used as the limiting reagent.  Excess amount of (R)-43 was required in the previous report of three-
component coupling reactions because the O-Boc group is labile and (R)-43 was converted to 
undesired by-products, and the reaction scale was limited (up to 200 mg starting material). 
Scheme 1.4.11. Stereodivergent Three-component Coupling 
 
Finally, (+)-44 was carried on to the one-pot homodimerization/steroretentive metathesis 
reaction, and the primary alcohol product 47 was obtained in 99% yield and >99% ee with high Z-
selectivity (>99:1 Z/E, Scheme 1.4.12).  Then, oxidation of 47 with PCC, and then Pinnick 
oxidation gave rise to the enantiopure 15d-PGJ2 (2) in 41.0 mg scale (65% yield over 2 steps). The 
enantiopurity was confirmed by synthesizing the methyl ester derivative of 2 with 
(trimethylsilyl)diazomethane, which 69 was obtained in 72% yield and 99% ee.  This route 
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retained throughout the synthesis.  In principle, this strategy can be applied to the synthesis of 
other ∆12-PGJ analogs to obtain those compounds with high enantiopurity for biological studies. 
Scheme 1.4.12. Synthesis of Enantiopure 15d-PGJ2 
 
1.5  CONCLUSIONS 
In conclusion, a concise and convergent synthesis of four ∆12-prostaglandin J natural 
products in shorter sequences (7–8 steps in the longest linear sequences) was developed, 
empowered by stereoretentive and stereoselective metathesis.  Furthermore, the reactivity, 
chemoselectivity, and functional group compatibility of stereoretentive metathesis was evaluated.  
This study should inspire further practical applications of stereoselective metathesis, such as a 
facile one-pot stereoretentive homodimerization/cross-metathesis strategy to introduce Z-alkenes 
with excellent geometric control.  An improved synthesis was also developed starting with 
enzymatic resolution of 3-oxodicyclopendadiene.  Racemization can be avoided in the three-
component coupling step  using the chiral 3-oxodicyclopendadiene starting material and 
enantiopure 15d-PGJ2 (>99% ee) was obtained.  The modularity and expediency of this chemistry 
opens the synthesis of other prostaglandins and analogues to enable SAR studies in cancer 
treatment.  With the well-defined kinetically Z/E-selective catalysts that have been developed to 
overcome the inherent thermodynamic preference of alkene product geometry, olefin metathesis 
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1.6  EXPERIMENTAL METHODS AND ANALYTICAL DATA 
 
1.6.1  Materials and Methods  
Unless noted in the specific procedure, reactions were performed in flame-dried glassware 
under argon atmosphere.  All metathesis reactions were carried out under air-free conditions in dry 
glassware in a Vacuum Atmospheres Glovebox filled with N2.  General solvents were purified by 
passing through solvent purification columns.  Commercially available substrates were used as 
received.  All solvents and substrates were sparged with Ar before bringing into the glovebox and 
filtered over basic alumina (Brockmann I) prior to use.  Reaction progress was monitored by thin-
layer chromatography (TLC) using E. Merck silica gel 60 F254 precoated plates (0.25 mm) and 
visualized by UV fluorescence quenching, potassium permanganate, or p-anisaldehyde staining.  
Silicycle SiliaFlash P60 Academic Silica gel (particle size 0.040-0.063 mm) was used for flash 
chromatography.  Analytical chiral HPLC was performed with an Agilent 1100 Series HPLC 
utilizing a Chiralcel OD-H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, 
Ltd. with visualization at 254 nm.  Analytical SFC was performed with a Mettler SFC supercritical 
CO2 analytical chromatography system utilizing Chiralcel (IC) column (4.6 mm x 25 cm) obtained 
from Daicel Chemical Industries, Ltd. with visualization at 210 nm.  GC conversion data was 
obtained using an HP-5 capillary column with an Agilent 6850 FID gas chromatograph.  1H and 
13C NMR spectra were recorded on a Varian Inova 500 spectrometer (500 MHz and 126 MHz, 
respectively), a Bruker AV III HD spectrometer equipped with a Prodigy liquid nitrogen 
temperature cryoprobe (400 MHz and 101 MHz, respectively), or a Varian Mercury 300 
spectrometer (300 MHz and 75 MHz, respectively) and are reported in terms of chemical shift 
relative to residual CHCl3 (δ 7.26 and δ 77.16 ppm, respectively).  Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
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Abbreviations are used as follows: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, 
quint = quintet, m = complex multiplet.  Infrared (IR) spectra were recorded on a Perkin Elmer 
Paragon 1000 spectrometer using neat samples on ATR diamond, and are reported in frequency of 
absorption (cm–1).  High-resolution mass spectra HRMS were acquired from the Caltech Mass 
Spectral Facility using fast-atom bombardment (FAB+), electrospray ionization (TOF ES+) or 
electron impact (EI+).  Optical rotations were measured on a Jasco P-2000 polarimeter using a 100 
mm path-length cell at 589 nm. 
 
1.6.2  Experimental Procedures 
Preparation of enone (R)-43: 
 
Under argon atmosphere, a 500 mL flask was charged with (±)-43 (prepared through procedures 
by Reiser and co-workers27) (5.02 g, 25.4 mmol, 2.0 equiv) in CH2Cl2 (100 mL), p-methoxyphenol 
(1.57 g, 12.7 mmol, 1.0 equiv) and Cs2CO3 (1.22 g, 3.75 mmol, 0.296 equiv) was added and the 
solution was cooled to 0 ºC.  In another 100 mL flask, Pd2(dba)3•CHCl3 (131 mg, 0.127 mmol, 
0.01 equiv) and ligand (R,R)-DACH (306 mg, 0.44 mmol, 0.035 equiv) in CH2Cl2 (50 mL) was 
stirred until the initially purple solution turned yellow brown (4–5 min), and the catalyst solution 
was transferred to the 500 mL flask through a cannula.  The solvent was removed under reduced 
pressure after 2.5 h stirring at 0 ºC.  The residue was purified by flash chromatography 














(41% yield, > 99% ee) (R)-43(±)-43
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TLC (4:1 hexanes/EtOAc): Rf= 0.4 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 5.7, 2.4 Hz, 1H), 6.32 (dd, J = 5.7, 1.3 Hz, 1H), 5.70 
(dtd, J = 6.2, 2.3, 1.3 Hz, 1H), 2.82 (dd, J = 18.7, 6.4 Hz, 1H), 2.39 (dd, J = 18.7, 2.3 Hz, 1H), 
1.49 (s, 9H). 
13C NMR (101 MHz, CDCl3): δ 204.7, 158.7, 152.8, 137.2, 83.4, 74.3, 41.1, 27.8.  
FTIR (ATR): 2981, 2937, 1722, 1591, 1475, 1459, 1395, 1369, 1334, 1272, 1253, 1152, 1104, 
994, 840, 791 cm–1.  
HRMS (FAB+, m/z): calc’d for C10H15O4 [M+H]+ 199.0965, found: 199.0986. 
[𝜶]𝑫𝟐𝟑: +78.7° (c = 1.0, CHCl3). 
 
SFC Conditions: 3% IPA, 4.0 mL/min, Chiralcel IC column, λ = 210 nm, tR (min): major = 2.36, 
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Preparation of 44: 
 
A 25 mL flask was flame dried and charged with CuBr•Me2S (195 mg, 0.95 mmol, 3.0 equiv) and 
LiCl (42 mg, 1 mmol, 3.2 equiv) in a nitrogen-filled glove box.  The flask was sealed with septum 
and brought out of glove box, and was heated under vacuum to remove residue water.  Anhydrous 
THF (10 mL) was added, and the solution was vigorously stirred for 10 minute at 23 ºC until a 
yellow homogeneous solution was formed.  At –78ºC, allylmagnesium bromide (0.9 mL, 1.0 M 
solution in THF, 0.9 mmol, 2.8 equiv) was added slowly.  The reaction mixture was stirred at –78 
ºC for 1 hour and a solution of (R)-43 (188 mg, 0.95 mmol, 3.0 equiv) in THF (1 mL) was added 
slowly.  After 30 minutes stirring at the same temperature, a solution of trans-2-octenal (40 mg, 
0.32 mmol, 1.0 equiv) in THF (1 mL) was added slowly.  The reaction was stirred for additional 
2 hours at –78 ºC before a solution of saturated NH4Cl and NH3•H2O (10 mL, 9:1 NH4Cl/NH3•H2O) 
was added.  The biphasic solution was vigorously stirred until a homogeneous dark blue solution 
was formed in aqueous phase.  The phases were separated and the organic phase was washed with 
10 mL saturated NH4Cl solution.  The combined aqueous phase was extracted with Et2O (2 × 30 
mL).  The combined organic phase was dried with anhydrous magnesium sulfate, and was 
concentrated in vacuo.  The residue was purified by flash chromatography (SiO2, hexanes/EtOAc 
15:1) to give a mixture of diasteromers of the aldol products (57 mg, 0.23 mmol). 
 
In a 25 mL flask, the crude aldol product was dissolved in CH2Cl2 (6 mL) and cooled to –10 ºC.  
DMAP (421 mg, 3.45 mmol, 15.0 equiv) and MsCl (53 μL, 0.69 mmol, 3.0 equiv) was added 
sequentially.  The reaction mixture was slowly warmed to 23 ºC and stirred for 2 h before diluted 
O
BocO 1. CuBr•Me2S, LiCl, allylMgBr
THF, –78 ºC
then trans-2-octenal
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC





Chapter 1 – Concise Total Syntheses of ∆12-Prostaglandin J  
Natural Products Via Stereoretentive Metathesis 
28 
with 10 mL EtOAc and washed with 1 M HCl (10 mL).  The aqueous phase was extracted with 
EtOAc (2 × 20 mL).  The combined organic phase was dried with anhydrous magnesium sulfate, 
and was concentrated in vacuo.  The residue was purified by flash chromatography (SiO2, 
hexanes/EtOAc 15:1) to give 44 (30 mg, 41% yield over 2 steps, 88% ee by chiral HPLC analysis) 
as a colorless liquid. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.56 (UV).  
1H NMR (300 MHz, CDCl3): δ 7.50 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 10.7, 1.2 Hz, 
1H), 6.35 (dd, J = 6.0, 1.8 Hz, 1H), 6.33 – 6.15 (m, 2H), 5.81 – 5.64 (m, 1H), 5.11 – 5.01 (m, 2H), 
3.60 (ddq, J = 8.5, 4.1, 1.9 Hz, 1H), 2.73 – 2.58 (m, 1H), 2.24 (dddd, J = 13.4, 9.7, 6.8, 1.5 Hz, 
3H), 1.54 – 1.37 (m, 2H), 1.38 – 1.22 (m, 4H), 0.89 (t, 3H, J = 6.9 Hz). 
13C NMR (75 MHz, CDCl3): δ 197.5, 160.6, 147.1, 135.4, 134.9, 134.3, 131.8, 125.7, 117.8, 43.2, 
37.4, 33.6, 31.5, 28.6, 22.6, 14.1. 
FTIR (ATR): 2954, 2928, 2859, 1699, 1642, 1581, 1458, 1344, 1194, 994, 918, 829, 734 cm–1.  
HRMS (FAB+, m/z): calc’d for C16H21O [M+H–H2]+ 229.1586, found: 229.1581. 
[𝜶]𝑫𝟐𝟑: +65.4° (c = 1.0, CHCl3). 
HPLC Conditions: 10% IPA, 1.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 
5.37, minor = 6.44 
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Preparation of 47: 
A. One-pot homodimerization/stereoretentive metathesis method 
 
 
In a nitrogen-filled glovebox, cis-5-octen-1-ol (113 mg, 0.88 mmol, 8.0 equiv) was dissolved in 
toluene (1 mL) in a 50 mL Schlenk flask and a solution of catalyst Ru-4 (7.5 mg, 8.8 μmol, 1 
mol%) in THF (0.6 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum.  The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing).  After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox.  The residue was diluted with THF (0.5 mL), and an 
aliquot was taken for GC analysis (conversion of homodimerization step was >98% by GC 
analysis).  A solution of 44 (25 mg, 0.11 mmol, 1.0 equiv) in THF (0.5 mL) was added into the 
Schlenk flask and an additional portion of catalyst Ru-4 (4.6 mg, 5.5 μmol, 5 mol%) solution in 
THF (0.2 mL) was added.  The Schlenk flask was sealed and brought out of glovebox.  The reaction 
was stirred for 24 h at 40 ºC before a few drops of ethyl vinyl ether were added.  The solvent was 
removed under reduced pressure.  The residue was purified by flash chromatography (SiO2, 





   toluene, 23 ºC, 2 torr
then 44, Ru-4 (5 mol%)






(93% yield, > 99:1 Z/E, 87% ee)
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TLC (4:1 hexanes/EtOAc): Rf= 0.2 (UV).  
1H NMR (400 MHz, CDCl3) δ 7.48 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.0, 1.3 Hz, 1H), 
6.35 (dd, J = 6.0, 1.8 Hz, 1H), 6.34 – 6.19 (m, 2H), 5.52 – 5.44 (m, 1H), 5.38 – 5.30 (m, 1H), 3.63 
(t, J = 6.5 Hz, 2H), 3.60 – 3.55 (m, 1H), 2.60 (dddd, J = 14.0, 6.2, 4.3, 1.4 Hz, 1H), 2.30 (dtd, J = 
14.4, 8.6, 1.2 Hz, 1H), 2.25 – 2.17 (m, 2H), 2.01 (qd, J = 7.3, 1.4 Hz, 2H), 1.59 – 1.49 (m, 2H), 
1.48 – 1.37 (m, 5H), 1.34 – 1.29 (m, 4H), 0.89 (t, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 160.9, 147.0, 135.4, 135.3, 132.6, 131.8, 125.8, 125.3, 
62.9, 43.7, 33.6, 32.5, 31.5, 30.9, 28.6, 27.2, 25.8, 22.6, 14.2. 
FTIR (ATR): 3445, 2960, 2930, 2862, 1690, 1629, 1580, 1447, 1264, 1207, 1054, 979, 732 cm–
1.  
HRMS (TOF, ES+, m/z): calc’d for C20H31O2 [M+H]+ 303.2319, found: 303.2320. 
[𝜶]𝑫𝟐𝟑: +115.8° (c = 0.5, CHCl3). 
HPLC Conditions: 10% IPA, 1.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 
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B. Cross-metathesis method  
 
 
In a nitrogen-filled glovebox, 44 (49 mg, 0.21 mmol, 1.0 equiv) and cis-5-octen-1-ol (205 mg, 1.6 
mmol, 7.6 equiv) was dissolved in THF (0.5 mL) in a 1-dram vial, and the solution was transferred 
to a 50 mL Schlenk flask.  A solution of catalyst Ru-4 (8.5 mg, 10 µmol, 5 mol%) in THF (0.5 
mL) was added. The Schlenk flask was sealed and brought out of the glovebox, and freeze-pump-
thaw for one time to keep it under static vacuum.  The reaction was stirred for 16 h at 40 ºC before 
quenched with a few drops of ethyl vinyl ether.  The solvent was removed under reduced pressure. 
The residue was purified by flash chromatography (hexanes/EtOAc 10:1 to 2:1) to give 47 (29 mg, 
53%, >99:1 Z/E) and 48 (30 mg, 47%, >99:1 Z/E) as two major products.   
 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.6 (UV).  
1H NMR (400 MHz, CDCl3) δ 7.48 (ddd, J = 5.9, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.2, 1.2 Hz, 1H), 
6.39 – 6.17 (m, 3H), 5.53 – 5.43 (m, 1H), 5.34 – 5.24 (m, 1H), 3.56 (ddq, J = 8.6, 4.1, 2.0 Hz, 1H), 
2.70 – 2.47 (m, 1H), 2.34 – 2.17 (m, 3H), 1.99 (pd, J = 7.5, 1.6 Hz, 2H), 1.46 (p, J = 7.3 Hz, 2H), 
1.31 (tt, J = 5.6, 2.8 Hz, 4H), 0.93 (t, J = 7.6 Hz, 3H), 0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 197.6, 160.9, 146.8, 135.4, 134.6, 131.7, 125.8, 124.3, 43.8, 33.6, 
31.5, 30.8, 28.6, 22.6, 20.8, 14.3, 14.1. 
FTIR (ATR): 2959, 2927, 2856, 2360, 1693, 1632, 1579, 1459, 1376, 1337, 1294, 1203, 1100, 
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HRMS (TOF, ES+, m/z): calc’d for C20H31O2 [M+H]+ 259.2056, found: 259.2207. 
[𝜶]𝑫𝟐𝟑: +210.8° (c = 1.0, CHCl3). 
 
Preparation of 15-deoxy-∆12,14-prostaglandin J2 (2): 
 
To a stirred solution of 47 (14 mg, 0.046 mmol, 1.0 equiv) in MeCN (0.5 mL) was added 
NMO•H2O (65 mg, 0.46 mmol, 10.0 equiv).  Tetrapropylammonium perruthenate (1.7 mg, 4.6 
μmol, 0.1 equiv) was added until NMO•H2O was fully dissolved and the reaction was stirred at 23 
ºC for 3 hours.  The reaction mixture was stirred for 3 hours and the solvent was removed in vacuo.  
The residue was loaded onto a silica gel column, flushed with CH2Cl2 then CH2Cl2/MeOH (20:1).  
15-deoxy-∆12,14-prostaglandin J2 (2) was obtained as a colorless oil (10 mg, 68% yield). 
 
TLC (100% EtOAc): Rf= 0.70 (UV). 
1H NMR (400 MHz, CDCl3): δ 7.47 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (d, J = 11.0 Hz, 1H), 
6.38 – 6.35 (m, 1H), 6.33 – 6.20 (m, 2H), 5.50 – 5.33 (m, 2H), 3.59 (ddd, J = 8.4, 4.1, 2.2 Hz, 1H), 
2.59 (m, 1H), 2.36 – 2.19 (m, 5H), 2.05 (q, J = 7.3 Hz, 2H), 1.68 (quint, J = 7.5 Hz, 2H), 1.50 – 
1.41 (m, 2H), 1.34 – 1.28 (m, 4H), 0.90 (t, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 177.9, 160.8, 147.2, 135.5, 135.1, 131.9, 131.5, 126.2, 
125.8, 43.6, 33.6, 33.2, 31.6, 30.8, 28.6, 26.7, 24.6, 22.6, 14.2. 
FTIR (ATR): 2960, 2928, 2850, 1708, 1692, 1629, 1456, 1265, 1207, 978, 734, 703 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C20H29O3 [M+H]+ 317.2111, found: 317.2127. 
[𝜶]𝑫𝟐𝟑: +106.2° (c = 0.2, CHCl3). 
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Preparation of (S)-non-1-en-4-ol (50): 
 
Following the procedure by Yadav and co-workers43, to a stirred solution of TiCl4 (1.0 M solution 
in CH2Cl2, 2.5 mL, 2.5 mmol) in CH2Cl2 (50 mL) was added dried Ti(Oi-Pr)4 (2.24 mL,7.5 mmol) 
at 0 °C under argon.  The solution was warmed to 23 ºC and stirred for 1 h, then Ag2O (1.15 g, 5.0 
mmol) was added, and the mixture was stirred for 5 h with the exclusion of direct light by 
aluminum foil.  The reaction mixture was diluted with CH2Cl2 (80 mL) and (R)-binaphthol (2.86 
g, 10 mmol) was added at 23 ºC.  After 2 h, the reaction mixture was cooled to –15 °C and hexanal 
(5.0 g, 50 mmol) and allyltributyltin (17 mL, 55 mmol) was added sequentially, then the reaction 
mixture was warmed to 0 °C.  After 8 h, saturated NaHCO3 (50 mL) was added.  The aqueous 
phase was extracted with diethyl ether (2 × 250 mL).  The combined organic phases were washed 
with brine (1 × 200 mL), dried with anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure.  Purification by flash column chromatography on silica gel (SiO2, 15:1 
hexanes/EtOAc) afforded compound 50 as a colorless oil (3.94 g, 55% yield, > 95% ee by Mosher-
ester analysis). 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.22 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 5.81 (dddd, J = 17.6, 9.4, 7.8, 6.5 Hz, 1H), 5.17 – 5.03 (m, 2H), 
3.62 (dtd, J = 8.0, 4.0, 2.4 Hz, 1H), 2.28 (dddt, J = 13.7, 6.8, 4.3, 1.3 Hz, 1H), 2.18 – 2.05 (m, 1H), 
1.74 (d, J = 3.6 Hz, 1H), 1.50 – 1.35 (m, 3H), 1.35 – 1.21 (m, 5H), 0.87 (t, J = 6.8 Hz, 3H). 











(55% yield, >95% ee)49
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FTIR (ATR): 3355, 3077, 2956, 2929, 2859, 1641, 1467, 1435, 1378, 1124, 1027, 994, 911, 865, 
725 cm–1.  
HRMS (EI+, m/z): calc’d for C9H18O [M]+ 142.1352, found: 142.1372. 
[𝜶]𝑫𝟐𝟑: –7.2° (c = 1.0, CHCl3). 
 
Mosher-ester analysis of 50: 
 
 
To a stirred solution of 50 (21 mg, 0.15 mmol, 1.0 equiv) in CH2Cl2 (1.5 mL) in a 4 mL vial was 
added pyridine (0.1 mL, 1.24 mmol, 8.0 equiv) and (S)-(+)-Mosher chloride (100 mg, 0.40 mmol, 
2.7 equiv) at 25 °C.  After stirring for 2 h at the same temperature, the reaction mixture was diluted 
with CH2Cl2 (3 mL) and saturated NH4Cl solution (3 mL) was added.  The phases were separated, 
and the aqueous layer was extracted with CH2Cl2 (2 × 5 mL).  The combined organic extracts were 
concentrated after drying over magnesium sulfate.  (R)-MTPA ester 50a was obtained through 
column chromatography (SiO2, 20:1 hexanes/EtOAc) as a colorless oil (50 mg, 94 %). 
 
Compound 50b was prepared in the same manner and on the same scale as above using (R)-(−)-
Mosher chloride.  (S)-MTPA ester 50b was obtained through column chromatography (SiO2, 
hexanes/EtOAc, 20:1) as a colorless oil (51 mg, 96 %). 
 
(R)-MTPA ester 50a: 
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1H NMR (400 MHz, CDCl3): δ 7.57 – 7.50 (m, 2H), 7.43 – 7.31 (m, 3H), 5.73 – 5.56 (m, 1H), 
5.14 (dq, J = 7.2, 5.7 Hz, 1H), 5.06 – 4.98 (m, 2H), 3.55 (q, J = 1.3 Hz, 3H), 2.35 (dddd, J = 6.2, 
5.0, 2.5, 1.3 Hz, 2H), 1.71 – 1.54 (m, 2H), 1.39 – 1.22 (m, 6H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 166.4, 133.0, 132.5, 129.7, 128.4, 127.6, 123.5 (q, J = 288.6 Hz), 
118.4, 84.7 (q, J = 27.5 Hz), 76.7, 55.6, 38.2, 33.4, 31.6, 25.0, 22.6, 14.1. 
 19F NMR (282 MHz, CDCl3): δ –71.3. 
FTIR (ATR): 2955, 2934, 2861, 1743, 1643, 1612, 1506, 1451, 1258, 1166, 1121, 1081, 1020, 
993, 912, 823, 764, 732, 716, 696, 648 cm–1.  
HRMS (FAB+, m/z): calc’d for C19H26O3F3 [M+H]+ 359.1829, found: 359.1839. 
 
(S)-MTPA ester 50b: 
TLC (10:1 hexanes/EtOAc): Rf= 0.57 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.58 – 7.52 (m, 2H), 7.43 – 7.34 (m, 3H), 5.76 (ddt, J = 16.1, 10.4, 
7.0 Hz, 1H), 5.16 (dt, J = 10.8, 5.2 Hz, 1H), 5.13 – 5.08 (m, 2H), 3.56 (q, J = 1.3 Hz, 3H), 2.42 
(ddt, J = 7.3, 6.1, 1.3 Hz, 2H), 1.65 – 1.49 (m, 2H), 1.27 – 1.10 (m, 6H), 0.84 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 166.4, 133.4, 132.6, 129.6, 128.4, 127.5, 123.5 (q, J = 288.6 Hz), 
118.5, 84.6 (q, J = 27.5 Hz), 76.7, 55.7, 38.5, 33.3, 31.6, 24.6, 22.6, 14.1. 
19F NMR (282 MHz, CDCl3): δ –71.3. 
FTIR (ATR): 2960, 2934, 2861, 1742, 1643, 1498, 1451, 1257, 1167, 1121, 1081, 1019, 992, 912, 
824, 764, 732, 717, 696, 648 cm–1.  
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1 5.01 5.11 0.1 
2 5.64 5.76 0.12 
3 2.35 2.42 0.07 
4 5.14 5.16 0.02 
5 1.62 1.57 –0.05 
6-8 1.28 1.20 –0.08 
9 0.88 0.84 –0.04 
 
Preparation of 51: 
 
To a stirred solution of 50 (2.0 g, 14 mmol) in CH2Cl2 (60 mL) was added imidazole (2.86 g, 42 
mmol, 3.0 equiv) and TBSCl (4.22 g, 28 mmol, 2.0 equiv).  Saturated NH4Cl solution (50 mL) 
was added after stirring overnight.  The aqueous layer was extracted with CH2Cl2 (2 × 30 mL) and 
the combined organic phases were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure.  Column chromatography (SiO2, 20:1 hexanes/EtOAc) gave 
51 as a colorless oil (2.85 g, 79% yield). 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.85 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 5.82 (ddt, J = 17.5, 10.4, 7.1 Hz, 1H), 5.08 – 4.99 (m, 2H), 3.68 
(quint, J = 5.7 Hz, 1H), 2.21 (dddt, J = 6.8, 5.3, 3.9, 1.3 Hz, 2H), 1.48 – 1.22 (m, 8H), 0.94 – 0.85 
(m, 12H), 0.05 (s, 3H), 0.05 (s, 3H). 
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FTIR (ATR): 2956, 2929, 2857, 1641, 1472, 1463, 1361, 1255, 1127, 1049, 1005, 939, 910, 834, 
807, 772, 664 cm–1.  
HRMS (EI+, m/z): calc’d for C15H31OSi [M+H–H2]+ 255.2138, found: 255.2174. 
[𝜶]𝑫𝟐𝟑: –15.7° (c = 1.0, CHCl3). 
 
Preparation of aldehyde 37: 
 
To a stirred solution of 51 (1.6 g, 6.25 mmol) in CH2Cl2 (30 mL) and MeOH (30 mL) was bubbled 
with O3 through a gas dispersion tube.  When the color of the solution turned blue, dimethyl sulfide 
(13.2 mL) and triethylamine (1.2 mL) was added.  The solution was stirred overnight and was 
concentrated under reduced pressure.  Column chromatography (SiO2, 20:1 hexenes/EtOAc) 
afforded 37 as a colorless oil (1.5 g, 93%) 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.77 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 9.81 (td, J = 2.6, 0.7 Hz, 1H), 4.17 (quint, J = 5.8 Hz, 1H), 2.51 
(ddd, J = 5.7, 2.6, 0.7 Hz, 2H), 1.56 – 1.41 (m, 2H), 1.37 – 1.22 (m, 6H), 0.96 – 0.83 (m, 12H), 
0.07 (s, 3H), 0.05 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 202.7, 68.4, 51.0, 38.0, 31.9, 25.9, 25.0, 22.7, 18.1, 14.2, –4.3, –
4.5. 
FTIR (ATR): 2956, 2929, 2857, 1713, 1472, 1361, 1253, 1096, 1050, 1005, 939, 834, 810, 774 
cm–1.  
HRMS (FAB+, m/z): calc’d for C14H31O2Si [M+H]+ 259.2088, found: 259.2088. 
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Preparation of 38: 
 
A 25 mL flask was flame dried and charged with CuBr•Me2S (144 mg, 0.70 mmol, 2.8 equiv) and 
LiCl (32 mg, 0.75 mmol, 3.0 equiv) in a nitrogen-filled glove box.  The flask was sealed with 
septum and brought out of glove box, and was heated under vacuum to remove residue water.  
Anhydrous THF (5 mL) was added, and the solution was vigorously stirred for 10 minutes at 23 
ºC until a yellow solution was formed.  At –78 ºC, allylmagnesium bromide (0.68 mL, 1.0 M 
solution in THF, 0.68 mmol, 2.7 equiv) was added slowly.  The reaction mixture was stirred at –
78 ºC for 1 hour and a solution of (R)-43 (149 mg, 0.75 mmol, 3.0 equiv) in THF (1 mL) was 
added slowly.  After 30 minutes stirring at the same temperature, a solution of 37 (65 mg, 0.25 
mmol, 1.0 equiv) in THF (1 mL) was added slowly.  The reaction was stirred for an additional 2 
hours at –78 ºC before a solution of saturated NH4Cl and NH3•H2O (10 mL, 9:1 NH4Cl/NH3•H2O) 
was added.  The biphasic solution was vigorously stirred until a homogeneous dark blue solution 
was formed in aqueous phase.  The phases were separated and the organic phase was washed with 
10 mL saturated NH4Cl solution.  The combined aqueous phase was extracted with Et2O (2 × 30 
mL).  The combined organic phase was dried with anhydrous magnesium sulfate, and concentrated 
in vacuo.  The residue was purified by flash chromatography (SiO2, hexanes/EtOAc 18:1) to give 
a mixture of diasteromers of the aldol product (82 mg, 0.22 mmol). 
 
In a 25 mL flask, the crude aldol product was dissolved in CH2Cl2 (6 mL) and cooled to –10 ºC.  
DMAP (403 mg, 3.3 mmol, 15.0 equiv) and MsCl (51 μL, 0.66 mmol, 3.0 equiv) were added 
O
BocO
1. CuBr•Me2S, LiCl, allylMgBr
THF, –78 ºC
then 37, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC
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sequentially.  The reaction mixture was slowly warmed to 23 ºC and was stirred for 12 h before 
diluted with 10 mL EtOAc and washed with 1 M HCl (10 mL).  The aqueous phase was extracted 
with EtOAc (2 × 20 mL).  The combined organic phase was dried with anhydrous magnesium 
sulfate, and was concentrated in vacuo.  The residue was purified by flash chromatography 
(hexanes/EtOAc 15:1) to give 38 (41 mg, 45% yield over 2 steps) as colorless liquid. 
TLC (9:1 hexanes/EtOAc): Rf= 0.25 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.52 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.60 (ddt, J = 8.3, 7.0, 1.3 Hz, 
1H), 6.33 (dd, J = 6.0, 1.8 Hz, 1H), 5.79 – 5.65 (m, 1H), 5.11 – 5.01 (m, 2H), 3.83 (quint, J = 5.8 
Hz, 1H), 3.50 (ddq, J = 8.4, 4.0, 2.0 Hz, 1H), 2.72 – 2.61 (m, 1H), 2.51 – 2.31 (m, 2H), 2.18 (dddt, 
J = 14.3, 9.0, 7.9, 1.1 Hz, 1H), 1.53 – 1.11 (m, 8H), 0.96 – 0.79 (m, 12H), 0.05 (s, 3H), 0.05 (s, 
3H). 
13C NMR (101 MHz, CDCl3): δ 196.5, 161.4, 138.5, 135.1, 134.3, 132.8, 117.8, 71.7, 43.1, 37.4, 
37.1, 32.0, 26.0, 25.1, 22.8, 18.2, 14.2, –4.2, –4.5. 
FTIR (ATR): 2955, 2928, 2856, 1705, 1656, 1582, 1472, 1360, 1252, 1207, 1127, 1050, 1005, 
915, 863, 834, 806, 773, 726, 663 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C22H39O2Si [M+H]+ 363.2714, found: 363.2711. 
[𝜶]𝑫𝟐𝟑: +85.3° (c = 1.0, CHCl3). 
 









   toluene, 23 ºC, 2 torr
then 38, Ru-4 (5 mol%)
THF, 40 ºC
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In a nitrogen-filled glovebox, cis-5-octen-1-ol (150 mg, 1.17 mmol, 8.0 equiv) was dissolved in 
toluene (2 mL) in a 50 mL Schlenk flask, and a solution of catalyst Ru-4 (9.9 mg, 11.7 μmol, 1 
mol%) in THF (0.7 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum.  The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing).  After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox.  The residue was diluted with THF (0.5 mL), and an 
aliquot was taken for GC analysis (conversion of homodimerization step was >98% by GC 
analysis).  A solution of 38 (53 mg, 0.146 mmol, 1.0 equiv) in THF (0.5 mL) was added into the 
Schlenk flask and an additional portion of catalyst Ru-4 (6.2 mg, 7.3 μmol, 5 mol%) solution in 
THF (0.3 mL) was added.  The Schlenk flask was sealed and brought out of glovebox.  The reaction 
was stirred for 24 h at 40 ºC before a few drops of ethyl vinyl ether were added.  The solvent was 
removed under reduced pressure.  The residue was purified by flash chromatography (SiO2, 
hexanes/EtOAc 2:1) to give 52 (60 mg, 95%, >99:1 Z/E).   
 
TLC (3:1 hexanes/EtOAc): Rf= 0.23 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.50 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.59 (ddt, J = 8.3, 7.0, 1.3 Hz, 
1H), 6.33 (dd, J = 6.0, 1.8 Hz, 1H), 5.49 (dddt, J = 8.6, 7.2, 5.5, 1.5 Hz, 1H), 5.35 (dtt, J = 11.0, 
8.4, 1.6 Hz, 1H), 3.84 (quint, J = 5.9 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.46 (ddt, J = 11.0, 4.2, 2.2 
Hz, 1H), 2.63 (dddd, J = 13.8, 6.5, 4.2, 1.5 Hz, 1H), 2.50 – 2.34 (m, 2H), 2.17 (dddd, J = 14.5, 9.4, 
8.0, 1.3 Hz, 1H), 2.07 – 1.97 (m, 2H), 1.60 – 1.51 (m, 2H), 1.47 – 1.34 (m, 6H), 1.32 – 1.19 (m, 
5H), 0.95 – 0.81 (m, 12H), 0.05 (s, 3H), 0.05 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 196.5, 161.8, 138.8, 135.0, 132.7, 132.5, 125.4, 71.7, 62.9, 43.6, 
37.5, 37.5, 32.5, 32.0, 30.7, 27.2, 26.0, 25.8, 25.1, 22.8, 18.2, 14.2, –4.2, –4.5. 
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FTIR (ATR): 3443, 2956, 2928, 2856, 1703, 1652, 1580, 1472, 1360, 1251, 1206, 1127, 1048, 
1005, 975, 866, 834, 806, 773, 726, 664 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C26H47O3Si [M+H]+ 435.3289, found: 435.3298. 
[𝜶]𝑫𝟐𝟑: +83.5° (c = 1.0, CHCl3). 
 




To a stirred solution of 52 (26 mg, 0.06 mmol, 1.0 equiv) in MeCN (0.3 mL) was added NMO•H2O 
(81 mg, 6 mmol, 10.0 equiv).  Tetrapropylammonium perruthenate (2.1 mg, 6 μmol, 0.1 equiv) 
was added until NMO•H2O was fully dissolved, and the reaction was stirred at 23 ºC for 3 hours.  
The solution was diluted with Et2O (5 mL), passed through a short pad of silica gel, concentrated, 
and subjected to the next reaction without further purification. 
 
The residue was dissolved in MeCN (1.0 mL) and cooled to 0 ºC.  A solution of hydrofluoric acid 
(48 wt. % in H2O, 0.2 mL) in MeCN (0.4 mL) was added dropwisely.  The solution was stirred in 
the same temperature for 30 min before saturated NaHCO3 solution (1.5 mL) and brine (1.5 mL) 
were added.  The aqueous phase was extracted with EtOAc (5 × 5 mL).  The combined organic 
phases were dried over magnesium sulfate, filtered, and concentrated (not to dryness).  The residue 
was purified by flash chromatography (SiO2, CH2Cl2/MeOH 20:1) to give 1 (18 mg, 89% over 2 





OH 1. TPAP, NMO•H2O
   MeCN
2. HF (aq.), MeCN
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TLC (20:1 CH2Cl2/MeOH): Rf= 0.14 (UV).  
1H NMR (500 MHz, CDCl3): δ 7.57 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.58 (ddt, J = 8.4, 7.2, 1.3 Hz, 
1H), 6.36 (dd, J = 6.0, 1.8 Hz, 1H), 5.54 – 5.38 (m, 2H), 3.86 (dtt, J = 7.9, 6.4, 4.0 Hz, 1H), 3.47 
(ddt, J = 9.5, 4.0, 2.1 Hz, 1H), 2.78 – 2.68 (m, 1H), 2.57 (dt, J = 14.8, 6.8 Hz, 1H), 2.52 – 2.42 (m, 
1H), 2.40 – 2.33 (m, 2H), 2.20 – 2.02 (m, 3H), 1.77 – 1.64 (m, 2H), 1.61 – 1.41 (m, 3H), 1.40 – 
1.24 (m, 5H), 0.90 (t, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 196.6, 177.3, 162.0, 139.8, 135.0, 131.8, 131.7, 126.2, 71.5, 43.9, 
37.3, 36.7, 33.1, 31.9, 30.6, 26.6, 25.4, 24.6, 22.8, 14.2. 
FTIR (ATR): 3445, 2960, 2929, 2858, 1699, 1646, 1579, 1463, 1406, 1265, 1237, 1135, 1084, 
1033, 842, 810, 734, 702 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C20H31O4 [M+H]+ 335.2217, found: 335.2223. 
[𝜶]𝑫𝟐𝟑: +99.5° (c = 0.2, CHCl3). 
Spectral data (1H NMR, 13C NMR, HRMS) matched with the published data.17e 
 
Preparation of 53: 
 
 
Procedures are same as Dai and co-workers.32 1,3-dithiane (1.2 g, 10 mmol, 1.0 equiv) was 
dissolved in THF (15 mL) and cooled to –78 ºC.  n-BuLi (2.5 M solution in hexanes, 4.4 mL, 11 
mmol, 1.1 equiv) was added and the solution was stirred at the same temperature for 15 min, then 
warmed up to –20 °C and stirred for 1 h.  The reaction mixture was cooled down to –78 °C and 
(R)-epichlorohydrin (1.1 mL, 14 mmol, 1.4 equiv) was added dropwisely.  The reaction mixture 
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to –40 ºC.  In another flame-dried flask, vinyl magnesium bromide (28 mL, 1.0 M in THF, 28 
mmol, 2.8 equiv) was added to a stirred solution of CuBr•Me2S (124 mg, 0.6 mmol, 0.06 equiv) 
in THF (20 mL), and the resulting solution was transferred into the reaction mixture through a 
cannula at –40 ºC.  The reaction mixture was slowly warmed to 23 ºC and stirred overnight before 
1 M HCl (50 mL) was added.  The biphasic mixture was extracted with EtOAc (3 × 50 mL).  The 
combined organic extract was washed with brine, dried with anhydrous magnesium sulfate, filtered, 
and concentrated under reduced pressure.  The residue was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 9:1) to afford 53 (1.20 g, 58% yield) as colorless liquid. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.27 (UV).  
1H NMR (400 MHz, CDCl3): δ 5.89 – 5.72 (m, 1H), 5.14 (m, 2H), 4.26 (dd, J = 7.8, 6.6 Hz, 1H), 
4.02 – 3.94 (m, 1H), 2.96 – 2.78 (m, 4H), 2.33 – 2.24 (m, 1H), 2.24 – 2.16 (m, 1H), 2.16 – 2.06 
(m, 1H), 2.01 (d, J = 4.2 Hz, 1H), 1.95 – 1.82 (m, 3H). 
13C NMR (101 MHz, CDCl3): δ 134.2, 118.7, 67.6, 44.3, 42.2, 42.1, 30.5, 30.2, 26.0. 
FTIR (ATR): 3413, 3073, 2930, 2900, 2851, 2827, 1640, 1422, 1275, 1242, 1172, 1123, 1062, 
1027, 993, 908, 866, 770, 664 cm–1.  
HRMS (FAB+, m/z): calc’d for C9H16OS2 [M]+ 204.0637, found: 204.0657. 
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Preparation of 54: 
 
To a stirred solution of 53 (0.70 g, 3.43 mmol) in CH2Cl2 (20 mL) was added imidazole (0.70 g, 
10.29 mmol, 3.0 equiv) and TBSCl (1.03 g, 6.86 mmol, 2.0 equiv).  Saturated NH4Cl solution (20 
mL) was added after stirring overnight.  The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) 
and the combined organic phase was dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure.  Column chromatography (SiO2, 20:1 hexanes/EtOAc) gave 
54 as a colorless oil (1.04 g, 95% yield). 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.54 (UV).  
1H NMR (400 MHz, CDCl3): δ 5.83 – 5.71 (m, 1H), 5.07 – 5.00 (m, 2H), 4.08 (dd, J = 7.8, 6.9 
Hz, 1H), 4.00 (qd, J = 6.2, 4.9 Hz, 1H), 2.92 – 2.75 (m, 4H), 2.23 (dtt, J = 7.5, 5.1, 1.3 Hz, 2H), 
2.09 (dddt, J = 10.6, 5.0, 4.2, 2.8 Hz, 1H), 1.93 – 1.83 (m, 1H), 1.83 – 1.78 (m, 2H), 0.88 (s, 9H), 
0.09 (s, 3H), 0.07 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 134.3, 117.6, 68.1, 44.1, 42.3, 42.3, 30.7, 30.1, 26.2, 26.0, 18.2, 
–4.3, –4.5. 
FTIR (ATR): 2952, 2928, 2896, 2855, 1640, 1472, 1423, 1360, 1254, 1185, 1070, 1004, 940, 915, 
834, 808, 773, 666 cm–1.  
HRMS (FAB+, m/z): calc’d for C15H31OS2Si [M+H]+ 319.1580, found: 319.1583. 
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To a solution of 54 (636 mg, 2 mmol, 1.0 equiv) in MeCN/H2O (20 mL, 9:1) was added CaCO3 
(1.0 g, 10 mmol, 5.0 equiv) and MeI (1.87 mL, 30 mmol, 15.0 equiv).  The reaction mixture was 
stirred at 50 ºC for 6 h, then diluted with water (20 mL) and extracted with EtOAc (3 × 20 mL).  
The combined organic extract was dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure.  The residue was purified by column chromatography (SiO2, 
20:1 hexanes/EtOAc) to afford 55 (430 mg, 94%) as a colorless liquid. 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.45 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 9.80 (td, J = 2.4, 0.8 Hz, 1H), 5.78 (ddt, J = 16.5, 10.8, 7.2 Hz, 
1H), 5.12 – 5.03 (m, 2H), 4.26 (quint, J = 5.9 Hz, 1H), 2.55 – 2.52 (m, 2H), 2.30 (ddt, J = 7.1, 6.0, 
1.2 Hz, 2H), 0.87 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 202.3, 133.9, 118.3, 67.9, 50.5, 42.5, 25.9, 18.1, –4.2, –4.7. 
FTIR (ATR): 2955, 2929, 2890, 2857, 1726, 1641, 1472, 1361, 1254, 1098, 1041, 1005, 915, 834, 
810, 774, 680 cm–1.  
HRMS (FAB+, m/z): calc’d for C12H25O2Si [M+H]+ 229.1618, found: 229.1629. 
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In a nitrogen-filled glovebox, 55 (146 mg, 0.64 mmol, 1 equiv) and cis-3-hexene (215 mg, 2.56 
mmol, 4 equiv) were weighed into a 4 mL vial.  A solution of catalyst Ru-4 (22 mg, 25.6 μmol, 4 
mol%) in THF (1.5 mL) was transferred into the vial.  The reaction mixture was stirred for 1 h at 
23 ºC.  An aliquot was taken for GC analysis to monitor the conversion.  Then the vial was brought 
out of the glovebox, and concentrated in vacuo.  The residue was purified by column 
chromatography (SiO2, hexanes/EtOAc 20:1) to afford 14 (145 mg, 88%) as a colorless liquid.   
 
TLC (10:1 hexanes/EtOAc): Rf= 0.45 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 9.80 (t, J = 2.4 Hz, 1H), 5.54 – 5.41 (m, 1H), 5.32 (dtt, J = 10.8, 
7.5, 1.6 Hz, 1H), 4.22 (dq, J = 7.1, 5.7 Hz, 1H), 2.51 (dd, J = 5.8, 2.4 Hz, 2H), 2.38 – 2.17 (m, 2H), 
2.10 – 1.92 (m, 2H), 0.96 (t, J = 7.5 Hz, 3H), 0.87 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 202.4, 134.8, 123.7, 68.3, 50.6, 35.7, 25.9, 20.9, 18.1, 14.3, –4.2, 
–4.7. 
FTIR (ATR): 2957, 2930, 2890, 2857, 1726, 1472, 1361, 1253, 1096, 1005, 938, 834, 811, 774, 
680 cm–1.  
HRMS (FAB+, m/z): calc’d for C14H27O2Si [M+H-H2]+ 255.1774, found: 255.1780. 
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A 25 mL flask was flame dried and charged with CuBr•Me2S (142 mg, 0.69 mmol, 3.0 equiv) and 
LiCl (31 mg, 0.74 mmol, 3.2 equiv) in a nitrogen-filled glove box.  The flask was sealed with a 
septum and brought out of the glove box, and heated under vacuum to remove residue water.  
Anhydrous THF (5 mL) was added, and the solution was vigorously stirred for 10 minute at 23 ºC 
until a yellow solution was formed.  At –78ºC, allylmagnesium bromide (0.65 mL, 1.0 M solution 
in THF, 0.65 mmol, 2.8 equiv) was added slowly.  The reaction mixture was stirred at –78 ºC for 
1 hour and a solution of (R)-43 (137 mg, 0.69 mmol, 3.0 equiv) in THF (1 mL) was added slowly.  
After 30 minutes stirring at the same temperature, a solution of 14 (59 mg, 0.23 mmol, 1.0 equiv) 
in THF (1 mL) was added slowly.  The reaction was stirred for an additional 2 hours at –78 ºC 
before a solution of saturated NH4Cl and NH3•H2O (10 mL, 9:1 NH4Cl/NH3•H2O) was added.  The 
biphasic solution was vigorously stirred until a homogeneous dark blue solution was formed in the 
aqueous phase.  The phases were separated and the organic phase was washed with 10 mL 
saturated NH4Cl solution.  The combined aqueous phase was extracted with Et2O (2 × 30 mL).  
The combined organic phase was dried with anhydrous magnesium sulfate, and concentrated in 
vacuo.  The residue was purified by flash chromatography (SiO2, hexanes/EtOAc 18:1) to give a 




1. CuBr•Me2S, LiCl, allylMgBr
THF, –78 ºC
then 14, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC
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In a 25 mL flask, the crude aldol product was dissolved in CH2Cl2 (5 mL) and cooled to –10 ºC.  
DMAP (242 mg, 2.0 mmol, 15.0 equiv) and MsCl (31 μL, 0.4 mmol, 3.0 equiv) was added 
sequentially.  The reaction mixture was slowly warmed to 23 ºC and was stirred for 12 h before 
diluted with 10 mL EtOAc and washed with 1 M HCl (5 mL).  The aqueous phase was extracted 
with EtOAc (2 × 10 mL).  The combined organic phase was dried with anhydrous magnesium 
sulfate, and concentrated in vacuo.  The residue was purified by flash chromatography 
(hexanes/EtOAc 15:1) to give 56 (33 mg, 40% yield over 2 steps) as a colorless liquid. 
 
TLC (4:1 hexenes/EtOAc): Rf= 0.67 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.51 (ddd, J = 6.1, 2.6, 1.0 Hz, 1H), 6.61 (ddt, J = 9.0, 8.0, 1.3 Hz, 
1H), 6.33 (dd, J = 6.0, 1.8 Hz, 1H), 5.79 – 5.64 (m, 1H), 5.52 – 5.41 (m, 1H), 5.42 – 5.30 (m, 1H), 
5.10 – 5.01 (m, 2H), 3.88 (quint, J = 6.0 Hz, 1H), 3.48 (ddd, J = 8.8, 4.0, 2.0 Hz, 1H), 2.72 – 2.61 
(m, 1H), 2.46 – 2.38 (m, 2H), 2.30 – 2.11 (m, 3H), 2.05 – 1.95 (m, 2H), 0.93 (t, J = 7.5 Hz, 3H), 
0.87 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 196.4, 161.4, 138.6, 135.1, 134.4, 134.1, 132.7, 124.4, 117.7, 
71.7, 43.1, 37.1, 36.9, 35.3, 26.0, 20.9, 18.2, 14.3, –4.4, –4.4. 
FTIR (ATR): 2957, 2929, 2894, 2856, 1706, 1657, 1582, 1472, 1366, 1253, 1148, 1083, 1005, 
966, 915, 835, 808, 775 cm–1.  
HRMS (FAB+, m/z): calc’d for C22H37O2Si [M+H]+ 361.2557, found: 361.2576. 
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Preparation of 57: 




In a nitrogen-filled glovebox, cis-5-octen-1-ol (72 mg, 0.55 mmol, 6.7 equiv) was dissolved in 
toluene (1 mL) in a 50 mL Schlenk flask and a solution of catalyst Ru-4 (4.7 mg, 5.6 μmol, 1 
mol%) in THF (0.6 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum.  The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing).  After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox.  The residue was diluted with 0.5 mL THF, and an aliquot 
was taken for GC analysis (conversion of homodimerization step was >98% by GC analysis).  A 
solution of 56 (30 mg, 0.083 mmol, 1 equiv) in 0.5 mL THF was added into the Schlenk flask and 
an additional 0.4 mL of catalyst solution with Ru-4 (2.9 mg, 3.5 μmol, 5 mol%) was added.  The 
Schlenk flask was sealed and brought out of glovebox.  The reaction was stirred for 12 h at 23 ºC 
before a few drops of ethyl vinyl ether were added.  The solvent was removed under reduced 
pressure.  The residue was purified by flash chromatography (hexanes/EtOAc 10:1 to 2:1).  57 (16 









   toluene, 23 ºC, 2 torr
then 56, Ru-4 (5 mol%)
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Compound 57: 
TLC (2:1 hexanes/EtOAc): Rf= 0.28 (UV).  
1H NMR (400 MHz, CDCl3) δ 7.50 (ddd, J = 6.0, 2.7, 1.0 Hz, 1H), 6.60 (ddt, J = 8.2, 7.0, 1.3 Hz, 
1H), 6.32 (dd, J = 6.0, 1.8 Hz, 1H), 5.53 – 5.43 (m, 2H), 5.41 – 5.31 (m, 2H), 3.89 (quint, J = 6.1 
Hz, 1H), 3.64 (t, J = 6.5 Hz, 2H), 3.45 (ddq, J = 8.4, 4.3, 2.2 Hz, 1H), 2.68 – 2.55 (m, 1H), 2.43 
(ddd, J = 7.7, 6.4, 2.3 Hz, 2H), 2.29 – 2.11 (m, 3H), 2.08 – 1.91 (m, 4H), 1.62 – 1.51 (m, 2H), 1.48 
– 1.36 (m, 2H), 0.94 (t, J = 7.6 Hz, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 196.5, 161.8, 138.9, 135.0, 134.2, 132.7, 132.5, 125.5, 124.4, 71.7, 
62.9, 43.6, 37.0, 35.3, 32.5, 30.8, 27.2, 26.0, 25.9, 20.9, 18.2, 14.3, –4.4, –4.4. 
FTIR (ATR): 3429, 2956, 2928, 2856, 2361, 2327, 1702, 1652, 1580, 1472, 1360, 1251, 1213, 
1066, 1005, 968, 834, 807, 774, 721, 668 cm–1.  
HRMS (FAB+, m/z): calc’d for C26H45O3Si [M+H]+ 433.3132, found: 433.3121. 
[𝜶]𝑫𝟐𝟑: +136.3° (c = 1.0, C6H6). 
 
Compound 59: 
TLC (2:1 hexanes/EtOAc): Rf= 0.6 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.43 (ddd, J = 5.9, 2.8, 1.0 Hz, 1H), 6.80 (ddt, J = 10.8, 8.8, 1.3 
Hz, 1H), 6.31 (dd, J = 5.9, 1.7 Hz, 1H), 5.76 (q, J = 9.1 Hz, 1H), 5.61 (dddd, J = 11.9, 10.7, 5.2, 
1.2 Hz, 1H), 4.08 – 4.02 (m, 1H), 3.27 (d, J = 9.6 Hz, 1H), 2.38 (dd, J = 9.5, 3.0 Hz, 2H), 2.24 (q, 
J = 11.6 Hz, 2H), 2.17 – 1.95 (m, 2H), 0.91 (s, 9H), 0.11 (s, 3H), 0.08 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 196.4, 162.3, 141.3, 134.0, 132.4, 130.6, 129.6, 73.1, 44.2, 34.7, 
34.5, 32.6, 26.0, 18.3, –4.6, –4.7. 
FTIR (ATR): 2952, 2926, 2886, 2855, 2359, 2339, 1705, 1654, 1586, 1471, 1369, 1251, 1190, 
1077, 1039, 997, 980, 938, 855, 835, 808, 790, 774, 727, 668 cm–1.  
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HRMS (FAB+, m/z): calc’d for C18H29O2Si [M+H]+ 305.1931, found: 305.1942. 
[𝜶]𝑫𝟐𝟑: –27.8° (c = 0.8, CHCl3) 
 
B. Z-selective cross-metathesis using Ru-2: 
 
In a nitrogen-filled glovebox, 56 (64 mg, 0.18 mmol, 1.0 equiv) and 5-hexen-1-ol (142 mg, 1.42 
mmol, 8.0 equiv) were weighed into a 4 mL vial.  THF (0.3 mL) was added to dissolve the mixture. 
Catalyst Ru-2 (24 mg, 20 mol%) was dissolved in THF (0.4 mL) and 0.1 mL of this catalyst 
solution was transferred into the vial.  The vial was sealed with a 14/20 septum and brought out of 
the glovebox.  The reaction was stirred at 40 ºC with a stream of argon (saturated with anhydrous 
THF) bubbling through a needle.  A portion of the catalyst solution (0.1 mL) was added into the 
vial in each 1 hour.  After all the catalyst was added, the reaction mixture was continued to stir for 
4 h with argon bubbling.  A few drops of ethyl vinyl ether were added, and the reaction mixture 
was concentrated in vacuo.  The residue was purified by column chromatography (SiO2, 
hexanes/EtOAc 2:1) to afford 57 (40 mg, 52%) as a colorless liquid.   Compund 58 was the 
proposed by-product (molar ratio of 57:58 was 32:1 as determined by crude NMR analysis). 
 
Compound 57: Characterization data were in agreement with previously obtained data. 
Compound 58: Characterization data not available due to the difficulty in separation; mass data 
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To a stirred solution of 57 (21.6 mg, 0.05 mmol, 1.0 equiv) in MeCN (0.5 mL) was added 
NMO•H2O (67.5 mg, 0.5 mmol, 10.0 equiv).  Tetrapropylammonium perruthenate (1.8 mg, 5 μmol, 
0.1 equiv) was added until NMO•H2O was fully dissolved and the reaction was stirred at 23 ºC for 
3 hours.  The solution was diluted with Et2O (5 mL), passed through a short pad of silica gel, 
concentrated, and subjected to the next reaction without further purification. 
 
The residue was dissolved in MeCN (1.0 mL) and cooled to 0 ºC.  A solution of hydrofluoric acid 
(48 wt. % in H2O, 0.2 mL) in MeCN (0.4 mL) was added dropwisely.  The solution was stirred in 
the same temperature for 30 min before saturated NaHCO3 solution (1.5 mL) and brine (1.5 mL) 
were added.  The aqueous phase was extracted with EtOAc (5 × 5 mL).  The combined organic 
phase was dried over magnesium sulfate, filtered, and concentrated (not to dryness).  The residue 
was purified by flash chromatography (SiO2, CH2Cl2/MeOH 20:1) and through Biotage® SNAP 
Ultra C18 column (H2O/MeOH) to give 3 (10 mg, 60% over 2 steps) as a colorless liquid. 
 
TLC (100% EtOAc): Rf= 0.55 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.58 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.57 (ddt, J = 8.4, 7.0, 1.2 Hz, 
1H), 6.36 (dd, J = 6.0, 1.8 Hz, 1H), 5.69 – 5.60 (m, 1H), 5.60 – 5.45 (m, 2H), 5.45 – 5.35 (m, 1H), 
3.91 (quint, J = 6.8 Hz, 1H), 3.50 – 3.44 (m, 1H), 2.75 (ddd, J = 13.9, 6.9, 4.4 Hz, 1H), 2.68 – 2.58 
1.TPAP, NMO•H2O
MeCN
2. HF (aq.), MeCN
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(m, 1H), 2.49 (ddd, J = 15.2, 8.4, 7.0 Hz, 1H), 2.36 (t, J = 6.8 Hz, 2H), 2.33 – 2.28 (m, 2H), 2.20 
– 1.98 (m, 5H), 1.68 (quint, J = 7.0 Hz, 2H), 0.96 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 196.4, 175.8, 161.8, 139.9, 136.4, 135.1, 131.7, 131.2, 126.3, 
123.6, 71.1, 44.0, 36.3, 34.5, 32.9, 30.7, 26.6, 24.7, 20.9, 14.4. 
 FTIR (ATR): 3449, 3010, 2956, 2919, 2850, 1728, 1703, 1650, 1579, 1455, 1375, 1222, 1182, 
1046, 959, 838, 809, 721 cm–1.  
HRMS (FAB+, m/z): calc’d for C20H29O4 [M+H]+ 333.2060, found: 333.2060. 
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Spectral data (1H NMR, 13C NMR, HRMS) matched with the published data.12,14,16  Comparisons 
of 1H NMR data of natural and synthetic ∆12-prostaglandin J3 (3) are listed in Table 1.6.2. 
 
 
























Natural  ∆12-PGJ3 1H NMR12 
600 MHz, CDCl3 1H [δ, multi, J 
(Hz)]  
This Work, Synthetic ∆12-PGJ3 1H 
NMR 
400 MHz, CDCl3 1H [δ, multi, J (Hz)]  
1 n.d.  
2 2.35 (t, J = 7.0 Hz) 2.36 (t, J = 6.8 Hz) 
3 hidden 1.78 – 1.66 (m) 
4 2.02 (m)       2.20 – 2.10 (m) 
5 5.42 (m) 5.60 – 5.51 (m) 
6 hidden 5.51 – 5.45 (m) 
7α 2.64 (m) 2.75 (ddd, J = 13.9, 6.9, 4.4 Hz) 
7β 2.08 (m) 2.20 – 2.10 (m) 
8 3.47 (ddd,  J = 10.0, 4.0, 2.0 Hz) 3.50 – 3.44 (m) 
9 7.56 (ddd,  J = 6.0, 2.0, 1.0 Hz) 7.58 (ddd, J = 6.0, 2.6, 1.0 Hz) 
10 6.35 (dd,  J = 6.0, 2.0 Hz) 6.36 (dd, J = 6.0, 1.8 Hz) 
11 n.d.  
12 n.d.  
13 6.58 (m) 6.57 (ddt, J = 8.4, 7.0, 1.2 Hz) 
14α 2.55 (dt,  J = 15.0, 7.0 Hz) 2.68 – 2.57 (m) 
14β 2.47 (ddd,  J = 15.0, 8.0, 6.0 Hz) 2.49 (ddd, J = 15.2, 8.4, 7.0 Hz) 
15 3.88 (quint,  J = 6.0 Hz) 3.91 (quint, J = 6.8 Hz) 
16 2.28 (m) 2.33 – 2.28 (m) 
17 hidden 5.45 – 5.35 (m) 
18 5.51 (m) 5.69 – 5.60 (m) 
19α 2.00 (m) 2.10 – 1.98 (m) 
19β 1.98 (m)   2.10 – 1.98 (m) 
20 0.96 (t,  J = 7.0 Hz) 0.96 (t, J = 7.5 Hz) 
Chapter 1 – Concise Total Syntheses of ∆12-Prostaglandin J  
Natural Products Via Stereoretentive Metathesis 
55 




A 25 mL flask was flame dried and charged with CuBr•Me2S (195 mg, 0.95 mmol, 1.9 equiv) and 
LiCl (42 mg, 1.0 mmol, 2.0 equiv) in a nitrogen-filled glove box.  The flask was sealed with septum 
and brought out of glove box, and was heated under vacuum to remove residue water.   Anhydrous 
THF (10 mL) was added, and the solution was vigorously stirred for 10 minute at 23 ºC until a 
yellow homogeneous solution was formed.  At –78ºC, allyl magnesium bromide (0.9 mL, 1.0 M 
solution in THF, 0.9 mmol, 1.8 equiv) was added slowly.  The reaction mixture was stirred at –78 
ºC for 1 hour and a solution of (R)-43 (198 mg, 1.0 mmol, 2.0 equiv) in THF (1 mL) was added 
slowly.  After 30 minutes of stirring at the same temperature, a solution of known compound 60 
(prepared according to Honda and co-workers44) (62 mg, 0.5 mmol, 1.0 equiv) in THF (1 mL) was 
added slowly.  The reaction was stirred for an additional 2 hours at –78 ºC before a solution of 
saturated NH4Cl and NH3•H2O (10 mL, 9:1 NH4Cl/NH3•H2O) was added.  The biphasic solution 
was vigorously stirred until a homogeneous dark blue solution formed in aqueous phase.  The 
phases were separated and the organic phase was washed with 10 mL saturated NH4Cl solution.  
The combined aqueous phase was extracted with Et2O (2 × 30 mL). The combined organic phase 
was dried with anhydrous magnesium sulfate, and concentrated in vacuo.  The residue was purified 
by flash chromatography (SiO2, hexanes/EtOAc 15:1) to give a mixture of diasteromers of the 
aldol products (51 mg, 0.21 mmol). 
O
BocO
1. CuBr•Me2S, LiCl, allylMgBr
THF, –78 ºC
then 60, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC
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In a 25 mL flask, the crude aldol product was dissolved in CH2Cl2 (6 mL) and cooled to –10 ºC.  
DMAP (384 mg, 3.15 mmol, 15.0 equiv) and MsCl (49 μL, 0.63 mmol, 3.0 equiv) was added 
sequentially.  The reaction mixture was slowly warmed to 23 ºC and was stirred for 2 h before 
diluted with 10 mL EtOAc and washed with 1 M HCl (10 mL).  The aqueous phase was extracted 
with EtOAc (2 × 20 mL).  The combined organic phase was dried with anhydrous magnesium 
sulfate, and concentrated in vacuo.  The residue was purified by flash chromatography 
(hexanes/EtOAc 15:1) to give 61 (41 mg, 36% yield over 2 steps) as a colorless liquid. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.56 (UV). 
1H NMR (400 MHz, CDCl3): δ 7.50 (ddd, J = 5.9, 2.6, 1.0 Hz, 1H), 7.03 – 6.90 (m, 1H), 6.36 (dd, 
J = 6.1, 1.8 Hz, 1H), 6.34 – 6.29 (m, 1H), 6.21 (dt, J = 15.1, 6.3 Hz, 1H), 5.79 – 5.66 (m, 1H), 5.54 
(dtt, J = 10.2, 7.2, 1.5 Hz, 1H), 5.37 (dtt, J = 10.5, 7.3, 1.6 Hz, 1H), 5.10 – 5.02 (m, 2H), 3.60 (ddq, 
J = 8.5, 4.0, 1.9 Hz, 1H), 3.00 – 2.95 (m, 2H), 2.65 (dddt, J = 13.7, 6.8, 4.2, 1.4 Hz, 1H), 2.25 
(dddt, J = 14.2, 8.8, 7.7, 1.1 Hz, 1H), 2.07 (dquint, J = 7.5, 1.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.5, 160.7, 144.5, 135.4, 135.4, 134.2, 134.1, 131.6, 125.8, 
124.6, 117.9, 43.3, 37.4, 31.2, 20.7, 14.3. 
FTIR (ATR): 3011, 2963, 2931, 2874, 2361, 2335, 1692, 1629, 1579, 1440, 1339, 1280, 1207, 
1100, 989, 915, 872, 839, 729, 668 cm–1.  
HRMS (FAB+, m/z): calc’d for C16H21O [M+H]+ 229.1587, found: 229.1588. 
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Preparation of 62:  




In a nitrogen-filled glovebox, cis-5-octen-1-ol (205 mg, 1.6 mmol, 8.0 equiv) was dissolved in 
toluene (1 mL) in a 50 mL Schlenk flask and a solution of catalyst Ru-4 (13.6 mg, 16 μmol, 1 
mol%) in THF (0.6 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum.  The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing).  After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox.  The residue was diluted with 0.5 mL THF, and an aliquot 
was taken for GC analysis (conversion of homodimerization step was >98% by GC analysis).  A 
solution of 61 (46 mg, 0.2 mmol, 1.0 equiv) in 0.5 mL THF was added into the Schlenk flask and 
an additional 0.4 mL of catalyst solution with Ru-4 (8.5 mg, 10 μmol, 5 mol%) was added.  The 
Schlenk flask was sealed and brought out of glovebox.  The reaction was stirred for 12 h at 23 ºC 
before a few drops of ethyl vinyl ether were added.  The solvent was removed under reduced 
pressure.  The residue was purified by column chromatography (SiO2, hexanes/EtOAc 2:1).  
Compounds 62 (22 mg, 36%) and 63 were separated as a mixture (28 mg, molar ratio of 62:63 was 
3:1 as determined by crude NMR analysis). 
 
Compound 62: Characterization data not available due to the difficulty in separation. 









   toluene, 23 ºC, 2 torr
then 61, Ru-4 (5 mol%)
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Compound 63: Characterization data not available due to the difficulty in separation, mass data 
was obtained by LC-MS (TOF, ES+, m/z): calc’d for C18H25O2 [M+H]+ 273.1849, found: 
273.1759. 
 




In a nitrogen-filled glovebox, 61 (23 mg, 0.1 mmol, 1.0 equiv) and 5-hexen-1-ol (80 mg, 0.8 mmol, 
8.0 equiv) were weighed into a 4 mL vial.  THF (0.1 mL) was added to dissolve the mixture.  
Catalyst Ru-2 (13.6 mg, 20 mol%) was dissolved in THF (0.4 mL) and 0.1 mL of this catalyst 
solution was transferred into the vial.  The vial was sealed with a 14/20 septum and brought out of 
the glovebox.  The reaction was stirred at 40 ºC with a stream of argon (saturated with anhydrous 
THF) bubbling through a needle.  A portion of the catalyst solution (0.1 mL) was added into the 
vial in each 1 hour.  After all the catalyst was added, the reaction mixture was continued to stir for 
2 h with argon bubbling.  A few drops of ethyl vinyl ether was added, and the reaction mixture 
was concentrated in vacuo.  The residue was purified by column chromatography (SiO2, 
hexanes/EtOAc 2:1).  Compounds 62 (9.2 mg, 31%) and 63 were separated as a mixture (12 mg, 
molar ratio of 62:63 was 3:1 as determined by crude NMR analysis). 
 
Compound 62: Characterization data not available due to the difficulty in separation. Mass data 
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Compound 63: Characterization data not available due to the difficulty in separation, mass data 
was obtained by LC-MS (TOF, ES+, m/z): calc’d for C18H25O2 [M+H]+ 273.1849, found: 
273.1855. 
 




Pyridinium chlorochromate (22 mg, 0.1 mmol, 3.0 equiv) was added to a solution of 62 (mixed 
with by-product 63) (10 mg, 0.033 mmol, 1.0 equiv) in CH2Cl2 (0.5 mL) at 23 ºC.  The reaction 
was monitored by TLC and was diluted with Et2O (3 mL) after stirring for 3 h.  The resulting 
solution was filtered through a short pad of silica gel, and was subjected to the next step without 
further purification. 
 
The residue was dissolved in t-BuOH (0.5 mL) at 23 ºC, and 2-methyl-2-butene (35 μL, 0.33 mmol, 
10 equiv), a solution of NaH2PO4•H2O (6.9 mg, 0.05 mmol, 1.5 equiv) in H2O (0.12 mL) and a 
solution of NaClO2 (80 %, 5.6 mg, 0.05 mmol, 1.5 equiv) in H2O (0.12 mL) was added sequentially.  
After stirring at 23 ºC for 30 minutes, the reaction mixture was diluted with a solution of 
NaH2PO4•H2O (108 mg) in H2O (2 mL) and extracted with EtOAc (5 × 5 mL).  The combined 
organic extracts were dried over anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure.  Flash column chromatography (SiO2, CH2Cl2/MeOH 20:1) and purification 
through Biotage® SNAP Ultra C18 column (H2O/MeOH) afforded pure compound 4 (4 mg, 0.013 
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TLC (10:1 CH2Cl2/MeOH): Rf= 0.44 (UV). 
1H NMR (500 MHz, CDCl3): δ 7.48 (ddd, J = 6.1, 2.6, 1.0 Hz, 1H), 6.96 (d, J = 11.5 Hz, 1H), 
6.42 – 6.31 (m, 2H), 6.22 (dt, J = 14.9, 6.3 Hz, 1H), 5.57 – 5.51 (m, 1H), 5.50 – 5.43 (m, 1H), 5.37 
(dtt, J = 10.1, 6.8, 1.7 Hz, 2H), 3.64 – 3.55 (m, 1H), 2.98 (t, J = 6.8 Hz, 2H), 2.60 (dt, J = 12.3, 5.9 
Hz, 1H), 2.43 – 2.25 (m, 3H), 2.12 – 2.00 (m, 4H), 1.69 (quint, J = 7.4 Hz, 2H), 0.99 (t, J = 7.5 
Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 176.6, 160.9, 144.5, 135.5, 135.5, 134.2, 131.6, 131.5, 
126.1, 125.8, 124.6, 43.6, 33.0, 31.2, 30.9, 26.7, 24.6, 20.7, 14.3. 
FTIR (ATR): 3010, 2960, 2926, 2874, 2854, 1710, 1693, 1626, 1578, 1512, 1455, 1208, 1154, 
1087, 1024, 977, 817, 728 cm–1.  
HRMS (FAB+, m/z): calc’d for C20H27O3 [M+H]+ 315.1955, found: 315.1968. 
[𝜶]𝑫𝟐𝟑: +129.6° (c = 0.07, C6H6). 
Spectral data (1H NMR, 13C NMR, HRMS) matched with the published data.15 
 
Preparation of (±)-65: 
 
 
Racemic enone (±)-33 was obtained from photooxygenation of dicyclopentadiene  catalyzed by 
tetraphenylporphyrin (TPP) according to Mihelich-Eickhoff’s procedure.39  In a 500 mL round 
bottom flask, (±)-33 (13.2 g, 8.9 mmol) was dissolved in anhydrous toluene (150 mL) under argon 
atmosphere. The solution was cooled to –78 ºC, and a solution of DIBAL-H (1.0 M solution in 
toluene, 13.4 mL, 13.4 mmol, 1.5 equiv) was added dropwisely.  After 1.5 h, MeOH (50 mL) was 
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temperature and poured into a saturated Na-K tartrate solution (150 mL) and the biphasic solution 
was stirred overnight. The aqueous phase was extracted with CH2Cl2 (3 × 200 mL). The combined 
organic phases were dried with anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure. Purification by flash column chromatography on silica gel (SiO2, 10:1 to 4:1 
hexanes/EtOAc) afforded compound (±)-65 as a white solid (10.9 g, 81% yield). 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.3 (KMnO4).  
1H NMR (400 MHz, CDCl3) δ 6.15 (dd, J = 5.7, 2.6 Hz, 1H), 5.81 (dd, J = 5.7, 3.2 Hz, 1H), 5.59 
(s, 2H), 4.67 (t, J = 9.0 Hz, 1H), 3.29 (dd, J = 7.6, 4.1 Hz, 1H), 2.99 – 2.87 (m, 3H), 1.51 (ddt, J = 
46.0, 8.0, 1.6 Hz, 2H), 1.23 (d, J = 9.6 Hz, 1H) 
 




In a 250 mL round bottom flask, (±)-65 (4.8 g, 32.4 mmol) was dissolved in MTBE (100 mL, 
0.33M), and vinyl acetate (1.78 mL, 0.6 equiv) was added via syringe. Lipase PS (10% on celite, 
480 mg, 10 wt%) was added to the flask. The flask was sealed with septum and kept under argon 
atmosphere, and placed in 37 ºC oil bath.  After 48 h, the reaction mixture was filtered through 
celite and concentrated. Column chromatography (SiO2, 10:1to 4:1 hexanes/EtOAc) afforded 
white solids (–)-66 (2.93 g, 48% yield) and (+)-65 (2.36 g, 49% yield). 
 
 
lipase PS (10 wt%)
vinyl acetate(0.6 equiv)
MTBE, 37 ºC, 48 h
+
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(–)-66: 
TLC (10:1 hexanes/EtOAc): Rf= 0.68 (KMnO4).  
1H NMR (400 MHz, CDCl3) δ 5.98 (dd, J = 5.7, 2.9 Hz, 1H), 5.76 (dd, J = 5.6, 3.1 Hz, 1H), 5.70 
(dt, J = 5.8, 2.0 Hz, 1H), 5.55 (dt, J = 5.8, 1.9 Hz, 1H), 5.44 (dq, J = 9.0, 1.7 Hz, 1H), 3.28 (ddt, J 
= 7.6, 3.5, 1.7 Hz, 1H), 3.08 (ddd, J = 8.9, 7.7, 4.1 Hz, 1H), 2.89 (ddp, J = 4.3, 2.9, 1.3 Hz, 1H), 
2.76 (s, 1H), 2.07 (s, 3H), 1.46 (ddt, J = 39.3, 8.2, 1.7 Hz, 2H). 
 
(+)-65: 
TLC (10:1 hexanes/EtOAc): Rf= 0.28 (KMnO4).  
1H NMR spectrum data matches (±)-65 
[𝜶]𝑫𝟐𝟑: +117.9° (c = 1.0, CHCl3). 
 
Preparation of (+)-33: 
 
To a stirred solution of (–)-66 (2.8 g, 14.7 mmol) in MeOH (50 mL) was added K2CO3 (2.03 g, 1 
equiv).  The solution was stirred for 12 h and concentrated, then dissolved in water (30 mL) and 
extracted by Et2O (30 mL).  Column chromatography (SiO2, 4:1 hexenes/EtOAc) afforded (–)-65 
as a white solid (2.04 g, 98%). Spectrum data matches (±)-65.   
[𝜶]𝑫𝟐𝟑: –138.1° (c = 1.0, CHCl3). 
 
A 100 mL round bottom flask containing 4Å molecular sieves (9.0 g) was flame dried under 
vacuum. After the flask cooled down to room temperature, (–)-65 (2.01 g, 13.6 mmol), NMO (3.19 
(–)-65 (98%)
K2CO3MeOH
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g, 27.2 mmol, 2 equiv) was added and dissolved in MeCN (3 mL) and CH2Cl2 (27 mL). TPAP 
(150 mg, 0.42 mmol, 0.03 equiv) and the reaction was stirred under argon for 1 hour, and the 
reaction progress was monitored by GC.  The reaction mixture was filtered over celite and 
concentrated. Column chromatography (SiO2, 4:1 hexenes/EtOAc) afforded (+)-33 as a white solid 
(1.24 g, 63%). NMR spectrum data matches (±)-33.   
 
TLC (4:1 hexanes/EtOAc): Rf= 0.35 (UV).  
1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 5.7, 2.6 Hz, 1H), 5.95 (ddd, J = 7.8, 5.6, 2.3 Hz, 2H), 
5.78 (dd, J = 5.7, 3.0 Hz, 1H), 3.42 (dddd, J = 5.6, 4.2, 2.6, 1.6 Hz, 1H), 3.22 (dt, J = 4.1, 1.8 Hz, 
1H), 2.97 (ddt, J = 4.2, 2.7, 1.4 Hz, 1H), 2.80 (t, J = 5.1 Hz, 1H), 1.78 – 1.60 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ 210.9, 164.7, 137.1, 132.7, 52.9, 50.4, 48.4, 45.1, 44.2. 
FTIR (ATR): 2990. 2972, 1683, 1576, 1347, 1333, 1294, 1251, 1224, 1194, 1178, 1120, 1091, 
1018, 959, 853, 817, 784, 739, 721, 652 cm–1.  
HRMS (FAB+, m/z): calc’d for C10H11O [M+H]+ 147.0810, found: 147.0809. 
[𝜶]𝑫𝟐𝟑: +136.6° (c = 1.0, CHCl3). 
 
Preparation of enone (–)-33: 
A. Oxidation using TPAP, NMO: 
 
A 100 mL round bottom flask containing 4Å molecular sieves (9.0 g) was flame dried under 
vacuum. After the flask cooled down to room temperature, (+)-65 (2.00 g, 13.5 mmol), NMO (3.16 
g, 27 mmol, 2 equiv) was added and dissolved in MeCN (3 mL) and CH2Cl2 (27 mL). TPAP (142 
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mg, 0.41 mmol, 0.03 equiv) was addedand the reaction was stirred under argon for 1 hour, and the 
reaction progress was monitored by GC.  The reaction mixture was filtered over celite and 
concentrated. Column chromatography (SiO2, 4:1 hexenes/EtOAc) afforded (–)-33 as a white solid 
(1.41 g, 71%).  
 
B. Oxidation using Stahl’s conditions: 
 
An oven-dried, 200 mL round-bottomed flask was charged with alcohol (+)-65  (2.01 g, 13.6 mmol, 
1.0 equiv) and anhydrous MeCN (100 mL). The solution was vigorously stirred (>700 rpm) open 
to air while being treated with MeObpy (147 mg, 0.68 mmol, 0.05 equiv), Cu(MeCN)4OTf (256 
mg, 0.68 mmol, 0.05 equiv), ABNO (0.04 M in MeCN, 3.4 mL, 135.6 µmol, 0.01 equiv), and then 
NMI (110 µL, 1.36 mmol, 0.10 equiv) via microsyringe.  The resulting brick-red reaction mixture 
was vigorously stirred exposed to air at ambient temperature until the reaction mixture turned a 
blue-green in an hour, at which point TLC analysis indicated the complete consumption of starting 
material. The reaction mixture was diluted with Et2O (50 mL), and filtered through Celite, washing 
with 50% EtOAc/hexanes. The filtrate was concentrated in vacuo and the crude residue was 
directly purified by flash chromatography (SiO2, 4:1 hexenes/EtOAc) to afford (–)-33 (1.92 g, 97% 
yield) as a white solid. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.35 (UV).  
1H NMR spectrum data matches (+)-33 
[𝛼]()*: –121.9° (c = 1.0, CHCl3). 










MeCN, air, 23 ºC
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HPLC Conditions:  
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A 250 mL flask was charged with CuI (2.56 g, 13.44 mmol, 1.2 equiv) and flame dried under 
vacuum.  After cooling to room temperature, anhydrous THF (100 mL) and Me2S (5 mL) was 
added, and the solution was vigorously stirred for 5 minutes at room temperature until a yellow 
homogeneous solution was formed. At –78ºC, allylmagnesium bromide (12.3 mL, 1.0 M solution 
in THF, 12.3 mmol, 1.1 equiv) was added slowly. The reaction mixture was stirred at –78 ºC for 
1 hour and a solution of (+)-33 (1.637 g, 11.2 mmol, 1.0 equiv) in THF (5 mL) was added slowly. 
After 30 minutes stirring at the same temperature, a solution of trans-2-octenal (2.826 g, 22.4 
mmol, 2.0 equiv) in THF (3 mL) was added slowly. The reaction was stirred for additional 1 hour 
at –78 ºC, and a solution of saturated NH4Cl and NH3•H2O (100 mL, 9:1 NH4Cl/NH3•H2O) was 
added. The biphasic solution was warmed to room temperature and was vigorously stirred until a 
homogeneous dark blue solution was formed in the aqueous phase. The phases were separated and 
the organic phase was washed with 20 mL saturated NH4Cl solution. The combined aqueous phase 
was extracted with Et2O (3 × 100 mL). The combined organic phase was dried with anhydrous 
magnesium sulfate, and was concentrated in vacuo. The residue was purified by flash 
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A portion of reaction mixture was taken out and the major diastereomer 68 was isolated as follow: 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.33 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3) δ 6.18 (dd, J = 5.7, 2.9 Hz, 1H), 6.10 (dd, J = 5.8, 3.0 Hz, 1H), 5.80 
(dddd, J = 15.7, 11.0, 8.1, 6.1 Hz, 1H), 5.63 (dt, J = 15.3, 6.7 Hz, 1H), 5.30 (ddt, J = 15.3, 8.0, 1.6 
Hz, 1H), 5.13 – 5.06 (m, 2H), 4.18 (d, J = 1.9 Hz, 1H), 4.04 (td, J = 8.2, 1.9 Hz, 1H), 3.19 (ddt, J 
= 4.5, 3.0, 1.4 Hz, 1H), 3.09 (ddd, J = 10.2, 4.7, 2.4 Hz, 1H), 2.98 (tt, J = 2.9, 1.6 Hz, 1H), 2.64 
(ddd, J = 9.9, 5.6, 4.1 Hz, 1H), 2.40 (dddd, J = 13.3, 5.5, 3.8, 1.7 Hz, 1H), 2.12 – 1.97 (m, 4H), 
1.57 (dt, J = 8.4, 1.8 Hz, 1H), 1.51 – 1.42 (m, 2H), 1.41 – 1.22 (m, 6H), 0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 136.3, 135.8, 134.0, 129.8, 117.2, 73.1, 61.8, 56.6, 52.5, 47.2, 45.9, 
45.5, 40.9, 40.4, 32.3, 31.6, 28.8, 22.6, 14.1. (Carbonyl peak not observed below 219 ppm) 
FTIR (ATR): 3465, 3073, 2957, 2925, 2857, 1709, 1640, 1600, 1439, 1413, 1338, 1249, 1224, 
1090, 973, 911, 836, 733 cm–1.  
HRMS (FAB+, m/z): calc’d for C21H29O2 [M+H–H2]+ 313.2168, found: 313.2158. 
[𝜶]𝑫𝟐𝟑: +28.1° (c = 1.0, CHCl3). 
Kobayashi et al. established that for compounds 68 (anti-aldols) 3JHa-Hb is in the range of 8.4 to 9.7 
Hz, while for the corresponding syn-aldols 3JHa-Hb is around 3 Hz.45  
 
Without further separation, the crude aldol product was dissolved in CH2Cl2 (200 mL) and cooled 
to 0 ºC. DMAP (20.5 g, 168 mmol, 15.0 equiv) and MsCl (2.6 mL, 33.6 mmol, 3.0 equiv) was 
added sequentially. The reaction mixture was slowly warmed to room temperature and stirred for 
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100 mL). The combined organic phase was dried with anhydrous magnesium sulfate, and was 
concentrated in vacuo. The residue was purified by flash chromatography (hexanes/EtOAc 20:1) 
to give (+)-67 (2.55 g, 77% yield over 2 steps) as a yellow liquid. 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.48 (UV).  
1H NMR (400 MHz, CDCl3) δ 6.70 (dd, J = 10.7, 2.1 Hz, 1H), 6.20 – 6.04 (m, 2H), 5.97 (qd, J = 
5.6, 2.7 Hz, 2H), 5.79 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.14 – 5.05 (m, 2H), 3.24 (tq, J = 2.8, 1.4 
Hz, 1H), 3.01 (dp, J = 4.4, 1.4 Hz, 1H), 2.97 (dd, J = 8.6, 4.8 Hz, 1H), 2.64 – 2.56 (m, 2H), 2.35 
– 2.26 (m, 1H), 2.22 – 2.07 (m, 3H), 1.49 – 1.37 (m, 4H), 1.35 – 1.23 (m, 4H), 0.89 (t, J = 6.8 Hz, 
3H). 
13C NMR (101 MHz, CDCl3) δ 209.8, 146.8, 141.1, 136.1, 136.0, 133.5, 132.7, 126.3, 117.1, 54.0, 
51.5, 47.4, 47.2, 43.7, 41.2, 40.3, 33.5, 31.4, 28.5, 22.5, 14.0. 
FTIR (ATR): 3062, 2957, 2928, 2858, 1701, 1625, 1600, 1438, 1341, 1293, 1202, 1178, 1122, 
973, 912, 727, 698 cm–1.  
HRMS (FAB+, m/z): calc’d for C21H29O [M+H]+ 297.2218, found: 297.2214. 
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Preparation of (–)-67: 
 
A 250 mL flask was charged with CuI (571 mg, 3 mmol, 1.2 equiv) and flame dried under vacuum.  
After cooling to room temperature, anhydrous THF (25 mL) and Me2S (1 mL) was added, and the 
solution was vigorously stirred for 5 minutes at room temperature until a yellow homogeneous 
solution was formed. At –78ºC, allylmagnesium bromide (2.75 mL, 1.0 M solution in THF, 2.75 
mmol, 1.1 equiv) was added slowly. The reaction mixture was stirred at –78 ºC for 1 hour and a 
solution of (–)-33 (365 mg, 2.5 mmol, 1.0 equiv) in THF (2 mL) was added slowly. After 30 
minutes stirring at the same temperature, a solution of trans-2-octenal (631 mg, 5.0 mmol, 2.0 
equiv) in THF (1 mL) was added slowly. The reaction was stirred for additional 1 hour at –78 ºC, 
and a solution of saturated NH4Cl and NH3•H2O (25 mL, 9:1 NH4Cl/NH3•H2O) was added. The 
biphasic solution was warmed to room temperature and vigorously stirred until a homogeneous 
dark blue solution was formed in the aqueous phase. The phases were separated and the organic 
phase was washed with 10 mL saturated NH4Cl solution. The combined aqueous phase was 
extracted with Et2O (3 × 30 mL). The combined organic phase was dried with anhydrous 
magnesium sulfate, and was concentrated in vacuo. The residue was purified by flash 
chromatography (SiO2, hexanes/EtOAc 15:1) to give a mixture of diasteromers of the aldol 
products (790 mg). 
 
Without further separation, the crude aldol product was dissolved in CH2Cl2 (40 mL) and cooled 
to 0 ºC. DMAP (4.58 g, 37.5 mmol, 15.0 equiv) and MsCl (0.58 mL, 7.5 mmol, 3.0 equiv) was 
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16 h before being washed with 1 M HCl (40 mL). The aqueous phase was extracted with EtOAc 
(3 × 40 mL). The combined organic phase was dried with anhydrous magnesium sulfate, and 
concentrated in vacuo.  The residue was purified by flash chromatography (hexanes/EtOAc 20:1) 
to give (–)-67 (559 mg, 75% yield over 2 steps) as a yellow liquid. 
Characterization data matches (+)-67. 
[𝜶]𝑫𝟐𝟑: –193.4° (c = 1.0, CHCl3). 
 
Preparation of (+)-44: 
 
In a 100 mL round bottom flask, (+)-67 (1.64 g, 5.54 mmol, 1.0 equiv) was dissolved in DCE (50 
mL) and maleic anhydride (5.4 g, 55.4 mmol, 10.0 equiv) and EtAlCl2 (6.0 mL, 1.0 M solution in 
hexanes, 6.0 mmol, 1.1 equiv) were added sequentially. A reflux condenser was attached and the 
reaction mixture was warmed to reflux under argon. After 2 hours, the reaction mixture was cooled 
down, concentrated, and directly loaded on silica gel. Purification by flash chromatography 
(hexanes/EtOAc 15:1) afforded (+)-44 (760 mg, 60% yield, >99% ee by chiral HPLC analysis) as 
a colorless liquid. 
TLC (4:1 hexanes/EtOAc): Rf= 0.56 (UV).  
1H NMR (300 MHz, CDCl3): δ 7.50 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 10.7, 1.2 Hz, 
1H), 6.35 (dd, J = 6.0, 1.8 Hz, 1H), 6.33 – 6.15 (m, 2H), 5.81 – 5.64 (m, 1H), 5.11 – 5.01 (m, 2H), 
3.60 (ddq, J = 8.5, 4.1, 1.9 Hz, 1H), 2.73 – 2.58 (m, 1H), 2.24 (dddd, J = 13.4, 9.7, 6.8, 1.5 Hz, 
3H), 1.54 – 1.37 (m, 2H), 1.38 – 1.22 (m, 4H), 0.96 – 0.84 (t, 3H, J = 6.9 Hz). 
13C NMR (75 MHz, CDCl3): δ 197.5, 160.6, 147.1, 135.4, 134.9, 134.3, 131.8, 125.7, 117.8, 43.2, 
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FTIR (ATR): 2956, 2926, 2856, 1692, 1631, 1580, 1440, 1338, 1280, 1207, 1102, 977, 915, 871, 
839, 801, 753, 730, 666 cm–1.  
HRMS (FAB+, m/z): calc’d for C16H21O [M+H–H2]+ 229.1586, found: 229.1581. 
[𝜶]𝑫𝟐𝟑: +150.4° (c = 1.0, CHCl3). 
 
Preparation of (–)-44: 
 
In a 50 mL round bottom flask, (–)-67 (667 mg, 2.25 mmol, 1.0 equiv) was dissolved in DCE (20 
mL) and maleic anhydride (2.2 g, 22.5 mmol, 10.0 equiv) and EtAlCl2 (2.5 mL, 1.0 M solution in 
hexanes, 2.5 mmol, 1.1 equiv) were added sequentially. A reflux condenser was attached and the 
reaction mixture was warmed to reflux under argon. After 2 hours, the reaction mixture was cooled 
down, concentrated, and directly loaded on silica gel. Purification by flash chromatography 
(hexanes/EtOAc 15:1) afforded (–)-44 (361 mg, 70% yield, >99% ee by chiral HPLC analysis) as 
a colorless liquid. 
Characterization data matches (+)-44. 
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HPLC Conditions:  
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In a nitrogen-filled glovebox, cis-5-octen-1-ol (205 mg, 1.6 mmol, 8.0 equiv) was dissolved in 
toluene (2 mL) in a 50 mL Schlenk flask and a solution of catalyst Ru-4 (13.5 mg, 16 µmol, 1 
mol%) in THF (0.8 mL) was added. The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum. The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing). After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox. The residue was diluted with THF (0.5 mL), and an 
aliquot was taken for GC analysis (conversion of homodimerization step was >98% by GC 
analysis). A solution of (+)-44 (46 mg, 0.2 mmol, 1.0 equiv) in THF (0.5 mL) was added into the 
Schlenk flask and an additional portion of catalyst Ru-4 (8.5 mg, 10 µmol, 5 mol%) solution in 
THF (0.5 mL) was added. The Schlenk flask was sealed and brought out of glovebox.  The reaction 
was stirred for 16 h at 40 ºC before quenched with a few drops of ethyl vinyl ether.  The solvent 
was removed under reduced pressure. The residue was purified by flash chromatography 
(hexanes/EtOAc 2:1) to give 47 (60 mg, 99%, >99:1 Z/E, >99% ee by chiral HPLC analysis).   
 
Spectral data (1H NMR, 13C NMR, HRMS, IR) matched with the published data.46 







   toluene, 23 ºC, 2 torr
then (+)-44, Ru-4 (5 mol%)
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HPLC Conditions:  










Pyridinium chlorochromate (129 mg, 0.6 mmol, 3.0 equiv) was added to a solution of 47 (60 mg, 
0.2 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at room temperature.  The reaction progress was monitored 
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through a short pad of celite, and was concentrated and subjected to the next step without further 
purification. 
 
The residue was dissolved in t-BuOH (3 mL) at room temperature, and 2-methyl-2-butene (210 
μL, 2.0 mmol, 10 equiv), a solution of NaH2PO4•H2O (41.4 mg, 0.3 mmol, 1.5 equiv) in H2O (0.72 
mL) and a solution of NaClO2 (80 %, 33.6 mg, 0.3 mmol, 1.5 equiv) in H2O (0.72 mL) was added 
sequentially. After stirring at room temperature for 30 minutes, the reaction mixture was diluted 
with a solution of NaH2PO4•H2O (648 mg) in H2O (12 mL) and extracted with EtOAc (5 × 10 mL). 
The combined organic extracts were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. Flash column chromatography (SiO2, CH2Cl2/MeOH 20:1) 
afforded pure compound 2 (41 mg, 65% yield over 2 steps) as a colorless oil.  
 
Spectral data (1H NMR, 13C NMR, HRMS, IR) matched with the published data.46 
[𝜶]𝑫𝟐𝟑: +154.4° (c = 1.0, CHCl3). 
 




In a 1-dram vial, 15d-PGJ2 (2) (8.0 mg, 25 µmol, 1.0 equiv) was dissolved in C6H6/MeOH (3:2, 
0.75 mL) at 23 °C. A solution of trimethylsilyldiazomethane (20 µL, 2.0 M in hexanes, 40 µmol, 
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under vacuum.  The residue was purified by flash column chromatography (SiO2, hexanes/EtOAc, 
4:1) to give 69 (6.0 mg, 72% yield, >99% ee) as a colorless oil. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.28 (UV).  
1H NMR (400 MHz, CDCl3) δ 7.47 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.0, 1.2 Hz, 1H), 
6.37 – 6.17 (m, 3H), 5.50 – 5.31 (m, 2H), 3.66 (s, 3H), 3.57 (ddt, J = 8.7, 3.8, 2.0 Hz, 1H), 2.64 – 
2.56 (m, 1H), 2.33 – 2.18 (m, 5H), 2.03 (q, J = 7.3 Hz, 2H), 1.66 (p, J = 7.5 Hz, 2H), 1.46 (p, J = 
7.2 Hz, 2H), 1.31 (ddt, J = 9.3, 5.3, 3.6 Hz, 4H), 0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 197.5, 174.0, 160.8, 147.1, 135.5, 135.2, 131.8, 131.6, 126.1, 
125.8, 51.7, 43.6, 33.6, 33.5, 31.6, 30.9, 28.6, 26.8, 24.8, 22.6, 14.1. 
FTIR (ATR): 2953, 2927, 2856, 2360, 2342, 1736, 1694, 1632, 1579, 1436, 1364, 1205, 1090, 
979, 836, 729, 668 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C20H29O3 [M+H]+ 331.2268, found: 331.2720. 
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SFC Conditions:  
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13C NMR (101 MHz, CDCl3) of compound 50a. 
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13C NMR (101 MHz, CDCl3) of compound 50b. 
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 1H–1H COSY NMR (400 MHz, CDCl3) of compound 68. 
  
1H–13C HSQC NMR (400 MHz, CDCl3) of compound 68. 
  


























































1H–13C HMBC NMR (400 MHz, CDCl3) of compound 68. 
  
NOESY NMR (400 MHz, CDCl3) of compound 68. 
  NOESY
 NMR (400 MHz, CDCl3) of compound 68. 
  
NOESY NMR (400 MHz, CDCl3) of compound 68. 
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Palladium-Catalyzed Aerobic Intramolecular Aminoacetoxylation of Alkenes 






Palladium-catalyzed aminoacetoxylation of alkenes has been applied as an efficient 
strategy in the synthesis of nitrogen-containing heterocycles.  The aminoacetoxylation products 
are generated from the reductive elimination of high-valent palladium intermediates and 
stoichiometric amount of strong oxidants are typically required to oxidize Pd(II) intermediates.  A 
mild aerobic intramolecular aminoacetoxylation method for the synthesis of pyrrolidine and 
indoline derivatives was achieved using molecular oxygen as oxidant.  A catalytic NOx species 
acts as an electron transfer mediator to access a high-valent palladium intermediate as the 
presumed active oxidant. 
 
2.1  INTRODUCTION 
 
Numerous alkene difunctionalization reactions enabled by palladium catalysts have been 
developed as efficient transformations for the construction of useful organic building blocks.1   For 
example, palladium-catalyzed amination of alkenes has been applied as a new strategy to 
                                               
† Adapted with permission from Li, J.; Grubbs, R. H.; Stoltz, B. M. Palladium-Catalyzed Aerobic Intramolecular 
Aminoacetoxylation of Alkenes Enabled by Catalytic Nitrate. Org. Lett. 2016, 18, 5449–5451.  
Copyright © 2019, American Chemical Society 
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synthesize nitrogen-containing heterocycles. 2   Arising from a key aminopalladation step, an 
alkylpalladium(II) intermediate can undergo versatile pathways to generate different structural 
motifs (Scheme 2.1.1).2a  From the mechanistic view, to realize the aminooxygenation of alkene, 
a rapid β-hydride elimination process3 should be avoided after forming the aminopalladation 
intermediate in the initial step.  Oxidation of aminopalladation intermediate could form a Pd(IV) 
intermediate, which could readily undergo reductive elimination to obtain the difunctionalization 
product (Scheme 2.1.1).  So, the key determinant to get the aminooxygenation product is the 
competition between two pathways, which relies on various reaction conditions, especially the 
choice of oxidants.4 
Scheme 2.1.1. Aminopalladation and Subsequent Transformations 
 
In the past decade, aminooxygenation has been achieved by oxidizing the alkylpalladium(II) 
intermediate into high-valent palladium (PdIV or PdIII) followed by C–O bond-forming reductive 
elimination.  However, a stoichiometric amount of a strong oxidant, such as PhI(OAc)2 or NFSI,  
is typically required to access the high-valent palladium intermediate.  PhI(OAc)2 is widely applied 
as a strong oxidant to generate the Pd(IV) intermediate to realize alkene difunctionalization and 
other reactions such as C–H functionalization, which have been reported by Sorensen5, Stahl,6 
Sanford,7 Muñiz,8 Dong,9 and Liu and co-workers10.  For example, in Sorensen’s pioneer study in 
2005, N-tosyl carbamates can be obtained as diamination products from internal or terminal 
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be oxidized to Pd(IV) species in the presence of 2 equivalents of PhI(OAc)2.  Muñiz and co-
workers in the same year achieved the aminoacetoxylation in similar conditions (Scheme 
2.1.2A).9a  Liu, Stahl, and co-workers also developed various aminooxygen reactions using 
PhI(OAc)2 as oxidant, and one impressive example is the intermolecular aminoacetoxylation by 
reacting terminal alkenes with phthalimide, to obtain protected amino alcohol products (Scheme 
2.1.2B).11    
 
Scheme 2.1.2. Examples of Alkene Difunctionalization Using PhI(OAc)2  
 
Another approach to generate high-valent palladium intermediate is to use N-
Fluorobenzenesulfonimide (NFSI) as oxidant, and several palladium-catalyzed alkene 
difunctionalization examples has been reported by Michael group.  NFSI, a bystanding F+ 
oxidant,11  is strong enough to oxidize Pd(II) to Pd(IV), thus facilitate the difunctionalization 
reaction happening through reductive elimination.  Such as the example shown in Scheme 2.1.2A, 
where 2 equivalents of NFSI were used to convert the Cbz-protected amino alkene into the 
pyrrolidine product catalyzed by PdCl2(MeCN)2, and the vicinal position is attached with methoxy 



























A. Intramolecular aminoacetoxylation/diamination (2005):
B. Intermolecular aminoacetoxylation (2006):
DCM
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An enantioselective diamination reaction was developed in 2013.  In the highly oxidative 
conditions in the presence of NFSI, most phosphine ligands that can be successfully used in many 
enantioselective processes, are incompatible in such conditions and subjected to be oxidized.  So, 
introduction of chiral elements becomes very challenging.  In this example, Ph-quinox was used 
as a chiral ligands and 82-98 % ee can be achieved (Scheme 2.1.3B).13  The key Pd(II) intermediate 
was isolated and the absolute structure was unambiguously determined by X-ray crystallography.  
This work shows very promising result that the challenging difunctionalization of alkene could be 
achieved by ligand design that could tolerate oxidative conditions, and new types of chiral ligands 
are anticipated by further research in this field. 
Scheme 2.1.3. Examples of Alkene Difunctionalization Using NFSI 
 
 
However, stoichiometric amount of wasteful high-energy oxidants, such as PhI(OAc)2, are 
typically required to access high-valent palladium centers and large quantities of by-products are 
generated.  Recently, milder conditions have also been developed using H2O2 as an 
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palladium-catalyzed aminohydroxylation reaction with 3 equivalents of H2O2 as oxidant.  Alkene 
tethered with N-tosyl carbamates can be converted to the aminohydroxylation product with a free 
hydroxyl group in high yield at room temperate (Scheme 2.1.4A).14  In 2015, another example 
showed the ability of hydrogen peroxide of oxidizing Pd(II) to achieve aminoacetoxylation 
reaction with similar aminoalkene substrates as previous examples.15  However, in this report, a 
six-membered piperidine derivative was formed as the major product over five-membered ring 
product, which is ascribed to the kinetic difference of 5-exo and 6-endo attack as they suggested.  
Bis-nitrogen ligands are very suitable to this reaction because they were proved to potentially 
suppress β-H elimination of palladium complex.16 
Scheme 2.1.4. Examples of Alkene Difunctionalization by Using H2O2 
 
 
2.2 PALLADIUM-CATALYZED AEROBIC TRANSFORMATIONS  
 
H2O2 was utilized as an environmentally tractable and inexpensive oxidant,  but aerobic 
conditions are still in high demand from a sustainable perspective.  A classic and well-studied 
example of a palladium-catalyzed aerobic homogeneous transformation is the Wacker process.  
This transformation was developed in the 1950s using O2 as the terminal oxidant in combination 
with a Cu salt as a redox co-catalyst to facilite the reoxidation of Pd0 to PdII.17  In contrast, reports 




35% aq. H2O2 (3 equiv)
CF3CO2Li (2 eq.)
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of the intermediate alkylpalladium(II) species using O2 as the sole oxidant is kinetically 
challenging;18   hence, care must be taken to avoid facile β-hydride elimination immediately 
(Scheme 2.1.1).  Recently, NOx species have been shown to be effective electron transfer mediators 
capable of facilitating the aerobic oxidation of alkylpalladium(II) intermediates to their high-valent 
counterparts.19  Sanford and co-workers reported that nitrate/nitrite could serve as a redox co-
catalyst in the aerobic acetoxylation of unactivated C(sp3)–H bonds via C–O bond reductive 
elimination of a high-valent palladacycle directed by oxime ether or pyridine-type directing groups 
(Scheme 2.2.1).20  Pd(OAc)2 was used as a catalyst, with NaNO3 as a co-catalyst, under 1 atm O2 
as the terminal oxidant.  NaNO2 can also play a similar activating role though the reactivity was 
lower than NaNO3.   
 
Scheme 2.2.1. Aerobic Palladium-catalyzed C(sp3)–H Acetoxylation with NOx Co-catalyst 
 
 
Grubbs and co-workers recently reported a nitrite-modified Wacker oxidation that shows 
anti-Markovnikov selectivity.21  In the presence of nitrite from AgNO2, aldehyde was obtained as 
the major product, which is catalyst-controlled.  A [Pd]-NO2 complex was proposed to be formed 
in situ and nitrite could be a donor of oxygen to form a [Pd]-NO complex, which could be re-
oxidized by O2 (Scheme 2.2.2).  The oxygen atom in aldehyde product was proved to be donated 






Pd(OAc)2, NaNO3 or NaNO2
AcOH/ Ac2O, O2, 100oC
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Scheme 2.2.2. Nitrite-modified Aldehyde-selective Wacker Oxidation  
 
Very recently, the Grubbs group reported a palladium-catalyzed aerobic alkene 
diacetoxylation method mediated by a catalytic amount of silver nitrite.  By simply changing the 
solvent from t-BuOH to AcOH, along with other slightly variations of reaction conditions, 
diacetoxylation of unbiased terminal alkenes was achieved by Grubbs and co-workers in 2014 
(Scheme 2.2.3A).22  NO2 was released in situ in these acidic conditions, and served as an ETM to 
oxidize Pd(II) to higher oxidation states such as Pd(III) or Pd(IV), which was suggested by the 
mechanistic studies by reacting with NO2 gas in the reaction conditions (Scheme 2.2.3B). 
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However, the ligand sets coordinating with Pd were not defined in those methods, and 
palladium-nitrite ligands could be present as suggested by previous studies.  The possible 
formation of [Pd]-NOx complexes is supported by previous work by Cámpora, Palma, and co-
workers.23  A [Pd]-NO complex was synthesized by the reaction of an in situ generated anionic 
Pd(II) salt with diazald (N-nitroso-N-methyl-p-toluenesulfonamide).  Oxidation of [Pd]-NO 
complex with O2 in toluene gave [Pd]-NO3 complex.  Although no direct evidence was gained for 
[Pd]-NO2 being formed as an intermediate in the reaction, its independent synthesis was 
accomplished by treating Pd(II) starting material with NO2 (Scheme 2.2.4).  This study suggests 
the redox conversions of [Pd]-NOx complexes in the presence of O2, which may provide some 
mechanistic evidences to the aerobic transformations mediated by Pd/NOx catalysts. 
Scheme 2.2.4. Evidence of [Pd]-NOx Complexes 
 
Based on the literature precedent of those aerobic transformations, we reasoned that a 
palladium-catalyzed aerobic aminooxygenation reaction might be possible using this electron 
transfer mediator strategy, as NOx species could be a kinetically suitable mediator in the aerobic 































(N ~ N ~ N = tris(pyrazolyl)borate ligand)
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reaction can be an environmentally tractable alternative to current methods using wasteful high 
energy oxidants.  
 
2.3 OPTIMIZATION OF PALLADIUM-CATALYZED AMINOOXYGENATION 
REACTIONS 
We started our investigation by subjecting acetyl-protected aminoalkene substrate 1a to 
our previously published intermolecular diacetoxylation reaction conditions.  11% of cyclized 
product 2a was obtained, which is identical to the authentic product sample directly synthesized 
from pyrrolidin-2-ylmethanol.  
Scheme 2.3.1.  Initial Trial and Synthesis of Authentic Product Sample 
 
 At the initial point of optimization, a control experiment was conducted to verify if all 
components are required for the conversion.  We were delighted to find that removing 
nitromethane from the reaction system could boost the yield to 50% as measured by GC analysis 
(Table 2.3.1).  However, AcOH and Ac2O are both necessary for the transformation.  In the solvent 
screen and solvent/co-solvent ratio experiments, the yield obtained in AcOH/Ac2O was 
significantly above other solvents/Ac2O tested, and removal of Ac2O co-solvent dropped the yield.  
The role of the Ac2O was not discussed in previous diacetoxylation conditions, but similar to 
Sanford’s C–H acetoxylation example19, it can potentially serve to sequester H2O in the reaction 
conditions.  In another set of reactions shown in Table 2.3.2, both AgNO2 and the O2 atmosphere 
are proved to be necessary for the product formation.  Although the role of Cu still remains elusive, 
it could potentially make the reaction more efficient, because less product could still be obtained 
NHAc
PdCl2(PhCN)2, CuCl2.2H2O, AgNO2 (10 mol%)
AcOH/Ac2O/MeNO2 (10:5:3)












TEA, DMAP, DCM, 23oC
Chapter 2 – Palladium-Catalyzed Aerobic Intramolecular Aminoacetoxylation of Alkenes 
Enabled by Catalytic Nitrate 
149 
in 34% yield without CuCl2 (Table 2.3.2, entry 3).  Methyl ketone was the major byproduct, which 
was generated from the competing b-hydride elimination pathway.  Possible alkene isomerization 
products were also detected. 
Table 2.3.1. Initial Control Experiment of Solvent 
 
 
Table 2.3.2. Initial Control Experiment of Catalysts 
 
 Next, different source of nitrates/nitrites were tested. To our delight, most of metal 
nitrates/nitrites and alkyl nitrites have shown decent reactivity, including very cheap source of 
sodium nitrate, sodium nitrite and iso-butylnitrite, the cheapest commercially available alkyl nitrite. 
Among them, cupric nitrate gave the highest yield of product (56%, Table 2.3.3 Entry 6).  So, it 
was used as the optimized source of NOx in the following optimization experiment, and a third 
a
1a 2a











PdCl2(PhCN)2 (10 mol %)
CuCl2•2H2O (10 mol %)
AgNO2 (10 mol%)
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catalyst component CuCl2 was not required anymore.  Furthermore, reactions could be performed 
without shielding from light because light-sensitive silver nitrite was replaced.  
 
Table 2.3.3. Nitrate/nitrite Sources Screening 
 
 
 A series of Pd(II) sources with different counterions were tested.  It was found that chloride 
ion gave the highest yield (Table 2.3.4, Entry 6) over the other counterions commonly used in 
palladium-catalyzed reactions.  Additionally, reaction could be performed at room temperature to 
get higher yield.  The following screening of ligands showed distinct results among different 
ligands (Table 2.3.5).  Only benzonitrile, triphenylphosphine, and norbornadiene ligands showed 
decent yield, but other ligands tested showed no conversion, including the previously used 









CuCl2•2H2O (10 mol%), MNOx (10 mol%)
AcOH/Ac2O (8:1)
35oC, O2 (1 atm), 16 h
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Table 2.3.4. Palladium Counterions Screen 
 
Table 2.3.5. Ligand Screen 
 
After the determination of best catalysts, the loading and ratio of those two catalysts were 
studied.  When decreasing the loading of Pd and Cu catalysts from 10 mol % to 5 mol%, acceptable 
yield of 51% could still be obtained, and there was no significant increase of yield when increasing 
the loading of Cu(NO3)2 while keeping PdCl2(MeCN)2 as 5 mol%.  However, when the loading of 
Cu(NO3)2 was lower than PdCl2(MeCN)2, decreased yield was obtained (Table 2.3.6 Entry 4).  
Similar result can be obtained by controlling Pd/Cu/nitrite ratio by adding PdCl2(MeCN)2, CuCl2 
and AgNO2, that the optimal ratio of Pd/Cu/nitrite was 1:1:2 (Table 2.3.6, Entry 6), which 
suggested that a sufficient amount of nitrite/nitrate was required to get high catalytic turnover.  
Keeping the loading of PdCl2(PhCN)2 and Cu(NO3)2 as 5 mol%, further screening was conducted 
by tuning the solvent ratio, concentration, reaction time, temperature, and additives.  For additives, 
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AcOH/Ac2O (8:1)
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common acidic and basic additives, including the previous effective trifluoroacetate salts in Liu’s 
work15 have been tried, but none of them showed increased yield.   
 
Table 2.3.6.  Studies of Catalyst Loading and Ratio 
 
  
By switching the counterions between Pd and Cu, we found that the combination of 
Pd(NO3)2•2H2O and CuCl2•2H2O also gave similar yield.  Surprisingly, by replacing CuCl2 into 
some simple chloride salts, such as sodium chloride or zinc chloride, decent yield could still be 
obtained, which suggests that Cu may not be necessary in this reaction (Table 2.3.7).  But chloride 
anion was very important in this reaction, since low yield was obtained if adding no chloride in 
the reaction conditions.  However, the reactions using Pd(NO3)2 as catalyst were less reproducible, 
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Table 2.3.7.  Reaction Conditions Using Pd(NO3)2 as Catalyst without Cu Salts 
 
 
2.4 SUBSTRATE SCOPE 
 
Next, we evaluated substrate scope and functional group tolerance under our optimized 
conditions.  First, several linear aliphatic acetyl-protected amino alkenes were tested in the 
optimized conditions (Scheme 2.4.1).  The gem-diphenyl substrate 1b has been tried and gave a 
higher yield of 75%, which was expected to have the Thorpe-Ingold effect that could facilitate the 
cyclization processes.  And gem-dibenzyl substrate also gave the corresponding pyrrolidine 
product 2c in 83% yield.  Different amine protecting groups were also tested at the initial stage. 
However, acetyl group is the best among different amine protecting groups that have been tested 
(Table 2.4.1, Entry 1).  
 







OAcPd(NO3)2•2H2O (5 mol%), MCln•xH2O (15 mol%)
AcOH/Ac2O (6:1)
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Table 2.4.1.  Reactions with Aliphatic Amino Alkenes  
 
 
Acetyl-protected aromatic amine substrates have been tried and we were delighted to find  
87% yield could be obtained from o-allyl aniline substrate 3a.  Based on the good result obtained 
from o-allyl aniline substrate, we tested a series of o-allylaniline derivatives, obtaining a variety 
of indoline derivatives 4b-i in moderate to excellent yields (Table 2.4.2, 30-95% yield).  A variety 
of substituents and functional groups were well tolerated, including fluoro, chloro, methyl ester, 
and trifluoromethyl groups.  A lesser extent nitro, and cyano groups gave lower yields due to the 
electronic effect.  Notably, we also tested the reaction under air and product 4a can also be obtained 








PdCl2(PhCN)2 (5 mol %) 
Cu(NO3)2•3H2O (5 mol %)
AcOH/Ac2O (6:1)
23 °C, O2 (1 atm, balloon), 16 h
R R

































R = Ac   69%
       Cbz 34%
Boc 20%
Ns     0%
Bz     0%
Me    0%
H      0%
75 %
83 %
Chapter 2 – Palladium-Catalyzed Aerobic Intramolecular Aminoacetoxylation of Alkenes 
Enabled by Catalytic Nitrate 
155 
Table 2.4.2.  Reactions with Aromatic Substrates 
 
 
Efforts have been made to investigate whether this method can be applied to other types of 
substrates, but the substrates shown in Scheme 2.4.2 showed no reactivity.  For example, 
alternation of the substrate structure gave no product, such as 2,2-disubstituted alkene 5, o-vinyl 
benzylamine substrates 6, and o-allylaniline with allylic substitution 7 (Scheme 2.4.2A), which 
may be ascribed to the steric bulk at the 2- or 3- positions of alkenes.  Internal olefins are also 
synthesized but the reactivity was much lower, that trace amount of product can be detected by 
LC-MS from the reaction with substrate 8.  A series of amide 9 were also synthesized, which 
would expect the similar electronic property to the well-reacted o-allylaniline substrates 3.  
However,  those substrates with different amide acidity all showed no reactivity.  Six-membered 
ring product 12 was not observed in the standard condition with substrate 10.  However, the 
diacetoxylation product 11 was observed in trace amount (Scheme 2.4.2B).  In all, this method is 
very restricted to o-allylaniline and other linear terminal alkenes.  The current reaction conditions 
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Scheme 2.4.2. Substrates with Low Reactivity 
 
 
Based on our observations and previous mechanistic studies, we propose the catalytic cycle 
shown in Scheme 2.4.3.  Aminopalladation of the substrate 1a likely forms Pd(II) intermediate I, 
which can be oxidized to high-valent palladium intermediate II by an NOx species (possibly be 
NO2) and molecular oxygen acts as the terminal oxidant.  We envision that high-valent palladium 
intermediate II can then undergo the C–O bond-forming reductive elimination to release a cationic 
intermediate III, which forms the aminoacetoxylation product 2a upon acetolysis.  The source of 
additional oxygen atoms in the product is not verified, but a previous 18O labeling study showed 
that the oxygen came from the AcOH solvent.  Although the role of copper still remains elusive, 
the presence of copper is clearly advantageous as a decrease in yield was observed when no source 






















AcOH/Ac2O (6:1), 23 ºC, O2 
(1 atm, balloon), 16 h
A. Substrates with no products formed
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Scheme 2.4.3. Proposed Mechanism 
 
2.5 CONCLUSIONS 
In summary, this chapter presented a mild, aerobic intramolecular aminoacetoxylation method, 
which provides another example that catalytic nitrite/nitrate is capable of mediating the aerobic 
oxidation from Pd(II) to high-valent Pd(IV) intermediate after aminopalladation process, forming 
the desired aminoacetoxylation products in good to high yield (30-95%) from a variety of 
substrates.  However, the amine protecting group is currently restricted to acetyl group.  Internal 
olefins and steric hindered terminal olefins always showed low reactivity.  Continuous efforts will 
be on the optimization of reaction conditions to fit in a larger range of substrates including the 
currently unreactive internal olefins.  In addition, it would be worth introducing chiral ligands 
which may influence the stereoselectivity in the initial aminopalladation step and form the 
pyrrolidine or indolines with high enantioselectivity.  Ongoing mechanistic studies, including a 
full stereochemical analysis, of this unique catalytic system would be beneficial to the 
development of novel stereoselective methods.  Finally, in today’s renaissance of NOx redox 
chemistry, we anticipate efficient utilization of the oxidation potential of O2 will enable access to 
even more environmentally benign processes rather than consuming other high-energy/high-cost 
stoichiometric oxidants. 
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2.6  EXPERIMENTAL METHODS AND ANALYTICAL DATA 
 
2.6.1  Materials and Methods 
Commercial reagents and metal salts were obtained from Sigma-Aldrich, TCI, Combi-Blocks, 
Alfa Aesar and used without further purification.  1H and 13C NMR spectra were recorded on a 
Varian 500 MHz, Varian 400 MHz, or a Varian 300 MHz spectrometer.  High-resolution mass 
spectra were provided by the California Institute of Technology Mass Spectrometry Facility, 
using JEOL JMS-600H High Resolution Mass Spectrometer.  Gas chromatography  data  was  
obtained  using  an  Agilent  6850  FID  gas chromatograph  equipped  with  a  HP-5  (5%-
phenyl)-methylpolysiloxane  capillary  column (Agilent).  Response factors relative to the 
internal standard tridecane were collected for the substrate N-(pent-4-en-1-yl)acetamide (1a), 
and the product (1-acetylpyrrolidin-2-yl)methyl acetate  (2a) following literature procedures.25 
 
2.6.2  Experimental Procedures 
 
General procedure A for isolation scale (0.5 mmol) aminoacetoxylation of alkenes:  
PdCl2(PhCN)2 (0.025 mmol, 9.6 mg), Cu(NO3)2•3H2O (0.025 mmol, 6.0 mg) and alkene 
substrate (0.5 mmol) were weighed into a 50 mL flame-dried round bottom flask (14/20 neck) 
with a stir bar.  The flask was sparged with oxygen (1 atm) from an oxygen balloon, through a 
vacuum adapter (14/20).  AcOH (9.0 mL) and Ac2O (1.5 mL) were premixed in a separated vial 
and sparged with oxygen (through needle and oxygen balloon) for 2 minutes.  The oxygenated 
solvent mixture was then transferred into the flask via syringe.  The reaction was then allowed to 
stir at 23 °C for 16 h under an atmosphere of oxygen (1 atm balloon).  The solvent was removed 
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under reduced pressure.  Dichloromethane (20 mL) was then added and the resulting mixture 
was washed with saturated NaHCO3 (20 mL).  The aqueous layer was extracted with 
dichloromethane (2 × 20 mL) and the combined organic layer was dried over MgSO4.  The 
solvent was removed under reduced pressure and the crude mixture was purified by silica gel 
chromatography.  
 
General procedure B for analytical scale (0.2 mmol) aminoacetoxylation of 1a:  
PdCl2(PhCN)2 (0.01 mmol, 3.8 mg), Cu(NO3)2•3H2O (0.01 mmol, 2.4 mg) and alkene substrate 
(0.5 mmol) were weighed into a 2-dram screw-cap vial charged with a stir bar.  The vial was 
sparged with oxygen (1 atm balloon) for 45 seconds.  AcOH (3.6 mL), Ac2O (0.6 mL) and 
tridecane (0.00246 mmol, 6 µL) were subsequently added via syringe.  The solution was 
saturated with oxygen by an additional 45 seconds of sparging.  The reaction was then allowed to 
stir at 23 °C for 16 h under an atmosphere of oxygen (balloon).  Next, an aliquot (ca.  0.2 mL) 
was injected into a 2 mL vial containing an estimated 1 mL of premixed EtOAc/pyridine solution 
(3:1) to quench the reaction.  The resulting solution was subjected to GC analysis to determine 
yield. 
Substrate Synthesis and Characterization Data 
 
N-(pent-4-en-1-yl)acetamide (1a): Prepared according to the literature procedure from 4-
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1H NMR (500 MHz, CDCl3) δ 6.59 (bs, 1H), 5.73 (ddt, J = 16.9, 10.1, 6.6 Hz, 1H), 5.10 – 4.82 
(m, 2H), 3.17 (td, J = 7.3, 5.8 Hz, 2H), 2.02 (m, 2H), 1.91 (s, 3H), 1.54 (ddd, J = 14.7, 7.9, 6.8 
Hz, 2H); 
13C NMR (126 MHz, CDCl3) δ 170.4, 137.7, 115.0, 39.1, 31.0, 28.6, 23.1;  
HRMS (FAB+) m/z calc’d for C7H14NO [M+H]+: 128.1075, found: 128.1077.  
 
 
N-(2,2-diphenylpent-4-enyl)acetamide (1b): Synthesized according to literature procedure27 as 
a white solid (3.03 g, 54% yield over 3 steps).   
1H NMR (500 MHz, CDCl3) δ 7.33 (dd, J = 8.2, 7.0 Hz, 4H), 7.28 – 7.24 (m, 2H), 7.22 – 7.19 
(m, 4H), 5.45 (ddt, J = 16.7, 10.4, 7.1 Hz, 1H), 5.06 (bs, 1H), 5.03 – 4.96 (m, 2H), 3.99 (d, J = 
5.8 Hz, 2H), 2.87 (dt, J = 7.2, 1.2 Hz, 2H), 1.87 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 169.9, 145.2, 133.6, 128.3, 128.0, 126.6, 118.7, 50.2, 46.0, 42.1, 
23.4;  
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N-(2,2-dibenzylpent-4-en-1-yl)acetamide (1c): 2,2-dibenzyl-4-pentenenitrile could be prepared 
from allyl 2-cyanoacetate according to the literature procedure28 as a colorless liquid (1.13 g,  
72% yield).  Then, LiAlH4 (0.9 g, 23 mmol) was weighed into a flame-dried flask, and the flask 
was exchanged with vacuum/argon 3 times.  100 mL Et2O was added to flask through cannula 
transfer. 2,2-dibenzyl-4-pentenenitrile (1.13 g, 4.3 mmol) was dissolved into 10 mL Et2O and 
added via syringe.  The reaction was stirred overnight and quenched with water and 1M NaOH 
solution.  After the grey color of suspension turned white completely, the reaction mixture was 
filtered through celite.  The filtrate was dried over Na2SO4 and concentrated in vacuo without 
purification.  Then the crude 2,2-dibenzylpent-4-en-1-amine was dissolved into 50 mL Et2O and 
acetic anhydride (1.2 mL, 12.9 mmol) was added.  After 3 h, the reaction mixture was washed 
with saturate NaHCO3 solution (20 mL), and then the aqueous layer was extracted with EtOAc (2 
× 20 mL).  The combined organic layers were concentrated in vacuo and purified by silica gel 
chromatography (50% EtOAc in hexanes).  Product 1c was obtained as a colorless oil (976 mg, 
74% yield over last two steps).   
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 4H), 7.30 – 7.25 (m, 2H), 7.23 – 7.20 (m, 4H), 
6.01 (ddt, J = 17.3, 10.2, 7.2 Hz, 1H), 5.24 – 5.13 (m, 2H), 5.02 (bs, 1H), 3.27 (d, J = 5.9 Hz, 
2H), 2.76 – 2.66 (m, 4H), 2.16 (dt, J = 7.2, 1.4 Hz, 2H), 1.74 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 169.8, 137.8, 134.5, 130.6, 128.3, 126.6, 118.8, 45.7, 43.4, 41.4, 
39.4, 23.3 (one quaternary carbon signal unresolved);  
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General procedure C: synthesis of o-allylaniline derivatives 3a, 3b, 3d, 3e 
 
N-allylanilines can be prepared from the literature procedure.29  In a 5 mL microwave tube, a 
solution of N-allylaniline (665 mg, 5 mmol) in 4 mL xylenes was added boron trifluoride 
etherate (0.7 mL, 5,5 mmol) under an argon atmosphere.  Then the microwave tubes was sealed 
and heated to 180 °C in the microwave reactor for 2 h.  After cooling down to room temperature, 
the reaction mixture was poured into 2 M NaOH solution (10 mL), and extracted with EtOAc (10 
mL × 2).  The combined organic layers were dried over MgSO4, and concentrated in vacuo.  The 
crude o-allylaniline was dissolved in DCM (30 mL) and acetic anhydride (1.4 mL, 15 mmol) was 
added dropwise.  After reacting 2 h in room temperature, the reaction mixture was poured into 
saturated NaHCO3 and extracted with EtOAc (2 × 30 mL).  The combined organic layers were 
dried over MgSO4.  The solvent was removed by rotary evaporation, and the residue was purified 
by column chromatography (30% EtOAc in hexanes). 
 
N-(2-allylphenyl)acetamide (3a): Prepared according to General Procedure C as a white solid 
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1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 8.3, 4.0 Hz, 1H), 7.32 – 7.26 (m, 1H), 7.20 (dd, J = 
7.7, 1.6 Hz, 1H), 7.14 (t, J = 7.4 Hz, 1H), 6.00 (ddt, J = 16.6, 11.4, 6.2 Hz, 1H), 5.25 – 5.08 (m, 
2H), 3.41 (d, J = 6.0, 2H), 2.17 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 168.4, 136.4, 136.0, 130.2, 130.0, 127.5, 125.4, 123.9, 116.6, 
37.0, 24.3; 
HRMS (FAB+) m/z calc’d for C11H14NO [M+H]+: 176.1075, found: 176.1083. 
 
 
N-(2-allyl-4-methylphenyl)acetamide (3b): Prepared according to General Procedure C from 
the corresponding N-allyl-4-methylaniline as a white solid (342 mg, 36% yield over 2 steps).  
1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 8.1 Hz, 1H), 7.18 (bs, 1H), 7.08 (dd, J = 8.2, 2.1 Hz, 
1H), 7.01 (d, J = 2.0 Hz, 1H), 5.98 (ddt, J = 16.5, 10.1, 6.1 Hz, 1H), 5.23 – 5.07 (m, 2H), 3.36 
(dd, J = 6.2, 1.8 Hz, 2H), 2.33 (s, 3H), 2.16 (s, 3H); 
13C NMR (126 MHz, CDCl3) δ 168.3, 136.5, 135.2, 133.3, 130.8, 130.3, 128.0, 124.2, 116.3, 
36.9, 24.2, 20.9; 
HRMS (FAB+) m/z calc’d for C12H16NO [M+H]+: 190.1232, found 190.1233. 
 
 
N-(2-allyl-4-fluorophenyl)acetamide (3d): Prepared according to General Procedure C from 
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1H NMR (500 MHz, CDCl3) δ 7.72 (dd, J = 8.9, 5.4 Hz, 1H), 7.12 (bs, 1H), 6.97 (td, J = 8.4, 3.0 
Hz, 1H), 6.93 (dd, J = 9.1, 3.0 Hz, 1H), 5.97 (ddt, J = 17.2, 10.1, 6.1 Hz, 1H), 5.26 – 5.08 (m, 
2H), 3.37 (dt, J = 6.1, 1.7 Hz, 2H), 2.18 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 168.4, 160.1 (d, J = 244.7 Hz), 135.5, 133.2 (d, J = 7.4 Hz), 
131.7 (d, J = 2.6 Hz), 126.1 (d, J = 8.4 Hz), 117.1, 116.7 (d, J = 22.8 Hz), 114.0 (d, J = 22.1 Hz), 
36.7, 24.1;  
HRMS (FAB+) m/z calc’d for C11H13NOF [M+H]+: 194.0981, found 194.0977. 
 
 
 N-(2-allyl-4-chlorophenyl)acetamide (3e): Prepared according to General Procedure C from 
the corresponding N-allyl-4-chloroaniline as a white solid (442 mg, 42% yield over 2 steps).  
1H NMR (500 MHz, CDCl3) δ 7.90 – 7.73 (m, 1H), 7.28 (bs, 1H), 7.25 – 7.22 (m, 1H), 7.18 (m, 
1H), 6.00 – 5.90 (m, 1H), 5.26 – 5.09 (m, 2H), 3.36 (dt, J = 6.4, 1.9 Hz, 2H), 2.16 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 168.3, 135.4, 134.6, 131.7, 130.3, 130.0, 127.4, 125.0, 117.2, 
36.6, 24.3;  
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General procedure D: synthesis of o-allyl aniline derivatives30 
 
4-Amino-3-bromobenzotrifluoride (960 mg, 4 mmol) dissolved in dry DMF (10 mL) was added 
allyltributyltin (1.50 mL, 4.8 mmol) under argon at room temperature.  Pd(PPh3)4 (457 mg, 0.39 
mmol) was then added and the reaction mixture was stirred at 85 °C for 16 h.  The reaction 
mixture was then cooled down to room temperature and diluted with water (10 mL).  The 
aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
over MgSO4, filtered and concentrated under reduced pressure.  Purification by flash column 
chromatography gave 2-allyl-4-(trifluoromethyl)aniline (685 mg, 85% yield) as yellow oil.  Then 
2-allyl-4-(trifluoromethyl)aniline was dissolved in DCM (30 mL) and acetic anhydride (1.0 mL, 
10.2 mmol) was added dropwise.  After reacting 2 h in room temperature, the reaction mixture 
was poured into saturated NaHCO3 and extracted with EtOAc (2 × 30 mL).  The combined 
organic layers were dried over MgSO4.  The solvent was removed by rotary evaporation, and the 
residue was purified by column chromatography (30% EtOAc in hexanes). 
 
N-(2-allyl-5-methylphenyl)acetamide (3c): Prepared according to General Procedure D from 
the corresponding 2-bromo-5-methylaniline as a white solid (605 mg, 80% yield over 2 steps). 
1H NMR (500 MHz, CDCl3) δ 7.68 (m, 1H), 7.23 (bs, 1H), 7.08 (d, J = 7.7 Hz, 1H), 6.96 – 6.94 
(m, 1H), 5.98 (ddt, J = 16.5, 10.1, 6.1 Hz, 1H), 5.21 – 5.07 (m, 2H), 3.36 (dt, J = 6.3, 1.7 Hz, 
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13C NMR (126 MHz, CDCl3) δ 168.4, 137.2, 136.7, 135.8, 130.0, 127.1, 126.2, 124.5, 116.3, 




Methyl 4-acetamido-3-allylbenzoate (3f): Prepared according to General Procedure D from the 
corresponding methyl 4-amino-3-bromobenzoate as a white solid (451 mg, 48% yield over 2 
steps).   
1H NMR (500 MHz, CDCl3) δ 8.15 – 8.09 (m, 1H), 7.95 – 7.91 (m, 1H), 7.87 (bs, 1H), 7.57 – 
7.50 (m, 1H), 5.97 (tdt, J = 11.1, 10.1, 6.0 Hz, 1H), 5.28 – 5.10 (m, 2H), 3.90 (s, 3H), 3.45 – 3.43 
(m, 2H), 2.17 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 168.3, 166.7, 140.6, 135.6, 131.7, 129.2, 128.1, 126.0, 121.9, 
117.3, 52.1, 36.9, 24.6;  
HRMS (FAB+) m/z calc’d for C13H16NO3 [M+H]+: 234.1130, found 234.1122. 
 
 
N-(2-allyl-4-(trifluoromethyl)phenyl)acetamide (3g): Prepared according to General 
Procedure D as a white solid (583 mg, 60% yield over 2 steps).   
1H NMR (500 MHz, CDCl3) δ 8.10 (d, J = 8.5 Hz, 1H), 7.51 (dd, J = 8.5, 2.2 Hz, 1H), 7.44 (d, J 
= 2.2 Hz, 1H), 5.97 (ddt, J = 17.3, 10.1, 6.1 Hz, 1H), 5.29 – 5.12 (m, 2H), 3.44 (dt, J = 6.1, 1.7 
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13C NMR (126 MHz, CDCl3) δ 168.5, 139.3, 135.2, 129.4, 127.1 (q, J = 4.2 Hz), 126.7 (q, J = 
32.6 Hz), 124.6 (q, J = 3.8 Hz), 124.0 (q, J = 272 Hz), 122.9, 117.6, 36.7, 24.4;  




N-(2-allyl-4-nitrophenyl)acetamide (3h): Prepared according to General Procedure D from the 
corresponding 2-bromo-4-nitroaniline as a white solid (183 mg, 21% yield over 2 steps).   
1H NMR (500 MHz, CDCl3) δ 8.35 (d, J = 9.1 Hz, 1H), 8.16 (dd, J = 9.0, 2.7 Hz, 1H), 8.10 (d, J 
= 2.7 Hz, 1H), 7.57 (bs, 1H), 6.00 (ddt, J = 16.5, 10.1, 6.1 Hz, 1H), 5.42 – 5.08 (m, 2H), 3.51 (dt, 
J = 6.1, 1.8 Hz, 2H), 2.22 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 168.3, 143.6, 142.3, 134.5, 128.4, 125.6, 123.5, 121.6, 118.3, 
36.8, 24.8;  




N-(2-allyl-4-cyanophenyl)acetamide (3i): Prepared according to General Procedure D from the 
corresponding 4-amino-3-bromobenzonitrile as a white solid (460 mg, 58% yield over 2 steps). 
1H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 8.5 Hz, 1H), 7.56 (dd, J = 8.5, 1.9 Hz, 1H), 7.51 (bs, 
1H), 7.48 (d, J = 1.9 Hz, 1H), 5.97 (ddt, J = 16.8, 10.1, 6.1 Hz, 1H), 5.40 – 5.03 (m, 2H), 3.43 
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13C NMR (126 MHz, CDCl3) δ 168.3, 140.5, 134.7, 133.9, 131.8, 128.9, 122.4, 118.8, 118.1, 
107.6, 36.5, 24.7;  




Mixture of rotamer may occur in most products.  A representative VT-NMR experiment was 
conducted on the product 4a.  At 75 °C in DMSO solvent, only one rotamer is predominantly 
appeared in 1H NMR and the characterization data is shown below. 
 
 
(1-acetylindolin-2-yl)methyl acetate (4a): Prepared according to the general procedure A to 
provide 4a (102 mg, 87% yield) as a colorless oil.  When the reaction was conducted under air 
(Table 3, entry 2), an air balloon was used instead of an oxygen balloon, which provided 4a (94 
mg, 80% yield) as a colorless oil.    
1H NMR (400 MHz, DMSO, 75 °C) δ 7.77 (bs, 1H), 7.23 (d, J = 7.4 Hz, 1H), 7.14 (t, J = 7.8 
Hz, 1H), 6.99 (t, J = 7.4 Hz, 1H), 4.82 – 4.74 (m, 1H), 4.08 (d, J = 5.7 Hz, 2H), 3.33 (dd, J = 
16.3, 9.2 Hz, 1H), 2.83 (d, J = 16.3 Hz, 1H), 2.26 (s, 3H), 1.87 (s, 3H);  
13C NMR (126 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 170.7, 168.7, 141.9, 129.7, 127.7, 124.8, 124.2, 118.1, 64.9, 58.5, 32.1, 23.4, 20.7; 
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For 1H and 13C NMR characterization of the rest of compounds, chemical shifts of only the 
major rotamer are reported.  In 1H and 13C NMR spectra of products, only the major rotamer 
peaks are integrated. 
 
 
(1-acetylpyrrolidin-2-yl)methyl acetate (2a) : Prepared according to the general procedure A to 
provide 2a (64 mg, 69% yield) as a colorless liquid.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from the major 
rotamer δ 4.32 (tt, J = 7.4, 3.7 Hz, 1H), 4.15 (dd, J = 10.8, 3.9 Hz, 1H) 4.09 (dd, J = 10.8, 6.8 
Hz, 1H), 3.50 – 3.37 (m, 2H), 2.03 (s, 3H), 2.03 (s, 3H) (two overlapped singlets), 1.96 – 1.88 
(m, 3H) 1.86 – 1.81 (m, 1H);  
13C NMR (126 MHz, CDCl3) δ 170.8, 169.7, 63.8, 55.2, 47.9, 27.5, 24.0, 21.9, 20.9;  
HRMS (FAB+) m/z calc’d for C9H16NO3 [M+H]+: 186.1130, found 186.1134. 
 
 
(1-acetyl-4,4-diphenylpyrrolidin-2-yl)methyl acetate (2b): Prepared according to the general 
procedure A to provide 2b (126 mg, 75% yield) as a white solid.  
1H NMR (500 MHz, DMSO, 23 °C) mixture of rotamers, chemical shifts reported are from 
major rotamer δ 7.46 – 7.43 (m, 2H), 7.38 – 7.35 (m, 2H), 7.33 – 7.28 (m, 4H), 7.19 (ddt, J = 
9.0, 7.9, 1.4 Hz, 2H), 4.68 (dd, J = 11.2, 2.0 Hz, 1H), 4.23 (dd, J = 10.6, 3.5 Hz, 1H), 4.06 (dd, J 
= 10.6, 6.3 Hz, 1H), 3.92 (dd, J = 10.0, 6.7, 1H), 3.82 (d, J = 11.2 Hz, 1H), 3.12 (ddd, J = 13.0, 
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13C NMR (126 MHz, CDCl3) δ 170.8, 169.3, 145.2, 144.6, 128.8, 128.7, 126.8, 126.8, 126.6, 
126.2, 64.1, 58.5, 55.0, 53.2, 40.1, 23.1, 20.9; 
HRMS (FAB+) m/z calc’d for C21H24NO3 [M+H]+: 338.1756, found 338.1757. 
 
 
(1-acetyl-4,4-dibenzylpyrrolidin-2-yl)methyl acetate (2c): Prepared according to the general 
procedure A to provide 2c (152 mg, 83% yield) as a white solid.  
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 7.38 – 7.22 (m, 6H), 7.19 – 7.09 (m, 4H), 4.33 (dd, J = 11.1, 4.1 Hz, 1H), 4.29 – 4.20 
(m, 1H), 4.17 (dd, J = 11.1, 2.5 Hz, 1H), 3.31 (dd, J = 10.5, 1.6 Hz, 1H), 3.18 (d, J = 10.5 Hz, 
1H), 2.80 (s, 2H), 2.69 (s, 2H), 2.03 (s, 3H), 1.93 – 1.89 (m, 1H), 1.79 (dd, J = 13.1, 9.1 Hz, 1H), 
1.72 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.8, 169.3, 137.5, 137.1, 130.8, 130.3, 128.4, 128.3, 126.9, 
126.6, 63.6, 55.0, 54.6, 45.7, 43.9, 41.8, 35.0, 23.2, 20.6;  
HRMS (FAB+) m/z calc’d for C23H28NO3 [M+H]+: 366.2069, found 366.2053. 
 
(1-acetyl-5-methylindolin-2-yl)methyl acetate (4b): Prepared according to the general 
procedure A to provide 4b (110 mg, 89% yield) as a colorless oil.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 7.98 (d, J = 8.1 Hz, 1H), 7.01 (m, 2H), 4.61 (m, 1H), 4.25 – 4.08 (m, 2H), 3.35 (dd, J = 
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13C NMR (126 MHz, CDCl3) δ 170.7, 168.4, 139.6, 133.8, 129.8, 128.1, 125.4, 117.8, 64.8, 
58.6, 32.0, 23.3, 21.0, 20.8;  
HRMS (FAB+) m/z calc’d for C14H18NO3 [M+H]+: 248.1287, found 248.1280. 
 
 
(1-acetyl-6-methylindolin-2-yl)methyl acetate (4c): Prepared according to the general 
procedure A to provide 4c (118 mg, 95% yield) as a colorless oil.  
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 7.95 (s, 1H), 7.06 (d, J = 7.6 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H), 4.60 (m, 1H), 4.19 (dd, 
J = 11.8, 6.2 Hz, 2H), 3.31 (dd, J = 16.1, 8.8 Hz, 1H), 2.81 (d, J = 15.9 Hz, 1H), 2.35 (s, 3H), 
2.34 (s, 3H), 2.04 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.7, 168.6, 142.0, 137.6, 126.8, 124.9, 124.4, 118.8, 64.8, 
58.8, 31.7, 23.4, 21.6, 20.7;  
HRMS (FAB+) m/z calc’d for C14H18NO3 [M+H]+: 248.1287, found 248.1280. 
 
 
(1-acetyl-5-fluoroindolin-2-yl)methyl acetate (4d). Prepared according to the general 
procedure A to provide 4d (110 mg, 88% yield) as a colorless oil.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.05 (dd, J = 8.4, 4.9 Hz, 1H), 6.97 – 6.83 (m, 2H), 4.63 (m, 1H), 4.20 (dd, J = 11.2, 
5.9 Hz, 2H), 3.37 (dd, J = 16.4, 8.9 Hz, 1H), 2.86 (d, J = 16.3 Hz, 1H), 2.34 (s, 3H), 2.03 (s, 3H); 
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131.8 (d, J = 8.5 Hz), 121.7 (d, J = 7.8 Hz), 115.5 (d, J = 22.3 Hz), 112.0 (d, J = 24.8 Hz), 64.7, 
58.8, 32.0, 23.1, 20.7;  
HRMS (FAB+) m/z calc’d for C13H15NO3F [M+H]+: 252.1036, found 252.1037. 
 
 
(1-acetyl-5-chloroindolin-2-yl)methyl acetate (4e). Prepared according to the general 
procedure A to provide 4e (107 mg, 80% yield) as a yellow oil.  
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.03 (d, J = 8.5 Hz, 1H), 7.18 – 7.15 (m, 2H), 4.63 (m, 1H), 4.19 (dd, J = 11.4, 5.8 Hz, 
2H), 3.35 (dd, J = 16.4, 8.9 Hz, 1H), 2.86 (d, J = 16.3 Hz, 1H), 2.35 (s, 3H), 2.03 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.6, 168.7, 140.7, 131.7, 129.0, 127.6, 124.9, 118.9, 64.7, 
58.7, 31.9, 23.2, 20.7;  
HRMS (FAB+) m/z calc’d for C13H15NO3Cl [M+H]+: 268.0740, found 268.0738. 
 
 
methyl 2-(acetoxymethyl)-1-acetylindoline-5-carboxylate (4f). Prepared according to the 
general procedure A to provide 4f (95 mg, 65% yield) as a colorless oil.  
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.13 (s, 1H), 7.93 – 7.90 (m, 1H), 7.86 (s, 1H), 4.67 (m, 1H), 4.18 (m, 2H), 3.88 (s, 
3H), 3.37 (m, 1H), 2.92 (d, J = 16.1 Hz, 1H), 2.39 (s, 3H), 2.00 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.6, 169.0, 166.6, 146.0, 130.1, 126.2, 125.8, 117.2, 114.0, 
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HRMS (FAB+) m/z calc’d for C15H18NO5 [M+H]+: 292.1185, found 292.1183. 
 
 
(1-acetyl-5-(trifluoromethyl)indolin-2-yl)methyl acetate (4g). Prepared according to the 
general procedure A to provide 4g (88 mg, 58% yield) as a colorless oil.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.21 (s, 1H), 7.58 – 7.39 (m, 2H), 4.69 (m, J = 8.5 Hz, 1H), 4.23 (m, 2H), 3.41 (m, 
1H), 2.96 (d, J = 16.3 Hz, 1H), 2.41 (s, 3H), 2.04 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.6, 169.0, 144.8, 130.5, 125.4, 123.1, 121.8, 117.7, 64.6, 
58.8, 31.9, 23.4, 20.6 (C–F coupling constants unresolved and one quaternary carbon signal 
unresolved);  




(1-acetyl-5-nitroindolin-2-yl)methyl acetate (4h).  Prepared according to the general procedure 
A to provide 4h (41 mg, 30% yield) as a yellow oil.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.24 (s, 1H), 8.17 (dd, J = 8.8, 2.4 Hz, 1H), 8.09 (m, 1H), 4.78 (s, 1H), 4.24 (dd, J = 
11.8, 5.1 Hz, 2H), 3.46 (dd, J = 16.5, 9.2 Hz, 1H), 3.03 (d, J = 16.5 Hz, 1H), 2.44 (s, 3H), 2.02 
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13C NMR (126 MHz, CDCl3) δ 170.6, 169.2, 147.4, 143.9, 124.7, 120.6, 117.3, 64.6, 59.2, 31.6, 
23.5, 20.6 (one quaternary carbon signal unresolved);  
HRMS (FAB+) m/z calc’d for C13H15N2O5 [M+H]+: 279.0981, found 279.0975. 
 
 
(1-acetyl-5-cyanoindolin-2-yl)methyl acetate (4i). Prepared according to the general procedure 
A to provide 4i (41 mg, 32% yield) as a colorless oil.   
1H NMR (500 MHz, CDCl3) mixture of rotamers, chemical shifts reported are from major 
rotamer δ 8.22 (s, 1H), 7.59 – 7.52 (m, 1H), 7.48 (s, 1H), 4.71 (m, 1H), 4.22 (d, J = 9.1 Hz, 2H), 
3.42 (d, J = 15.1 Hz, 1H), 2.97 (d, J = 16.4 Hz, 1H), 2.41 (s, 3H), 2.02 (s, 3H);  
13C NMR (126 MHz, CDCl3) δ 170.6, 169.2, 145.8, 132.8, 128.4, 119.0, 118.1, 107.0, 64.6, 
58.7, 31.7, 23.6, 20.6 (one quaternary carbon signal unresolved);  
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A Convenient Synthesis of Geminal-Dialkyl Dienes  





A new, robust synthesis of gem-dialkyl acyclic diene monomers has been developed.  This 
route is scalable and flexible, allowing for the production of a wide range of diene monomers of 
different lengths and different gem-dialkyl substitution.  The metathesis polymerization of these 
monomers and the hydrogenation of the resulting polyolefins leads to telechelic gem-dialkyl 
polyethylenes, which can be used as elastomers in the synthesis of polyurethanes and other block 
polymers. 
 
3.1  INTRODUCTION 
Poly(isobutylene) (PIB, Scheme 3.1.1, equation 1) is a homopolymer of isobutylene that 
has a number of unique properties, among them being low permeability, and excellent chemical 
compatibility and oxidative stability.  PIB is particularly useful as a component of elastomeric 
polyurethanes as these properties provide superior performance over other polyester and polyether 
based materials.  Poly(ethylene)-co-isobutylene (PEIB, Scheme 3.1.1, equation 2) is a copolymer 
of ethylene and isobutylene that has shown promise as an alternative to PIB, especially telechelic 
PEIB.  The gem-dimethyl groups along the polymer backbone act as defects to interfere with the 
crystallization of the polymer, and so amorphous material with low glass transition temperature  
can be produced that is especially attractive for use in thermoplastic polyurethanes. 
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Scheme 3.1.1. Poly(isobutylene) and Poly(ethylene)-co-isobutylene  
 
 
PEIB and its analogues have been difficult to produce due to the different reactivities of 
ethylene and isobutylene.  Nevertheless, there are numerous examples of its synthesis using 
metallocene catalysts, 1  Lewis acid catalysts, 2  and olefin metathesis catalysts.  Ring opening 
metathesis polymerization (ROMP) is well-suited for the production of these types of polymers, and it 
has been used by Grubbs (Scheme 3.1.2A),3 Buchmeiser (Scheme 3.1.2B),4 and the Hillmyer group 
(Scheme 3.1.2C) 5 to access PEIB and its related derivatives. 
 






















x = 3, 6, 9
x x
Me Me
















A. ROMP of 3,3-Dimethylcyclobutene (Grubbs 1995)





B. ROMP of 3,3-Dimethylcyclopropene (Buchmeiser 2008)
Me Me
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Linear polyolefins with precisely spaced gem-dimethyl groups, analogous to PEIB, have been 
synthesized using Acyclic Diene Metathesis (ADMET) polymerization, as first reported by 
Schwendeman and Wagener (Scheme 3.1.2D).6,7  They showed that a higher frequency of gem-
dimethyl groups in the polymer backbone led to amorphous polymers.6  These “liquid rubbers” 
were incorporated into telechelic diols using Ru catalysis.  Telechelic PEIB has also been 
synthesized using ring-opening metathesis polymerization (ROMP) from (Z)-5,5-dimethylcyclooct-
1-ene (5)5 and cis-1,4-diacetoxy-2-butene to afford polyolefins of different molecular weights (Scheme 
3.1.2C).  Hydrogenation of these polymers afforded the telechelic PEIB, which has been used in PEIB-
polyurethane (PU) thermoplastic elastomers, which perform exceptionally well for biomedical 
applications.8  Due to the amorphous PEIB component, the oxidative, hydrolytic, thermal stability, and 
the barrier properties of these copolymers are much improved than conventional PUs containing 
polyesters and polyethers as soft segments.9 
 
The synthesis of any polymer is predicated on the synthetic accessibility of the constituent 
monomers, which may be challenging to produce.  For gem-dialkyl containing monomers, several 
different routes have previously been developed.  Hillmyer and co-workers synthesized (Z)-5,5-
dimethylcyclooct-1-ene (5) in five steps.5 Starting from inexpensive 1,5-cyclooctadiene (1,5-
COD), the tert-butyl ester 1 was prepared through Pd-catalyzed alkoxycarbonylation in 84% yield.  
Methylation with LDA and iodomethane gave α-methyl tert-butyl ester 2 in 92% yield.  Then 2 
was reduced to the primary alcohol 3 by LiAlH4, and the alcohol was removed by tosylation and 
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Scheme 3.1.3. Synthesis of 5,5-gem-dimethyl Cyclooctene by Hillmyer 
 
As an alternative to ROMP, acyclic diene metathesis (ADMET) polymerization has also 
been used to prepare gem-dimethyl containing polymers.  To prepare the monomer for ADMET 
polymerization, the Wagener group developed a synthetic route to diene monomers with different 
number of methylene units between the gem-dimethyl branch point and the terminal alkenes.6  
Propionic acid was treated with LDA, and alkylated by the addition of two equivalents of an 
alkenyl bromide to form the carboxylic acid intermediate (7a-c).  Reduction of carboxylic acid 
with LiAlH4 generates the primary alcohol (8a-c), which is deoxygenated through tosylation and 
reduction with LiAlH4 to give the requisite symmetrical gem-dimethyl substituted diene monomers 
possessing 3, 6, and 9 methylene “spacer” units (10a-c, Scheme 3.1.4). 

















-78 ºC to 0 ºC
2. MeI, 0 ºC
(92%)
LiAlH4 






























10a, x = 3, 27% overall
10b, x = 6, 10% overall
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However, these routes to this type of gem-dimethyl substituted diene monomers required 
long synthetic sequences and wasteful materials.  Due to the need of large quantities of these 
monomers (kilogram scale) in biomedical device development, we aimed to optimize a synthetic 
route from inexpensive sources, with fewer steps and operations.  In this work, we have developed 
a new synthetic route to gem-dialkyl diene monomers for ADMET polymerization using the 
Claisen condensation of an unsaturated ester as the key step.  This approach offers several benefits 
in terms of cost and scalability as well as synthetic flexibility.  In particular, the unsaturated ester 
can be sourced from seed oils enabling a biorenewable route to these polymers.  Telechelic 
polymers with different gem-dialkyl substituted diene monomers were prepared using Ru-
catalyzed olefin metathesis, and the desired thermal properties (low glass transition temperature) 
has been accomplished. 
 
3.2 DEVELOPMENT OF SYNTHETIC ROUTES TO GEM-DIALKYL DIENES  
 
In Hillmyer’s synthesis of gem-dimethyl cyclooctene monomers, the major disadvantage 
is the use of  wasteful amount of tosyl chloride and dangerous LiAlH4 reductant in order to remove 
the  oxygen atom to furnish the all-carbon structure.  Our initial proposal is to directly oxidize 1,5-
COD to the ketone 11 in modified Wacker oxidation conditions with hydrogen peroxide as oxidant.  
Geminal-dimethylation through in situ formed TiMe2Cl2 reagent was reported by Reetz and co-
workers in 1980,10 and has been applied in the syntheses of a variety of gem-dimethyl containing 
molecules.11  However, when the ketone 11 was subjected to the reaction conditions, a complex 
mixture of products was formed; the desired product 5 was never observed.  We reasoned a fast 
transannular reaction caused the disappearance of alkenes after this reaction (Scheme 3.2.1).  
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Scheme 3.2.1. Gem-dimethylation of Ketone 11. 
 
After several attempts to convert the ketone 11 with various approaches, we found that α-
methylation with 2.5 equivalents KOt-Bu and 5 equivalents iodomethane gave the α,α-gem-
dimethyl ketone 12 as the major product (dimethyl product 12:monomethyl product 13 > 50:1), 
which was used as a precursor to the gem-dimethyl cyclooctene monomer upon deoxygenation.  
Ketone 12 was first reduced to the secondary alcohol 14 by Red-Al, then the alcohol was converted 
to xanthate 15.  Treatment of the crude xanthate 15 with BEt3, H2O and O2 bubbling according to 
a radical deoxygenation conditions developed by Wood and co-workers,12 finally provided the (Z)-
4,4-dimethylcyclooct-1-ene (16, Scheme 3.2.2).  However, this route still requires 5 steps to synthesize 
the gem-dimethyl cyclooctene monomer from 1,5-COD, and the scaling up of those reactions could be 
challenging. 
















35% H2O2 (1.5 equiv)
30 ºC, 5 d
(27%)
1. KOt-Bu (2.5 equiv)
THF, –40 ºC, 1 h
2. MeI (5 equiv)








–78 ºC – 23 ºC
2. NaH (4 equiv)
CS2 (10 equiv)
MeI (10 equiv)




23 ºC, 24 h
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In light of these synthetic difficulties, we decided to focus on the preparation of linear diene 
monomers instead of cyclooctene-based monomers.  We were initially drawn to the Claisen 
condensation as a key step.  The Claisen condensation reaction has been an important synthetic 
reaction for more than 100 years.13 The b-ketoester intermediate from the Claisen condensation 
can be transformed into a symmetric linear ketone by hydrolysis and decarboxylation, and so the 
use of unsaturated esters provides linear dienes containing ketone groups, which are versatile 
intermediates upon further synthetic manipulations.  Watson and Wagener used this transformation 
to synthesize diene monomers en route to ethylene/CO copolymers.14  These long chain ketones 
provided a convenient starting point for our synthesis.  Importantly, established ethenolysis 
chemistry can provide methyl 9-decenoate (17) from methyl oleate from plant oils,15 providing an 
opportunity for a biorenewable synthesis of the ketone 18, which can be used to synthesize the 
subsequent gem-dimethyl containing diene monomers such as 21 (Scheme 3.2.3). 
Scheme 3.2.3. Claisen Condensation Route 
 
There are several reports of the direct transformation of ketones to the gem-dimethyl 
moiety. Unfortunately, TiCl2Me2,16 AlMe3,17 and AlMe3 in the presence of Me3SiOTf18 were all 
unsuccessful for the direct transformation of 18 to the desired monomer 21.  Instead, either olefin 
polymerization by TiCl2Me2 or the addition of a methyl nucleophile to the ketone by AlMe3 was 
observed.  The two methyl groups were installed sequentially: the first by a Grignard addition to 
18, and the second by SN1 reaction of a subsequent tertiary alkyl halide with a nucleophilic 
alkylating reagent (Scheme 3.2.4).  Precedent for the use of both alkyl zinc10 and alkyl aluminum19 
nucleophiles to accomplish this transformation prompted us to explore these options.  The addition 
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was easily transformed into the tertiary chloride 20 using SOCl2.  Substitution of 20 using AlMe3 
completed the sequence.  The transformation of tertiary alcohol 19 to 21 can be achieved in a 
single pot procedure.20  Me2Zn was also a viable nucleophile, but AlMe3 gave higher yields and is 
more economically viable. 
Scheme 3.2.4. Synthesis of Gem-dimethyl Diene Monomer 21 
 
Following this success, several other linear diene monomers were prepared from ketones 
of varying lengths.  Ethyl pent-4-enoate (22) was easily converted to nona-1,8-dien-5-one (23)21 
and the subsequent 9-carbon gem-dimethyl monomer 24.  Alkylation of acetone 
dimethylhydrazone 25 with 5-bromo-1-pentene provided the medium length ketone 26 in good 
yield (Scheme 3.2.5), which was readily transformed into the 13-carbon monomer 27 in 58% yield 
over three steps.  Longer linear diene monomers were also synthesized from long chain unsaturated 
esters.  Ethyl 10-undecenoate 28, a precursor to Nylon,22 was readily transformed into the ketone 
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Scheme 3.2.5. The Synthesis of Gem-dimethyl Diene Monomers with Different Lengths
 
 
The gem-dialkyl groups can easily be varied by using different Grignard and alkylzinc 
reagents or alkylaluminum reagents to provide both homo- and heterodialkyl substitution, as 
demonstrated by the preparation of 32, 33, 34, and 35 (Scheme 3.2.6).  This route tolerates both 
terminal and internal olefins with no detectable olefin isomerization, as demonstrated by the 
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Scheme 3.2.6. Diene Monomers with Varying Alkyl Substitutions  
 
 
3.3 ADMET POLYMERIZATION OF GEM-DIALKYL DIENES  
 
The two major types of metathesis polymerizations include ROMP and ADMET 
polymerization.  ROMP is a chain-growth polymerization, whereas ADMET is a step-growth 
polymerization.  The mechanism for ADMET polymerization is shown in Scheme 3.3.1. The olefin 
initially reacts with the metal alkylidene to form a metallacyclobutane intermediate by reversible 
[2+2] cycloaddition.   Subsequent cycloreversion gives the growing polymer and a new alkylidene 
species, which undergoes further coordination, cycloaddition and cycloreversion.  The productive 
pathway in ADMET polymerization of terminal olefins features the generation of the methylidene 
carbene catalyst and the condensate (e.g. ethylene).  Note that each step in the mechanism is 
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is required to drive the equilibrium towards chain growth.  ADMET polymerization was firstly 
observed in the late 1980s by Wagener and Lindmark-Hamburg23 while studying the condensation 
of unconjugated α,ω-dienes with the WCl6/EtAlCl2 catalyst system.  The development of well-
defined ruthenium-based catalyst allowed ADMET to become a feasible and useful method of 
polymerization.24 
Scheme 3.3.1. Mechanism of ADMET Polymerization 
 
The ADMET polymerization25 of 21, 24, 27, and 30 using the 2nd generation Ru catalyst 
(G2) produced the desired polyolefins with targeted molecular weights of 2000 g/mol.  The 
polymerization of 24 was complicated by the formation of both polyolefin poly-24 and the 7-
membered cyclic olefin 37 (Scheme 3.3.2).  ADMET polymerization is well-known to produce 
cyclic oligomers 26  as the reaction proceeds, but the gem-dimethyl substitution results in a 
pronounced Thorpe-Ingold effect27 that favors cyclization.  The cyclic olefin 37 also possesses low 
ring-strain, and did not fully incorporate into the growing polymer chain; prolonged reaction times 
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observed, in both the ADMET polymerization of 24 and 36).  However, once the desired molecular 
weight is achieved, 37 can easily be removed in vacuo and recycled in a subsequent ring-opening 
polymerization.  The ROMP of 37 afforded the same distribution of poly-24 and 37 as was 
achieved in the ADMET of 24.  
Scheme 3.3.2. ADMET Polymerization of Short Chain Monomer 24 
 
The longer diene monomers (21, 27 and 30) did not suffer from the competing ring-closing 
metathesis and readily polymerized using G2 under static vacuum.30 We used the 
“polymerization/depolymerization” method developed by Wagener7 to produce the target 
telechelic diols.  The chain transfer agent (CTA) 38 was added to the polyolefin mixture after 
sufficient reaction time to cleave the longer polyolefins and install the protected telechelic 
endgroups.  Hydrogenation of the unsaturated polymers was accomplished using Pd/C under H2 
and the resulting telechelic PEIB derivatives were isolated in high yield after filtration and 
concentration in vacuo (Scheme 3.3.3).  




















1. G2 (0.5 mol%)
    CH2Cl2, static vacuum, 60 ºC
2. 












x = 2, 24
x = 4, 27
x = 7, 21








x = 2, poly-24a
x = 4, poly-27a
x = 7, poly-21a
x = 8, poly-30a
x = 2, poly-24a
x = 4, poly-27a
x = 7, poly-21a
x = 8, poly-30a
x = 2, poly-24b
x = 4, poly-27b
x = 7, poly-21b
x = 8, poly-30b
38
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Differential scanning calorimetry (DSC) was used to determine the effects of substitution 
and molecular weight on the thermal behavior for the series of polymers (see DSC traces in Figure 
3.5.1).  The measured Tg values (Table 3.3.1) were in agreement with those for the PEIB analogues 
prepared by both Wagener6,7 and Hillmyer5, and a higher density of substitution (e.g. poly-24b) 
resulted in amorphous materials without melting points.  Polymers derived from the longer 
monomers 21 and 30 displayed broad, multimodal melting points indicating the semicrystalline 
nature of the longer saturated segments of the polymer, as described by Wagener.7  
Table 3.3.1. Molecular Weight, Polydistribution, and Thermal Properties of  Telechelic 
Polymers 
Polymer Mna PDIb Tg Tm 
Poly-21b 4200 1.4  No Tg observed –50 – 8 °Cc 
Poly-24b 2200 1.4 –60 °C –d 
Poly-27b 2000 1.5 –60 °C –d 
Poly-30b-1 3100 1.5 –50 °C –24 – 0 °Cc 
Poly-30b-2 6300 1.1 –60 °C –14 – 10 °Cc 
Poly-30b-3 17200 1.5 –26 °C –12 – 50 °Cc 
Poly-30b-4 28700 1.7 –30 °C 30 °C 
Poly-32b 3200 1.1 –52 °C –d 
Poly-34b 6800 1.4 –59 °C –18 °Cc 
 
a Determined by 1H NMR b PDI = Mw/Mn (determined by GPC) c broad melting point d no melting point observed 
 
3.4 CONCLUSIONS 
We have described a new synthetic route to gem-dialkyl diene monomers for ADMET 
polymerization.  This route enables the use of unsaturated fatty acid esters as a raw material source,  
offers several benefits in terms of cost and scalability as well as synthetic flexibility.  Several 
different diene monomers have been prepared and polymerized using Ru-catalyzed ADMET 
polymerization to access short (Mn ~2–7 kDa) amorphous telechelic polymers.  These telechelic 
polymers are desirable as the soft segment of polyurethane elastomers for biomedical applications, 
and this work demonstrates a cost-effective and convenient route for their preparation. 
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3.5  EXPERIMENTAL METHODS AND ANALYTICAL DATA 
3.5.1  Materials and Methods 
Unless otherwise stated, all reactions were performed under argon atmosphere using oven 
dried glassware.  Anhydrous solvents were dried using activated alumina and stored in Schlenk 
flasks over activated 3 Å molecular sieves.  All reagents were purchased from commercial 
suppliers and used as received.  NMR spectra were collected using Varian 500 or 600 MHz 
spectrometers or a Bruker 400 MHz spectrometer.  Mass spectrometry was performed at the 
Caltech Mass spectrometry facility.  Differential Scanning Calorimetry was performed using a 
Mettler Toledo DSC 3+ Star System. Ethyl-(E)-hex-4-enoate,28 and nona-1,8-dien-5-one21 were 
synthesized according to literature precedent. 
 
3.5.2  Experimental Procedures 
 
 
(Z)-cyclooct-4-en-1-one (11): According to a known procedure,29  to a solution of hydrogen 
peroxide (35% in water, 5 mL, 60 mmol) was added to a mixture of palladium acetate (90 mg, 0.4 
mmol), benzoquinone (87 mg, 0.8 mmol) and 1,5-cyclooctadiene (5.4 mL, 40 mmol).  The mixture 
was stirred for 5 days at 30° C. The mixture was poured into Et2O (100 mL) and water was added 
(100 mL) then the mixture was slowly basified with 1M NaOH solution while cooling with ice.  
The layers were separated and the aqueous layer was extracted with Et2O (2 × 100 mL).  The 
combined organic layers were twice washed with 1M NaOH and dried over Na2SO4.  Distillation 
under reduced pressure afforded ketone 11 (1.36 g, 27% yield) as a colorless oil. 
Spectral data matched those reported in the literature.30  
OPd(OAc)2 (1 mol%)
BQ (2 mol%)
35% H2O2 (1.5 equiv)
30 ºC, 5 d
(27%)
11
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(Z)-2,2-dimethylcyclooct-4-en-1-one (12): To a stirred solution of KOt-Bu (5.61 g, 2.5 equiv) in 
THF (100 mL) was added ketone 11 (2.48 g, 20.0 mmol) in THF (20 mL).  The solution was stirred 
for 1 hour at –40 ºC, and MeI (6.3 mL, 5.0 equiv) was added.  The reaction mixture was slowly 
warmed to 23 ºC and stirring was continues for 20 hours.  Water (50 mL) was then added and the 
aqueous phase was extracted by Et2O (3 × 50 mL).  GC analysis showed > 50:1 ratio of products 
12 and 13, and pure compound 12 can be isolated by column chromatography (SiO2, 10:1 
pentane/Et2O) as a colorless liquid (1.29 g, 42%).   
 
TLC (10:1 pentane/Et2O): Rf= 0.4 (KMnO4).  
1H NMR (400 MHz, CDCl3) δ 5.69 – 5.56 (m, 1H), 2.45 (dd, J = 8.0, 4.0 Hz, 1H), 2.25 (d, J = 7.2 
Hz, 1H), 2.15 – 2.07 (m, 1H), 1.64 – 1.54 (m, 1H), 1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 217.5, 131.9, 129.2, 52.6, 37.8, 36.5, 27.3, 26.3, 23.7. 




(Z)-4,4-dimethylcyclooct-1-ene (16): Ketone 12 (2.10 g, 13.8 mmol) in THF (50 mL) was added 
to a solution of Red-Al (16.6 mmol, 1.2 equiv) in THF (40 mL) dropwise at –78 °C under argon 
atmosphere.  After stirring at the same temperature for 3 hours, the solution was quenched with 
0.1 M HCl (100 mL), and the aqueous layer was extracted with EtOAc (3 × 100 mL).  The 
combined organic layers were then washed with saturated aqueous NaHCO3 (50 mL) and brine 
OO 1. KOt-Bu (2.5 equiv)
THF, –40 ºC, 1 h
2. MeI (5 equiv)














–78 ºC – 23 ºC








23 ºC, 24 h
(72% over 3 steps)
12 14 15 16
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(50 mL), dried over Na2SO4, and concentrated under reduced pressure. The residue was filtered 
through a plug of silica with Et2O wash.  The crude alcohol product 14 was obtained as a colorless 
oil (2.23 g), which was used in the next step without further purification. 
To a suspension of NaH (60% in mineral oil, 2.24 g, 96 mmol, 4.0 equiv) in THF (100 mL) 
at 0 °C was added alcohol 14 (2.23 g, 14 mmol, 1.0 equiv) in THF (20 mL).  The mixture was 
stirred for 30 min, at which point CS2 (8.4 mL, 140 mmol, 10.0 equiv) was added. The mixture 
was stirred for an additional 30 min, at which point iodomethane (8.7 mL, 140 mmol, 10.0 equiv) 
was added.  The reaction mixture was allowed to warm to room temperature for 3 hours before 
being quenched with MeOH (50 mL) and evaporated in vacuo.  The residue was dissolved in 
EtOAc (100 mL), washed with water (50 mL) and brine (50 mL).  The organic layer was dried 
over Na2SO4 and concentrated. Column chromatography (SiO2, hexanes) afforded crude xanthate 
15 (4.42 g) as a yellow oil. 
Then, methyl xanthate 15 (733 mg, 3 mmol, 1.0 equiv) was dissolved in a flame-dried 500 
mL flask with benzene (100 mL), combined with H2O (0.27 mL, 15 mmol, 5.0 equiv) and allowed 
to stir for 1 h.  Argon gas was then bubbled through the solution for a period of 1 h, after which, a 
solution of BEt3 (1.0 M in THF, 15 mL, 15 mmol, 5.0 equiv) was added via syringe pump over 1 
h.  On completion of BEt3 addition, dry oxygen (54 mL, 2.4 mmol O2, 0.8 equiv) was introduced 
via syringe pump at a rate of 1.2 ml/hr through a stainless steel cannula positioned beneath the 
reaction surface.  Upon completion of air addition, hydrogen peroxide (30 % in water, 50 mL) and 
sodium hydroxide (3.0 M in water, 50 mL) were introduced simultaneously into the reaction 
mixture (Caution: reaction is exothermic).  After stirring for 10 min, the solution was diluted with 
brine (100 mL), and the aqueous layer was extracted with EtOAc (3 × 100 mL).  Combined organic 
portions were dried over anhydrous sodium sulfate, filtered, and concentrated.  Distillation under 
reduced pressure afforded 16 as a colorless oil (297 mg, 72%). 
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TLC (pentane): Rf= 0.9 (KMnO4).  
1H NMR (400 MHz, CDCl3) δ 5.85 – 5.48 (m, 2H), 2.17 – 2.04 (m, 2H), 1.92 (d, J = 8.2 Hz, 2H), 
1.49 (dd, J = 6.0, 3.2 Hz, 4H), 1.33 – 1.23 (m, 2H), 0.89 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ 131.4, 128.9, 39.7, 37.5, 36.1, 30.3, 29.0, 26.8, 23.5. 
HRMS (EI+, m/z): calc’d for C10H18 [M]+• 138.1409, found: 138.1408. 
 
 
Nonadeca-1,18-dien-10-one (18): A 100 mL three-necked round bottom flask was fitted with a 
dropping funnel and two ground glass stoppers and charged with a magnetic stirbar, NaH (60 wt% 
in mineral oil, 3.7 g, 92 mmol, 1.2 equiv), and toluene (25 mL).  This suspension was heated to 
100 °C and a solution of methyl 9-decenoate (14.3 g, 80 mmol, 1 equiv) in toluene (10 mL) was 
added dropwise over the course of 30 min. The reaction mixture was then heated to 110 °C with 
stirring for 24 h, cooled to ambient temperature and quenched by the slow addition of MeOH. The 
solvent was removed in vacuo and the residue was suspended in EtOH (50 mL) and water (25 mL). 
NaOH (1.6 g, 1.0 equiv) was added and the reaction mixture was heated to reflux for 2 h. After 
cooling to ambient temperature, the reaction mixture was extracted with Et2O (3 × 50 mL) and the 
combined organic layers were washed with water (3 × 50 mL), brine (30 mL), dried over anhydrous 
MgSO4, filtered, and concentrated.  Crystallization with MeOH afforded 18 as a white solid (10.2 
g, 90% yield over two steps) 









7 7 6 7 7110 ºC
PhMe
17 18a 18 (90%)
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Trideca-1,12-dien-7-one (26): To a stirred solution of hydrazone 25 (4.0 g, 40 mmol, 1.0 equiv) 
in THF (80 mL) was added n-butyl lithium solution (16.8 mL, 2.5 M solution in hexanes, 42 mmol, 
1.05 equiv).  After stirring 30 minutes at 0 ºC, 5-bromo-1-pentene (4.8 mL, 40 mmol, 1.0 equiv) 
was added and the reaction mixture was stirred for 1 hour at 23 ºC. Then the reaction mixture was 
cooled to 0 ºC again and n-butyl lithium solution (16.8 mL, 2.5 M solution in hexanes, 42 mmol, 
1.05 equiv) was added.  After stirring 30 minutes at 0 ºC, 5-bromo-1-pentene (4.8 mL, 40 mmol, 
1.0 equiv) was added again and the reaction mixture was stirred for 2 hours at 23 ºC before 
quenched by saturated NH4Cl solution (100 mL). The aqueous layer was extracted with Et2O (2 × 
100 mL) and the combined organic phases were washed with brine (100 mL), dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The crude reaction mixture was 
dissolved in CH2Cl2 (40 mL), and HCl solution (16 mL, 3.0 M) was added.  After 12 h, the phases 
were separated and the aqueous phase was extracted with CH2Cl2 (2 × 50 mL).  The combined 
organic phases are washed with saturated NaHCO3 solution (100 mL).  Column chromatography 
(SiO2, 10:1 hexanes/EtOAc) gave 26 as a colorless oil (7.0 g, 90% yield). 
 
1H NMR (400 MHz, CDCl3): δ 5.66 (ddt, J = 16.9, 10.2, 6.5 Hz, 2H), 4.94 – 4.77 (m, 4H), 2.32 
– 2.23 (m, 4H), 1.97 – 1.88 (m, 4H), 1.46 (dt, J = 15.2, 7.3 Hz, 4H), 1.30 – 1.20 (m, 4H). 
13C NMR (101 MHz, CDCl3): δ 211.2, 138.5, 114.6, 42.6, 33.6, 28.5, 23.3.   














2. HCl (aq.), CH2Cl2
25
4
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Henicosa-1,20-dien-11-one (29): A 500 mL flamed-dried round bottom flask charged with ethyl 
10-undecenoate (21.0 g, 100 mmol, 1.0 equiv) and sodium ethoxide (3.4 g, 50 mmol, 0.5 equiv) 
was equipped with a reflux condenser and a vacuum adapter.  The reaction was stirred at 100 ºC 
under a dynamic vacuum (2 torr) for 12 hours to remove the ethanol produced.  After the reaction 
was cooled to 23 ºC, the crude b-keto ester 29a was dissolved in ethanol (50 mL) and 2 M NaOH 
solution (20 mL, 1.0 equiv) was added.  The reaction mixture was warmed to reflux for 2 hours 
and cooled to 23 ºC.  A white solid precipitated and was collected by filtration and recrystallized 
from refluxing methanol, to give ketone 29 as a white solid (7.47 g, 63% yield over two steps).  
 
1H NMR (400 MHz, CDCl3): δ 5.73 (ddt, J = 16.9, 10.1, 6.6 Hz, 2H), 4.97 – 4.82 (m, 4H), 2.31 
(t, J = 7.5 Hz, 4H), 2.01 – 1.91 (m, 4H), 1.49 (q, J = 7.0 Hz, 4H), 1.34 – 1.25 (m, 4H), 1.24 – 
1.17 (m, 16H).   
13C NMR (101 MHz, CDCl3): δ 211.7, 139.2, 114.2, 42.8, 33.8, 29.4, 29.3, 29.3, 29.1, 28.9, 
23.9.   
HRMS (EI+, m/z): calc’d for C21H38O [M]+• 306.2923, found: 306.2927. 
 
 
An oven-dried 500 mL three-necked round bottom flask was equipped with a magnetic 
stirbar and fitted with two rubber septa and a ground glass flow adaptor to introduce inert 








8 8 7 8 8100 ºC
2 torr




     toluene, -78 ºC
2. NaOH
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140 mmol) via syringe.  Anhydrous toluene (350 mL) was added by cannula, and the reaction 
mixture was cooled to –78 °C.  TiCl4 (18.4 mL, 168 mmol) was added dropwise via syringe over 
twenty minutes, causing the reaction mixture to become deep red in color.  The reaction mixture 
was stirred with warming to ambient temperature for 10 h, and saturated aqueous NaHCO3 was 
carefully added to quench the reaction.  The organic layer was separated, the aqueous layer was 
extracted with Et2O (3 × 25 mL), and the combined organic layers were washed with water (20 
mL), brine (2 × 20 mL), dried over MgSO4, and concentrated to a clear, yellow oil. 
 
The yellow oil was dissolved in EtOH (200 mL) and water (50 mL) and NaOH pellets were added 
(3 g).  The reaction mixture was heated to 85 °C and monitored by TLC (5% Et2O in hexanes) 
until the starting material was fully consumed. The reaction mixture was concentrated and 
extracted with Et2O (3 × 50 mL), and the combined organic layers were washed with water (3 × 
25 mL) and brine (25 mL), dried over MgSO4, filtered and concentrated.  The product 31 was 
purified by column chromatography (SiO2, 5% Et2O in hexanes) to yield a clear, pale yellow oil 
(11 g, 60 mmol, 85 %) 
 
1H NMR (600 MHz, CDCl3) δ 5.49 – 5.34 (m, 4H), 2.43 (t, J = 7.4 Hz, 4H), 2.28 – 2.19 (m, 4H), 
1.65 – 1.59 (m, 6H). 
13C NMR (101 MHz, CDCl3) δ 210.4, 129.7, 126.0, 42.8, 26.9, 18.0. 
HRMS (EI+) calc’d for C11H18O [M]+• 166.1358; found 166.1346 
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(Z)-dibenzyl oct-4-ene-1,8-diyl bis(carbonate) (38): In a nitrogen-filled glovebox, 4-penten-1-
ol (1.72 g, 20 mmol) was dissolved in 6 mL THF in a 20 mL vial equipped with a stir bar, and 
Ru-2 (13.5 mg, 0.1 mol%) was added.  The vial was placed on a 35 ºC stir plate without capping 
and stirring was continued for 4 hours.  At that time the reaction progress was monitored by GC 
analysis to ensure full conversion, and the vial was brought outside the glovebox and the reaction 
mixture was quenched with a few drops of ethyl vinyl ether.  Column chromatography (SiO2, 2:1 
hexanes/EtOAc) gave 38a as a colorless oil (1.06 g, 74% yield).   
 
To the diol 38a (1.06 g, 7.35 mmol, 1.0 equiv) in 30 mL CH2Cl2 , pyridine (3.0 mL, 36.75 mmol, 
5.0 equiv) and DMAP (180 mg, 1.47 mmol, 0.2 equiv) was added sequentially at 0 ºC.  Then 
benzyl chloroformate (4.2 mL, 29.4 mmol, 4.0 equiv) was added dropwisely. The mixture was left 
to stir at 23 ºC for overnight before it was quenched with 1 M HCl (30 mL). The aqueous phase 
was extracted by Et2O three times. The combined organic phases were dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. Column chromatography (SiO2, 9:1 
hexanes/EtOAc) gave 38 as a colorless oil (2.52 g, 83% yield).  
 
 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.30 (m, 10H), 5.38 (ddd, J = 5.6, 4.4, 1.1 Hz, 2H), 5.15 
(s, 4H), 4.13 (t, J = 6.6 Hz, 4H), 2.18 – 2.03 (m, 4H), 1.72 (dq, J = 8.2, 6.7 Hz, 4H). 
13C NMR (101 MHz, CDCl3) δ 155.3, 135.4, 129.5, 128.7, 128.6, 128.5, 69.6, 67.7, 28.6, 23.4. 
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HRMS (FAB+, m/z): calc’d for C24H29O6 [M+H]+ 413.1964, found: 413.1961. 
 




In a flame-dried round-bottom flask, ketone (1.0 equiv) was dissolved in THF and the reaction 
mixture was cooled to 0 ºC.  Methylmagnesium bromide solution (3.0 M solution in diethyl ether, 
1.5 equiv) was added dropwise, and the reaction mixture was slowly warmed to 23 ºC.  After 1 
hour, the reaction mixture was cooled to 0 ºC, and quenched by saturated NH4Cl solution.  The 
aqueous phase was extracted with Et2O twice, dried over anhydrous MgSO4, filtered over a short 
silica plug, and concentrated under reduced pressure. 
 
The crude tertiary alcohol was transferred into a Schlenk flask (with one side arm fitted with a 
glass stopcock) with dry CH2Cl2.  The residual solvent was removed by connecting the side arm 
to vacuum.  The flask was back-filled with argon and cooled to 0 ºC, and then SOCl2 (2.5 equiv) 
was added slowly.  A minimal amount of CH2Cl2 can be added to aid with stirring.  The reaction 
mixture was stirred at 0 ºC for 1 hour, and the reaction progress can be monitored by TLC (using 
Al2O3 plate).  The side arm of the Schlenk flask was reconnected to vacuum and excess SOCl2 was 
removed at 0 ºC.  Then the crude tertiary chloride product was dissolved in CH2Cl2 (0.3 M) and 
the reaction mixture was cooled to –78 ºC. Trimethylaluminum (2.0 M solution in hexanes, 2.0 










x = 2, 23
x = 4, 26
x = 7, 18
x = 8, 29
x = 2, 24
x = 4, 27
x = 7, 21
x = 8, 30
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hours and then quenched with aqueous HCl solution (1.0 M) at 0 ºC.  The aqueous layer was 
extracted with CH2Cl2, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure.  The gem-dimethylation products were purified by column chromatography (SiO2, 100% 
hexanes) or distillation. 
 
10,10-dimethylnonadeca-1,18-diene (21): Prepared according to General Procedure A from 
ketone 18 (10.2 g, 37 mmol) as a colorless liquid (9.1 g, 83% yield). 
 
1H NMR (600 MHz, CDCl3) δ 5.82 (ddt, J = 16.9, 10.1, 6.7 Hz, 2H), 5.00 (dq, J = 17.1, 1.7 Hz, 
2H), 4.93 (ddt, J = 10.2, 2.4, 1.2 Hz, 2H), 2.07 – 2.00 (m, 4H), 1.42 – 1.09 (m, 24H), 0.81 (s, 
6H). 
13C NMR (126 MHz, CDCl3) δ 139.3, 114.1, 42.0, 33.8, 32.6, 30.6, 29.6, 29.2, 29.0, 27.3, 24.0. 
HRMS (EI+, m/z): calc’d for C21H40 [M]+• 292.3130, found: 292.3144. 
 
 
5,5-dimethylnona-1,8-diene (24): Prepared according to General Procedure A from 
ketone 23 (25 g, 181 mmol) as a colorless liquid (13 g, 58% yield). 
 
1H NMR (400 MHz, CDCl3) δ 5.81 (ddt, J = 16.9, 10.2, 6.6 Hz, 2H), 4.99 (dq, J = 17.1, 1.7 Hz, 
2H), 4.94 – 4.86 (m, 2H), 2.02 – 1.93 (m, 4H), 1.30 – 1.22 (m, 4H), 0.86 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ 139.80, 113.77, 41.06, 32.65, 28.58, 27.08. 
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7,7-dimethyltrideca-1,12-diene (27): Prepared according to General Procedure A from 
ketone 26 (1.94 g, 10 mmol) as a colorless liquid (1.2 g, 58% yield). 
 
1H NMR (400 MHz, CDCl3) δ 5.75 (ddt, J = 16.9, 10.1, 6.7 Hz, 2H), 4.98 – 4.81 (m, 4H), 2.03 – 
1.94 (m, 4H), 1.32 – 1.23 (m, 4H), 1.19 – 1.05 (m, 8H), 0.75 (s, 6H).  
13C NMR (101 MHz, CDCl3) δ 139.3, 114.1, 41.8, 33.9, 32.7, 29.9, 27.3, 23.5. 
 HRMS (EI+, m/z): calc’d for C15H28 [M]+• 208.2191, found: 208.2177. 
 
 
11,11-dimethylhenicosa-1,20-diene (30): Prepared according to General Procedure A from 
ketone 29 (7.47 g, 24.4 mmol) as a colorless liquid (5.66 g, 72% yield). 
 
1H NMR (400 MHz, CDCl3) δ 5.84 (ddt, J = 16.9, 10.2, 6.7 Hz, 2H), 5.08 – 4.89 (m, 4H), 2.14 – 
2.00 (m, 4H), 1.40 (q, J = 6.9 Hz, 4H), 1.35 – 1.12 (m, 24H), 0.84 (s, 6H).  
13C NMR (101 MHz, CDCl3) δ 139.4, 114.2, 42.1, 34.0, 32.7, 30.8, 29.8, 29.7, 29.3, 29.1, 27.5, 
24.2. 
HRMS (EI+, m/z): calc’d for C23H44 [M]+• 320.3443, found: 320.3425. 
 
 
5,5-diethylnona-1,8-diene (33): Prepared according to modified General Procedure A from 








Chapter 3 – A Convenient Synthesis of Geminal-Dialkyl Dienes  




1H NMR (600 MHz, CDCl3) δ 5.82 (ddt, J = 16.9, 10.2, 6.6 Hz, 2H), 5.00 (dq, J = 17.1, 1.6 Hz, 
2H), 4.91 (ddt, J = 10.0, 2.3, 1.2 Hz, 2H), 1.96 – 1.87 (m, 4H), 1.26 – 1.19 (m, 8H), 0.75 (t, J = 
7.5, 1.0 Hz, 6H). 
13C NMR (101 MHz, CDCl3) δ 139.9, 113.9, 37.3, 34.9, 28.0, 27.7, 7.6. 
HRMS (EI+) calc’d for C13H24 [M]+• 180.1878; found 180.1894.	
 
 
11-butyl-11-ethylhenicosa-1,20-diene (34): Prepared according to modified General Procedure 
A from ketone 29 (918 mg, 3 mmol) with n-butylmagnesium chloride solution (2.0 M solution in 
diethyl ether, 1.5 equiv) and triethylaluminum (2.0 equiv). 34 was obtained as a colorless liquid 
(680 mg, 60% yield). 
 
1H NMR (400 MHz, CDCl3) δ 5.74 (ddt, J = 17.0, 10.2, 6.7 Hz, 2H), 4.96 – 4.82 (m, 4H), 2.01 – 
1.92 (m, 4H), 1.35 – 1.25 (m, 4H), 1.25 – 1.11 (m, 24H), 1.07 – 0.99 (m, 8H), 0.82 (td, J = 7.2, 
2.0 Hz, 3H), 0.64 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 139.4, 114.2, 37.5, 37.1, 36.2, 35.9, 33.9, 33.9, 33.5, 30.8, 30.3, 
29.8, 29.7, 29.7, 29.3, 29.1, 28.7, 26.8, 25.4, 23.8, 23.3, 23.1, 14.4, 14.4, 7.7. 
 HRMS (EI+, m/z): calc’d for C27H52 [M]+• 376.4069, found: 376.4120. 
 
 
11-ethyl-11-octylhenicosa-1,20-diene (35): Prepared according to modified General Procedure A 
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THF, 1.5 equiv) and triethylaluminum (2.0 equiv). 35 was obtained as a colorless liquid (154 mg, 
71% yield). 
 
1H NMR (400 MHz, CDCl3) δ  5.74 (ddt, J = 16.9, 10.2, 6.7 Hz, 2H), 4.99 – 4.80 (m, 4H), 2.04 – 
1.90 (m, 4H), 1.34 – 1.26 (m, 4H), 1.25 – 1.10 (m, 34H), 1.05 – 1.00 (m, 6H), 0.83 – 0.78 (m, 3H), 
0.64 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 139.4, 114.2, 37.5, 37.2, 36.2, 34.0, 33.8, 32.1, 30.8, 30.8, 30.5, 
30.3, 30.3, 29.8, 29.8, 29.8, 29.7, 29.7, 29.6, 29.5, 29.3, 29.1, 28.7, 26.8, 23.1, 22.9, 14.3, 7.7. 
 HRMS (EI+, m/z): calc’d for C31H60 [M]+• 432.4695, found: 432.4714. 
 
 
(2E,9E)-6,6-dimethylundeca-2,9-diene (36): Prepared according to general procedure A from 
ketone 31 (258 mg, 1.6 mmol) as a colorless liquid (230 mg, 82%). 
 
1H NMR (500 MHz, CDCl3) δ 5.49 – 5.39 (m, 4H), 1.96 – 1.89 (m, 4H), 1.66 (dt, J = 4.8, 1.3 Hz, 
6H), 1.27 – 1.21 (m, 4H), 0.86 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ 132.3, 124.2, 41.8, 32.6, 27.3, 27.1, 18.0. 
HRMS (EI+) calc’d for C13H24 [M]+• 180.1878; found 180.1865. 
 
 












Me BrPBr3 Et2Zn, ZnCl2
n n
Et Me
n = 2, 23 n = 2, 32
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In a flame-dried round-bottom flask, ketone (1.0 equiv) was dissolved in THF and the reaction 
mixture was cooled to 0 ºC.  Methylmagnesium bromide solution (3.0 M solution in diethyl ether, 
1.5 equiv) was added dropwise, and the reaction mixture was slowly warmed to 23 ºC.  After 1 
hour, the reaction mixture was cooled to 0 ºC, and quenched by saturated NH4Cl solution.  The 
aqueous phase was extracted with Et2O twice, dried over anhydrous MgSO4, filtered over a short 
silica plug, and concentrated under reduced pressure. 
 
A 100 mL round bottom flask equipped with a magnetic stirbar was charged with the tertiary 
alcohol (1.0 equiv) and dissolved in anhydrous CH2Cl2 (1 M). This solution was cooled to 0 °C 
and PBr3 (0.35 equiv) was added dropwise. The reaction mixture was stirred for 2 h at 0 °C, and 
then concentrated in vacuo. The flask was fitted with a short path distillation head and the residue 
was distilled under vacuum to afford the tertiary bromide as a clear, colorless oil. 
 
A 250 mL round bottom flask equipped with a magnetic stirbar was charged with ZnCl2 (0.1 equiv) 
and the tertiary bromide (1 equiv) and dissolved in anhydrous CH2Cl2 (0.5 M). This solution was 
cooled to –40 °C and the dialkylzinc reagent (1.0 equiv) was added dropwise via syringe. The 
reaction mixture was stirred with warming to ambient temperature for 12 h, and then quenched by 
the dropwise addition of MeOH. The reaction mixture was washed with 1 M HCl, the organic layer 
was separated, washed with brine, dried over MgSO4, and concentrated in vacuo. The product was 
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5-ethyl-5-methylnona-1,8-diene (32): Prepared according to general procedure B from ketone 23 
(5.86 g, 42.5 mmol) and Et2Zn to afford 32 as a clear, colorless oil (4.3 g, 61% yield). 
 
1H NMR (600 MHz, CDCl3) δ 5.79 (ddt, J = 16.9, 10.1, 6.6 Hz, 2H), 4.97 (dt, J = 17.0, 1.8 Hz, 
2H), 4.92 – 4.86 (m, 2H), 1.96 – 1.88 (m, 4H), 1.27 – 1.18 (overlapping m, 6H), 0.79 (s, 3H), 
0.76 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 139.8, 113.7, 38.1, 34.9, 31.4, 28.1, 24.4, 7.9. 
HRMS (EI+) calc’d for C12H22 [M]+• 166.1722; found 166.1700. 
 




In a nitrogen-filled glovebox, monomer 30 (320 mg, 1 mmol) in 0.5 mL CH2Cl2 was transferred 
into a 50 mL Schlenk flask equipped with a stir bar, followed by Grubbs 2nd Generation Catalyst 
(4.2 mg, 0.5 mol%) in 0.5 mL CH2Cl2. The Schlenk tube was sealed and removed from the 
glovebox and placed under static vacuum after one freeze-pump-thaw cycle. Then the Schlenk 
flask was placed in to a 60 ºC oil bath for 12 hours. The valve was opened to dynamic vacuum and 
stirring was continued for 2 hours until the mixture turned viscous and became difficult to stir.  
1. G2 (0.5 mol%)
    CH2Cl2, static vacuum, 60 ºC
2. 












x = 2, 24
x = 4, 27
x = 7, 21








x = 2, poly-24a
x = 4, poly-27a
x = 7, poly-21a
x = 8, poly-30a
x = 2, poly-24a
x = 4, poly-27a
x = 7, poly-21a
x = 8, poly-30a
x = 2, poly-24b
x = 4, poly-27b
x = 7, poly-21b
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The Schlenk tube was sealed and taken into the glovebox where the CTA 38 (20.6 mg, 0.05 mmol, 
20:1 monomer: CTA ratio) in 2 mL toluene was added. The Schlenk tube was removed from the 
glovebox and the side arm was flame dried under vacuum and backfilled three times with argon. 
Then the Schlenk tube was opened to the argon line and placed in a 60 °C oil bath for 72 h.  The 
reaction mixture was transferred into a flame-dried round bottom flask and the solvent was 
removed under reduced pressure to obtain crude polymer poly-30a.  
 
1H NMR (500 MHz, CDCl3) δ 7.47 – 7.14 (m, 5H), 5.47 – 5.32 (m, 11H), 5.16 (s, 1H), 4.21 – 
4.10 (m, 1H), 2.08 – 1.91 (m, 21H), 1.46 – 1.06 (m, 131H), 0.82 (s, 29H). 1H NMR determined n 
= 22, Mn = 6800. GPC data: Mn = 5400; PDI (Mw/Mn) = 1.2. 
 
The crude polymer poly-30a was dissolved in toluene (10 mL) and 10% palladium on carbon (100 
mg, 0.1 equiv) was added in a round-bottom flask with a stir bar.  The flask was sealed with a 
septum and back-filled with argon for three times, and then back-filled with H2 using a balloon.  
The reaction was allowed to stir at 23 °C for 24 hours under an atmosphere of hydrogen (1 atm H2 
balloon).  After that time the reaction mixture was filtered through a short pad of Celite (caution: 
Palladium on carbon is highly flammable and the palladium waste must be collected separately 
and covered with water).  The filtered solution was concentrated upon heating under high vacuum 
to obtain the hydroxyl telechelic polymer poly-30b (286 mg, 97% yield).  1H NMR (500 MHz, 
CDCl3) δ 3.65 (t, J = 6.6 Hz, 1H), 1.39 – 1.10 (m, 210H), 0.82 (s, 32H). 1H NMR determined n = 





Table 3.5.1. Summary of Telechelic Polymer Samples Prepared. 
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poly-21b 10:1 95 15 4200 
poly-24b 22:1 55 16 2200 
poly-27b 12:1 99 10 2000 
poly-30b-1 8:1 99 10 3100 
poly-30b-2 20:1 97 21 6300 
poly-30b-3 50:1 96 58 17200 
poly-30b-4 100:1 89 97 28700 
poly-32b 22:1 56 22 3200 
poly-34b 20:1 95 19 6800 
 
 
Telechelic polymer poly-21b: 1H NMR (400 MHz, CDCl3) δ 3.57 (t, J = 6.6 Hz, 1H), 1.62 – 
1.48 (m, 7H), 1.32 – 1.00 (m, 122H), 0.74 (s, 22H). 1H NMR determined n = 15, Mn = 4200. 
GPC data: Mn =2800; PDI (Mw/Mn) = 1.44.	
 
 
Telechelic polymer poly-24b: 1H NMR (600 MHz, CDCl3) δ 3.63 (t, J = 6.7 Hz, 1H), 1.59 – 
1.52 (m, 1H), 1.36 – 1.04 (m, 46H), 0.80 (s, 20H).1H NMR determined n = 16, Mn = 2200. GPC 
data: Mn =4000; PDI (Mw/Mn) = 1.4.	
 
 
Telechelic polymer poly-27b: 1H NMR (500 MHz, CDCl3) δ 3.65 (t, J = 6.6 Hz, 1H), 1.43 – 
1.09 (m, 58H), 0.82 (s, 13H).1H NMR determined n = 10, Mn = 2000. GPC data: Mn = 3800; PDI 
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poly-30b-1: 1H NMR (500 MHz, CDCl3) δ 3.65 (dt, J = 6.5, 4.8 Hz, 1H), 1.41 – 1.17 (m, 94H), 
0.82 (s, 15H). 1H NMR determined n = 10, Mn = 3100. 
 
poly-30b-2: 1H NMR (500 MHz, CDCl3) δ 3.65 (t, J = 6.6 Hz, 1H), 1.34 – 1.11 (m, 208H), 0.82 
(s, 32H). 1H NMR determined n = 21, Mn = 6300. 
poly-30b-3: 1H NMR (500 MHz, CDCl3) δ 3.65 (dt, J = 6.7, 5.6 Hz, 1H), 1.32 – 1.12 (m, 571H), 
0.82 (s, 88H). 1H NMR determined n = 58, Mn = 17200. 
 
poly-30b-4: 1H NMR (500 MHz, CDCl3) δ 3.65 (dt, J = 6.6, 5.5 Hz, 1H), 1.35 – 1.11 (m, 943H), 
0.82 (s, 146H). 1H NMR determined n = 97, Mn = 28700. 
 
 
Telechelic polymer poly-32b: 1H NMR (600 MHz, CDCl3) δ 3.63 (t, J = 6.7 Hz, 1H), 1.55 (q, J 
= 6.9 Hz, 2H), 1.38 – 1.05 (m, 83H), 0.78 – 0.68 (m, 34H). 1H NMR determined n = 22, Mn = 
3200. GPC data: Mn =6800; PDI (Mw/Mn) = 1.1.	
 
 
poly-34b: 1H NMR (500 MHz, CDCl3) δ 3.65 (q, J = 6.4 Hz, 1H), 1.34 – 1.19 (m, 265H), 1.14 – 
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5,5-dimethylcyclohept-1-ene (37): After the polymerization of 24, the cyclic olefin was 
removed by vacuum distillation from the reaction mixture (23 °C, 100 mTorr). 
 
1H NMR (400 MHz, CDCl3) δ 5.60 (ddd, J = 3.8, 2.9, 0.8 Hz, 2H), 2.06 – 1.94 (m, 4H), 1.40 – 
1.32 (m, 4H), 0.87 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ 131.5, 40.3, 33.7, 29.3, 24.4. 
HRMS (EI+, m/z) calc’d for C9H16 [M]+• 124.1252, found: 124.1264. 
 
 
5-ethyl-5-methylcyclohept-1-ene (39): After the polymerization of 32, the cyclic olefin was 
removed by vacuum distillation from the reaction mixture (23 °C, 100 mTorr). 
1H NMR (600 MHz, CDCl3) δ 5.63 (t, J = 3.2 Hz, 2H), 2.09 – 2.01 (m, 4H), 1.49 – 1.33 (m, 4H), 
1.29 (q, J = 7.5 Hz, 2H), 0.83 (s, 3H), 0.80 (t, J = 7.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 131.4, 38.3, 35.9, 33.6, 25.2, 24.1, 8.1. 
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Mn = 2200 DaMn = 4200 Da Mn = 2000 Da
Mn = 17200 DaMn = 6300 DaMn = 3100 Da
Mn = 28700 Da Mn = 3200 Da Mn = 6800 Da
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 1H–1H COSY NMR (400 MHz, CDCl3) of compound 12. 
  
1H–13C HSQC NMR (400 MHz, CDCl3) of compound 12. 
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 1H–1H COSY NMR (400 MHz, CDCl3) of compound 16. 
  
1H–13C HSQC NMR (400 MHz, CDCl3) of compound 16. 
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